0001213900-21-061727.txt : 20211124 0001213900-21-061727.hdr.sgml : 20211124 20211123214455 ACCESSION NUMBER: 0001213900-21-061727 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 58 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211124 DATE AS OF CHANGE: 20211123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Embark Technology, Inc. CENTRAL INDEX KEY: 0001827980 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 853343695 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39881 FILM NUMBER: 211441027 BUSINESS ADDRESS: STREET 1: 424 TOWNSEND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 671-9628 MAIL ADDRESS: STREET 1: 424 TOWNSEND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: Northern Genesis Acquisition Corp. II DATE OF NAME CHANGE: 20201009 10-Q/A 1 f10q0921a1_embarktech.htm AMENDMENT NO.1 TO FORM 10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

 

(MARK ONE)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended September 30, 2021

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                    to                       

 

Commission file number: 001-39881

 

EMBARK TECHNOLOGY, INC.

(Exact Name of Registrant as Specified in Its Charter) 

 

Delaware  

86-3343965

(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

424 Townsend Street

San Francisco, CA  

(Address of principal executive offices)

 

(415) 671-9628

(Issuer’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A common Stock, par value $0.0001 per share   EMBK   The Nasdaq Stock Market LLC
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share   EMBKW   The Nasdaq Stock Market LLC

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer   Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No ☐

 

As of November 9, 2021, there were 51,750,000 shares of common stock, $0.0001 par value issued and outstanding.

 

 

 

 

 

EXPLANATORY NOTE

 

Embark Technology, Inc., formerly known as Northern Genesis Acquisition Corp. II (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on this Form 10-Q/A for the three and nine month period ended September 30, 2021 (the “First Amendment”), as originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 10, 2021 (the “Original Form 10-Q”) to amend and restate the Company’s September 30, 2021 Quarterly Report on Form 10-Q, as further described below.

 

This amended and restated report on Form 10-Q/A is presented as of the filing date of the Original Form 10-Q and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the restatement as described below. Accordingly, this Amendment No. 1 on Form 10-Q/A should be read in conjunction with our filings with the SEC subsequent to the date on which we filed the Original Form 10-Q.

 

The Company is filing this First Amendment on Form 10-Q/A to reflect a restatement of the Company’s condensed financial statements as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021 to correct errors in the Company’s classification of public shares as permanent equity as further described below.

 

On November 10, 2021, subsequent to the fiscal quarter ended September 30, 2021, Northern Genesis Acquisition Corp. II, our predecessor and a Delaware corporation (“NGA”), consummated the previously announced business combination pursuant to the agreement and plan of merger, dated as of June 22, 2021 (the “Merger Agreement”), by and among NGA, NGAB Merger Sub Inc., a Delaware corporation (“Merger Sub”), and Embark Trucks Inc., a Delaware corporation (“Embark Trucks”).Pursuant to the Merger Agreement, NGA acquired Embark Trucks, by way of Merger Sub merging with and into Embark Trucks, with Embark Trucks becoming a direct subsidiary of NGA as a result thereof (the “Business Combination”).

 

On November 9, 2021, NGA held a special meeting of stockholders (the “Special Meeting”), at which the NGA stockholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Merger Agreement and (b) approving the other transactions contemplated by the Merger Agreement and related agreements described in the proxy statement/prospectus related thereto.

 

Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, on November 10, 2021 (the “Closing Date”), the Business Combination was consummated (the “Closing”).

 

On November 11, 2021, the business day following the Closing Date, the Company’s Class A common stock and warrants began trading on Nasdaq under the symbols “EMBK” and “EMBKW”. NGA’s public units automatically separated into their component securities upon consummation of the Business Combination and, as a result, no longer trade as a separate security and were delisted from the New York Stock Exchange.

 

Unless stated otherwise, this report contains information about NGA before the consummation of the Business Combination. References to the “Company” in this report refer to NGA before the consummation of the Business Combination.

 

Background of Restatement

 

In the Company’s previously issued financial statements as of January 15, 2021 and March 31, 2021, a portion of the public shares were classified as permanent equity to maintain stockholders’ equity greater than $5,000,000 on the basis that the Company could consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001 under the Company’s charter. Thus, the Company can only complete a merger and continue to exist as a public company if there are sufficient public shares that do not redeem at the merger and so it was deemed appropriate to classify the portion of its public shares required to keep its stockholders’ equity above the $5,000,000 threshold as “shares not subject to redemption.”

 

 

 

 

However, in light of recent comment letters issued by the Securities & Exchange Commission (“SEC”) to several special purpose acquisition companies, management re-evaluated the Company’s application of ASC 480-10-99 to its accounting classification of public shares. Upon re-evaluation, management determined that the public shares include certain provisions that require classification of the public shares as temporary equity regardless of the minimum net tangible asset required by the Company to complete its initial business combination.

 

The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate all of the Company’s previously issued financial statements to report all public shares as temporary equity as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021.

 

This First Amendment on Form 10-Q/A sets forth the Original Form 10-Q in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Form 10-Q have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-Q, and such forward-looking statements should be read in their historical context.

 

The following items have been amended as a result of the restatement:

 

Part I, Item 1, “Financial Statements” and

 

Part I, Item 4, “Controls and Procedures.”

 

In accordance with applicable SEC rules, this First Amendment on Form 10-Q/A includes an updated signature page and certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15.

 

Refer to Note 2, Restatement of Previously Issued Financial Statements of this Form 10-Q/A for additional information and for the summary of the accounting impacts of these adjustments to the Company’s condensed financial statements as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021.

  

The Company previously identified a material weakness in internal controls related to the accounting for warrants issued in connection with our initial public offering. As a result of the restatement described in this First Amendment on Form 10-Q/A, the Company has concluded there was a material weakness in the Company's internal control over financial reporting at the time the abovementioned financial statements were issued, and its disclosure controls and procedures were not effective at the time the abovementioned financial statements were issued.

 

 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

 

FORM 10-Q/A FOR THE QUARTER ENDED SEPTEMBER 30, 2021

 

TABLE OF CONTENTS

 

  Page
Part I. Financial Information  
Item 1. Interim Financial Statements  
  Condensed Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020 1
  Condensed Consolidated Statements of operations for the three and nine months ended September 30, 2021 (Unaudited) and for the period from September 25, 2020 (inception) through September 30, 2020 2
  Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2021 (Unaudited) and for the period from September 25, 2020 (inception) through September 30, 2020 3
  Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2021 (Unaudited) and for the period from September 25, 2020 (inception) through September 30, 2020 4
  Notes to Condensed Consolidated Financial Statements (Unaudited) 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk 27
Item 4. Controls and Procedures 27
Part II. Other Information  
Item 1. Legal Proceedings 28
Item 1A. Risk Factors 28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
Item 3. Defaults Upon Senior Securities 28
Item 4. Mine Safety Disclosures 28
Item 5. Other Information 28
Item 6. Exhibits 29
Part III. Signatures 30

 

i 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Interim Financial Statements.

 

NORTHERN GENESIS ACQUISITION CORP. II

CONDENSED CONSOLIDATED BALANCE SHEETS

  

  

September 30,

2021

   December 31,
2020
 
   (Unaudited)     
ASSETS        
Current assets        
Cash  $34,688   $
 
Prepaid expenses and other current assets   116,653    
 
Total Current Assets   151,341    
 
           
Deferred offering costs   
    249,917 
Marketable securities held in Trust Account   414,028,694    
 
TOTAL ASSETS  $414,180,035   $249,917 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accrued expenses  $1,091,604   $1,450 
Accrued offering costs   
    107,000 
Promissory note – related party   750,000    117,917 
Total Current Liabilities   1,841,604    226,367 
           
FPA liability   713,334    
 
Warrant liability   22,255,067    
 
Deferred underwriting fee payable   14,490,000    
 
Total Liabilities   39,300,005    226,367 
           
Commitments   
 
    
 
 
           
Common stock subject to possible redemption 41,400,000 and 0 shares at redemption value at September 30, 2021 and December 31, 2020, respectively   414,000,000     
           
Stockholders’ Equity          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding   
    
 
Common stock, $0.0001 par value; 100,000,000 shares authorized; 10,350,000 at September 30, 2021 and December 31, 2020   1,035    1,035 
Additional paid-in capital   
    23,965 
Accumulated deficit   (39,121,005)   (1,450)
Total Stockholders’ Equity (Deficit)   (39,119,970)   23,550 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $414,180,035   $249,917 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

1 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

  

Three Months

Ended

September 30,

  

For the
Period from
September 25,
2020
(Inception)
through

September 30,

  

Nine Months
Ended

September 30,

 
   2021   2020   2021 
             
Operating and formation costs  $1,554,197   $1,000   $3,016,548 
Loss from operations   (1,554,197)   (1,000)   (3,016,548)
                
Other income (loss):               
Change in fair value of warrant liability   12,701,734    
    8,328,400 
Change in fair value of FPA liability   393,333    
    253,333 
Loss on initial issuance of private warrants   
    
    (267,467)
Offering costs allocated to warrant and FPA liabilities   
    
    (1,148,289)
Interest earned on marketable securities held in Trust Account   5,328    
    28,694 
Total other income, net   13,100,395    
    7,194,671 
                
Net income (loss)  $11,546,198   $(1,000)  $4,178,123 
                
Basic and diluted weighted average shares outstanding, redeemable common stock subject to possible redemption   41,400,000        39,125,275 
Basic and diluted net income (loss) per share, redeemable common stock  $0.22   $   $0.08 
Basic and diluted weighted average shares outstanding, non-redeemable common stock subject to possible redemption   10,350,000    10,350,000    10,275,824 
Basic and diluted net income (loss) per shares, non-redeemable common stock  $0.22   $0.00   $0.08 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

2 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021

 

   Common Stock   Additional
Paid-In
   Retained Earnings /
(Accumulated
   Total
Stockholders’
Equity
 
   Shares   Amount   Capital   Deficit)   (Deficit) 
Balance — January 1, 2021   10,350,000   $1,035   $23,965   $(1,450)  $23,550 
                          
Accretion for common stock subject to redemption amount       
    (23,965)   (42,335,161)   (42,359,126)
                          
Net Income       
    
    4,880,183    4,880,183 
Balance – March 31, 2021   10,350,000   $1,035   $
   $(37,456,428)  $(37,455,393)
                          
Initial classification of FPA liability       
    
    (966,667)   (966,667)
                          
Net Loss       
    
    (12,244,108)   (12,244,108)
Balance – June 30, 2021   10,350,000   $1,035   $
   $(50,667,203)  $(50,666,168)
                          
Net Income       
    
    11,546,198    11,546,198 
Balance – September 30, 2021   10,350,000   $1,035   $
   $(39,121,005)  $(39,119,970)

 

FOR THE PERIOD FROM SEPTEMBER 25, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020

 

   Common Stock   Additional
Paid-in
   Accumulated    Total
Stockholders’
 
 
   Shares    Amount   Capital   Deficit    Equity   
Balance—September 25, 2020 (inception)   
   $
   $
   $
   $
         — 
 
Issuance of common stock to Sponsor    10,350,000    1,035    23,965    
    25,000 
Net loss        
    
    (1,000)   (1,000)
Balance—September 30, 2020   10,350,000   $1,035   $23,965   $(1,000)  $24,000 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

3 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(UNAUDITED)

 

   Nine Months
Ended
September 30,
   For the period from September 25, 2020 (inception) through September 30, 
   2021   2020 
         
Cash Flows from Operating Activities:           
Net income (loss)  $4,182,273   $(1,000)
Adjustments to reconcile net income to net cash used in operating activities:           
Interest earned on marketable securities held in Trust Account    (28,694)   
-
 
Changes in fair value of warrant liability    (8,328,400)   
-
 
Change in fair value of FPA liability    (253,333)   
-
 
Loss on initial issuance of private warrants    267,467    
-
 
Offering costs allocable to warrant liabilities    1,148,289    
-
 
Changes in operating assets and liabilities:           
Prepaid expenses and other current assets    (116,653)   
-
 
Accrued expenses    1,090,154    1,000 
Net cash used in operating activities    (2,038,897)   
-
 
           
Cash Flows from Investing Activities:           
Investment of cash in Trust Account    (414,000,000)   
-
 
Net cash used in investing activities    (414,000,000)   
-
 
           
Cash Flows from Financing Activities:           
Proceeds from sale of Units, net of underwriting discounts paid    405,720,000    
-
 
Proceeds from sale of Private Placement Warrants    10,030,000    
-
 
Proceeds from promissory note - related party    750,000    5,000 
Repayment of promissory note – related party    (117,917)   
-
 
Payment of offering costs    (308,498)   (5,000)
Net cash provided by financing activities    416,073,585    
-
 
           
Net Change in Cash    34,688    
-
 
Cash – Beginning of period    
    
-
 
Cash – End of period   $34,688   $
-
 
           
Non-Cash investing and financing activities:           
Initial classification of common stock subject to possible redemption   $414,000,000   $
-
 
Initial Classification of Warrant Liabilities   $30,583,467   $
-
 
Deferred underwriting fee payable   $14,490,000   $
-
 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements. 

 

4 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Northern Genesis Acquisition Corp. II (the “Company”) was incorporated in Delaware on September 25, 2020. The Company is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to initially concentrate on target businesses making a positive contribution to sustainability through the ownership, financing and management of societal infrastructure.

 

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

The Company has a wholly owned subsidiary NGAB Merger Sub Inc., which was incorporated in Delaware on June 21, 2021 (“Merger Sub”).

 

As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

 

The registration statement for the Company’s Initial Public Offering was declared effective on January 12, 2021. On January 15, 2021, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares, which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000, which is described in Note 3.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,686,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Company’s sponsor, Northern Genesis Sponsor II LLC (the “Sponsor”), generating gross proceeds of $10,030,000, which is described in Note 4.

 

Transaction costs amounted to $23,221,415 consisting of $8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $451,415 of other offering costs.

 

Following the closing of the Initial Public Offering on January 15, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.

 

5 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company intends to only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully complete a Business Combination.

 

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

 

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, if a majority of the then outstanding shares of common stock present and entitled to vote at the meeting to approve the business combination (or such greater number as may be required by applicable law or the rules of any applicable national securities exchange) are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

 

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

 

The Sponsor and the Company’s officers, directors and director nominees will agree (a) to waive redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination and certain amendments to the Amended and Restated Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provisions that specifically apply only to the period prior to the consummation of our initial business combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment (See Note 7).

 

The Company will have until January 15, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

 

6 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

The holders of the Founder Shares will agree to waive liquidation rights with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

 

In order to protect the amounts held in the Trust Account, the Sponsor will agree to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Capital Resources

 

As of September 30, 2021, the Company had $34,688 in its operating bank accounts, $414,028,694 in marketable securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem stock in connection therewith and working capital deficit of ($1,544,413), which excludes franchise taxes payable of $150,000, of which such amount will be paid from interest earned on the Trust Account and $28,694 of franchise taxes paid and not yet reimbursed from the trust.

 

The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may but are not obligated to (except as described above), loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing, the Company believes it will have sufficient cash to meet its needs through the earlier of consummation of a Business Combination or January 15, 2023, the deadline to complete a Business Combination pursuant to the Company’s Amended and Restated Certificate of Incorporation (unless otherwise amended by stockholders).

 

NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

In connection with the preparation of the Company’s financial statements as of September 30, 2021 in its Original Form 10-Q, the Company concluded it should restate its financial statements to classify all Public Shares in temporary equity. In accordance with ASC 480, paragraph 10-S99, redemption provisions not solely within the control of the Company require common stock subject to possible redemption to be classified outside of permanent equity. The Company previously determined the common stock subject to possible redemption to be equal to the redemption value of $10.00 per share of common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. Accordingly, effective with this filing, the Company presents all redeemable common stock as temporary equity. Additionally, the Company in its Original Form 10-Q referred to these adjustments as a ‘revision’, however, these adjustments should have been identified as a ‘restatement’ of the previously issued financial statements.

 

As a result, management has noted a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and common stock.

 

7 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

The impact of the restatement on the Company’s financial statements is reflected in the following table:

 

   As Previously
Reported
   Adjustment   As Restated 
Balance Sheet as of January 15, 2021            
Common stock subject to redemption  $365,248,533   $48,751,367   $414,000,000 
Common stock shares  $1,523   $(488)  $1,035 
Additional paid-in capital  $6,415,718   $(6,415,718)  $ 
Accumulated deficit  $(1,417,236)  $(42,335,161)  $(43,752,397)
Total Stockholders’ Equity (Deficit)  $5,000,005   $(48,751,367)  $(43,751,362)
                
Balance Sheet as of March 31, 2021               
Common stock subject to possible redemption  $371,544,602   $42,455,398   $414,000,000 
Common stock shares  $1,460   $(425)  $1,035 
Additional paid-in capital  $119,812   $(119,812)  $ 
Retained Earnings (Accumulated deficit)  $4,878,733   $(42,335,161)  $(37,456,428)
Total Stockholders’ Equity (Deficit)  $5,000,005   $(42,455,398)  $(37,455,393)
                
Statement of Cash Flows for the Three Months Ended March 31, 2021    As Previously Reported    Adjustment    As Restated 
Initial classification of common stock subject to possible redemption  $365,248,633   $48,751,367   $414,000,000 
Change in value of common stock subject to possible redemption  $6,295,969   $(6,295,969)  $ 
                
Statement of Cash Flows for the Six Months Ended June 30, 2021               
Initial classification of common stock subject to possible redemption  $365,248,633   $48,751,367   $414,000,000 
Change in value of common stock subject to possible redemption  $48,751,367   $(48,751,367)  $ 
                
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) March 31, 2021   As Previously Reported    Adjustment    As Restated 
Sale of 41,400,000 Units, net of underwriting discounts  $371,629,911   $(371,629,911)  $ 
Initial value of common stock subject to possible redemption at IPO date   (365,248,633)   365,248,633     
Change in value of common stock subject to redemption   6,295,969    (6,295,969)    
Accretion for common stock to redemption amount       (42,359,126)   (42,359,126)
Total stockholders’ equity (deficit)   5,000,005    (42,455,398)   (37,455,393)
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) June 30, 2021               
Change in value of common stock subject to redemption  $42,455,398   $(42,455,398)  $ 
Total stockholders’ equity   (50,666,168)       (50,666,168)

 

In connection with the change in presentation for common stock subject to redemption, the Company also restated its income (loss) per share. The impact of this restatement on the Company’s financial statements is reflected in the following table:

  

   

Basic and diluted

weighted average shares outstanding, Class A common stock subject to possible redemption

 

    Basic and diluted net loss per share, Class A common stock     Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption     Basic and diluted net loss per share, Class B common stock  
For the three months ended, March 31, 2021                        
As Previously Reported     36,524,863     $
      14,187,614     $ 0.34  
As Restated     34,500,000     $ 0.11       10,125,000     $ 0.11  
For the three months ended, June 30, 2021                                
As Previously Reported     37,153,752     $
      14,596,248     $ (0.84 )
As Restated     41,400,000     $ (0.24 )     10,350,000     $ (0.24 )
For the six months ended, June 30, 2021                                
As Previously Reported     61,945,851     $
      14,393,060     $ (0.51 )
As Restated     37,969,061     $ (0.15 )     10,238,122     $ (0.15 )
For the three months ended, September 30, 2021                                
As Previously Reported     51,750,000     $ 0.22      
    $
 
As Restated     41,400,000     $ 0.22       10,350,000     $ 0.22  
For the nine months ended, September 30, 2021                                
As Previously Reported     48,906,593     $ 0.09      
    $
 
As Restated     39,125,275     $ 0.08       10,275,824     $ 0.08  

 

8 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form10-K as filed with the SEC on April 15, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods.

 

Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Risks and Uncertainties

 

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Initial Public Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

9 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.

  

Marketable Securities Held in Trust Account

 

At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

 

Warrant and FPA Liabilities

 

The Company accounts for the Warrants and forward purchase warrants (as defined in Note 7) in accordance with the guidance contained in ASC 815-40, under which the Warrants and forward purchase warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants and forward purchase warrants as liabilities at their fair value and adjust the Warrants and forward purchase warrants to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statement of operations. The fair value of the Public Warrants were initially estimated using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Warrants as of each relevant date. The Private Placement Warrants and forward purchase warrants are valued using a Modified Black Scholes Option Pricing Model.

 

Common Stock Subject to Possible Redemption

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 41,400,000 shares of common stock subject to possible redemption at September 30, 2021 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s condensed consolidated balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

 

At September 30, 2021 and December 31, 2020, the Class A common stock reflected in the condensed consolidated balance sheets are reconciled in the following table:

 

Gross proceeds  $414,000,000 
Less:     
Proceeds allocated to Public Warrants  $(20,286,000)
Class A common stock issuance costs  $(22,073,126)
Plus:     
Accretion of carrying value to redemption value  $42,359,126 
Class A common stock subject to possible redemption  $414,000,000 

 

10 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2021, due to the valuation allowance recorded on the Company’s net operating losses and permanent differences.

 

Net income (loss) per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value.

 

The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,486,667 shares in the calculation of diluted loss per share, since the average stock price of the Company’s common stock for the three and nine months ended September 30, 2021 was less than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive.

 

11 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

 

   Three Months Ended
September 30, 2021
   Nine Months Ended
September 30, 2021
   For the Period from September 25, 2020 (Inception) Through
September 30, 2020
 
   Redeemable   Non-redeemable   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
Basic and diluted net income (loss) per common share                        
Numerator:                        
Allocation of net income (loss), as adjusted  $9,233,638   $2,308,410   $3,309,040   $869,083   $
   $(1,000)
Denominator:                              
Basic and diluted weighted average shares outstanding   41,400,000    10,350,000    39,125,275    10,275,824    
    10,350,000 
                               
Basic and diluted net income (loss) per common share  $0.22   $0.22   $0.08   $0.08   $
   $(0.00)

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 10).

  

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
     
  Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
     
  Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

12 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Recent Accounting Standards

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

 

NOTE 4. PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 5,400,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one-third of one redeemable warrant redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). 

 

NOTE 5. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,686,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $10,030,000, from the Company in a private placement. Each Private Placement Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the Private Placement Warrants were deposited into the Company’s operating account, $8,280,000 of which was used to pay deferred underwriting fees and $1,080,000 was due to the Sponsor for working capital and $670,000 was maintained in the operating account to be used towards working capital purposes. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

 

13 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

  

NOTE 6. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On October 2, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 8,625,000 shares of the Company’s common stock (the “Founder Shares”). On January 12, 2021, the Company effected a stock dividend of 0.2 shares for each founder share outstanding, resulting in 10,350,000 shares of common stock outstanding. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, a total of 1,350,000 Founder Shares are no longer subject to forfeiture.

 

The Sponsor will agree, subject to limited exceptions, not to transfer title to any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. 

 

Administrative Services Agreement

 

The Company entered into an agreement, commencing on January 12, 2021, pursuant to which the Company will pay an affiliate of the Sponsor a total of up to $10,000 per month for office space, utilities, secretarial support and administrative services. For the three and nine months ended September 30, 2021, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 is included in accrued expenses in the accompanying balance sheet. For the period from September 25, 2020 (inception) through September 30, 2020, the Company did not incur any fees for these services. 

 

Due from Sponsor

 

At the closing of the Initial Public Offering on January 15, 2021, a portion of the proceeds from the sale of the Private Placement Warrants in the amount of $1,080,000 was due to the Company to be held outside of the Trust Account for working capital purposes. Such amount was paid by the Sponsor to the Company on January 18, 2021.

 

Promissory Note — Related Party

 

On September 25, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $150,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii.) the consummation of the Initial Public Offering or (iii) the abandonment of the Initial Public Offering. As of September 30, 2021 and December 31, 2020, there was $0 and $117,917, respectively, outstanding under the Promissory Note.

 

On August 12, 2021 the sponsor committed to provide up to $1,000,000 in working capital loans as needed by the Company in order to finance transaction costs in connection with a Business Combination. The loans, if issued, will be non-interest bearing, unsecured and will be repaid upon the consummation of an initial business combination. If the Company does not consummate an initial business combination, all amounts loaned to the Company will be forgiven except to the extent that we have funds available outside of the Trust Account to repay such loans. As of September 30, 2021 there was $750,000 of working capital loans outstanding. On September 30, 2021 the sponsor committed to provide up to an additional $2,000,000 in working capital loans as needed by the Company in order to finance transaction costs in connection with a Business Combination. The loans will follow the same structure as the $1,000,000 working capital loans as described above. This borrowing is in addition to the above note initiated on August 12, 2021. The total commitment provided by the Sponsor will total $3,000,000, where $750,000 of which has been borrowed as of September 30, 2021.

 

Personnel Services Agreement

 

The Company entered into a Personnel Services Agreement, dated April 1, 2021, with the Sponsor pursuant to which, subject to maintaining funds adequate for our projected obligations, the Company expects to pay up to $2,000,000 in the aggregate in respect of the services of personnel affiliated with the Sponsor, including persons who may be directors or officers of the Company, for activities on the Company’s behalf, including services related to identifying, investigating and completing an initial business combination and other operational and support services. To the extent any amounts are in respect of the services of individuals who also serve as directors or executive officers of the Company, such amounts will be reviewed and approved by its audit committee. For the nine months ended September 30, 2021, the Company incurred $680,000, inclusive of $200,000 in initial payment of the agreement and $80,000 for each month within the second and third quarter for these services, of which $80,000 is included in accounts payable in the accompanying balance sheets.

 

The Sponsor, the Company’s officers, and directors or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf. For the three and nine months ended September 30, 2021, there were no amounts relating to the above arrangement recorded.

 

14 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

  

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers, directors and director nominees or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of the notes may be converted into warrants at a price of $1.50 per warrant (“Working Capital Warrants”). Such Working Capital Warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. 

 

NOTE 7. COMMITMENTS 

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on January 12, 2021, the holders of the Founder Shares, Private Placement Warrants and any Working Capital Warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or Working Capital Warrants) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to four demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The agreement was amended as described below under “–Forward Purchase Agreement” to add the forward purchase securities.

   

Underwriting Agreement

 

The underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or $14,490,000. The deferred fee will be payable in cash to the underwriters solely in the event that the Company completes a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

 

Forward Purchase Agreement

 

On January 8, 2021. the Company entered into the forward purchase agreement (the “Forward Purchase Agreement”) with Northern Genesis Capital LLC (the “forward purchase investor”), pursuant to which, if the Company determines to raise capital by issuing equity securities in connection with the closing of its initial business combination, the forward purchase investor, an entity which is affiliated with the Company’s Sponsor, agreed and has the first right to purchase, subject to certain conditions, in an aggregate maximum amount of $75,000,000 of either (i) a number of units (the “forward purchase units”), consisting of one share of Class A common stock (the “forward purchase shares”) and one-sixth of one redeemable warrant (the “forward purchase warrants”), for $10.00 per unit or (ii) a number of forward purchase shares for $9.75 per share (such forward purchase shares valued at $9.75 per share or the forward purchase units, as the case may be, the “forward purchase securities”), in a private placement that would close simultaneously with the closing of the Initial Business Combination. The forward purchase warrants would have the same terms as the Public Warrants and the forward purchase shares would be identical to the shares of common stock included in the Units sold in the Initial Public Offering, except the forward purchase shares and the forward purchase warrants would be subject to transfer restrictions and certain registration rights. The funds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination and for expenses in connection with an initial Business Combination, and any excess funds may be used for the working capital needs of the post-transaction company.

 

The forward purchase transaction is not dependent upon or affected by the percentage of stockholders electing to redeem their Public Shares and may provide the Company with an increased minimum funding level for the initial Business Combination. The forward purchase transaction is subject to conditions, including the forward purchase investor giving the Company its irrevocable written confirmation, confirming its commitment to purchase forward purchase securities and the amount thereof, no later than fifteen days after the Company notifies it of the Company’s intention to raise capital through the issuance of equity securities in connection with the closing of an initial Business Combination. The forward purchase investor may grant or withhold its consent and confirmation entirely within its sole discretion. Accordingly, if the forward purchase investor does not consent to and confirm the purchase, it will not be obligated to purchase any of the forward purchase securities.

 

On April 21, 2021, the Company entered into an Amended and Restated Forward Purchase Agreement with Northern Genesis Capital II LLC (formerly known as Northern Genesis Capital LLC) (“NGC”) (the “NGC Forward Purchase Agreement”), and certain additional forward purchase agreements with additional institutional investors (collectively, with the NGC Forward Purchase Agreement, the “Forward Purchase Agreements”). The Forward Purchase Agreements collectively replace that certain Forward Purchase Agreement previously entered into by the Company and NGC in connection with the closing of the Company’s initial public offering (the “Original Agreement”).

 

15 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

Pursuant to the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of its initial business combination (subject to certain limited exceptions), the members of NGC (institutional investors that also are members of the Company’s Sponsor,) and the parties to the additional Forward Purchase Agreements have the first right to purchase an aggregate amount of up to 7,500,000 “forward purchase units” of the Company (under all Forward Purchase Agreements, taken together) for $10.00 per forward purchase unit, or an aggregate total of $75,000,000. Each forward purchase unit would consist of one share of the Company’s common stock and one-sixth of one warrant, with each whole warrant exercisable to purchase one share of the Company’s common stock at $11.50 per share. The common stock and warrants included in the forward purchase units would have the same terms as the Company’s publicly traded common stock and warrants but would not be freely tradable until registered. As with the Original Agreement, any commitment by any potential purchaser under any of the Forward Purchase Agreements is subject to and conditioned upon written confirmation from the prospective purchaser, following the Company’s notification to such purchaser of its intention to enter into an initial business combination agreement, which a prospective purchaser was grant or withhold in its sole discretion.

 

In addition, if a private placement of equity securities in connection with the Company’s initial business combination exceeds $75,000,000, the Company agreed under each Forward Purchase Agreement to use its commercially reasonable efforts to permit priority participation in such additional amount by the members of NGC and the parties to the additional Forward Purchase Agreements, in an aggregate additional amount up to $150,000,000, on the same terms as those offered to other prospective purchasers in connection with such additional private placement amount.

 

Each Forward Purchase Agreement that the holders of the shares of common stock and warrants included in the forward purchase units will be entitled to registration rights pursuant to the terms of any registration rights agreement applicable to any equity securities issued by way of private placement in connection with the closing of the Company’s initial business combination or, in the absence of the foregoing, pursuant to the terms of the registration rights agreement entered into by the Company, Sponsor and NGC in connection with the Company’s initial public offering (the “Registration Rights Agreement”). Pursuant to the foregoing, on April 21, 2021, the Registration Rights Agreement was amended to clarify that the shares and warrants included in up to 7,500,000 total forward purchase units remain subject to the Registration Rights Agreement, regardless of the specific Forward Purchase Agreement pursuant to which they may be issued.

 

Each Forward Purchase Agreement contains representations and warranties by each party, conditions to closing, and additional provisions that are customary for agreements of this nature. The terms of all of the Forward Purchase Agreements are substantively the same, except that the NGC Forward Purchase Agreement gives NGC board observation rights prior to the Company’s initial business combination, and gives the members of NGC a priority right to subscribe for any of the forward purchase units that any other prospective purchasers do not elect to purchase under any of the other Forward Purchase Agreements.

 

Proposed Business Combination

 

On June 22, 2021, the Company, Embark Trucks Inc., a Delaware Corporation (“Embark”), and NGAB Merger Sub Inc., a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), entered into an agreement and plan of merger (the “Merger Agreement”), pursuant to which, among other things, Merger Sub will be merged with and into Embark (the “Merger,” together with the other transactions related thereto, the “Embark Business Combination”), with Embark surviving the Merger as a wholly owned subsidiary of us (the “Surviving Corporation”).

 

On the date of closing of the Merger (the “Closing”) immediately prior to the effective time of the Merger (the “Effective Time”), the Company will amend and restate our certificate of incorporation (the “Post-Closing Charter”), pursuant to which, among other things, (i) the Company will have a dual class share structure with (x) shares of Class A common stock that will carry voting rights in the form of one vote per share (the “New Class A Common Stock”), and (y) shares of Class B common stock that will carry voting rights in the form of ten votes per share (the “New Class B Common Stock” and, together with the New Class A Common Stock, the “New Common Stock”) and (ii) all outstanding shares of Company common stock will be reclassified into shares of New Class A Common Stock. At Closing, the Company will also change its name to Embark Technology, Inc.

 

Consummation of the transactions contemplated by the Merger Agreement is subject to customary conditions of the respective parties, including the approval of the Embark Business Combination by the Company’s stockholders. (See Note 11)

 

Subscription Agreements

 

In connection with the execution of the Merger Agreement, the Company and Embark entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to purchase, and the Company agreed to sell to the PIPE Investors, an aggregate of 16,000,000 shares of New Class A Common Stock (the “PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $160 million, in the PIPE Financing.

 

In addition, in connection with the execution of the Merger Agreement, and pursuant to the Forward Purchase Agreements, certain FPA PIPE Investors agreed to purchase, and the Company agreed to sell to the FPA PIPE Investors, an aggregate of 4,000,000 units, consisting of one share of New Class A Common Stock and one-sixth of a warrant (the “PIPE Units”), for a purchase price of $10.00 per unit and an aggregate purchase price of $40 million, in the PIPE Financing.

 

The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements and PIPE Units pursuant to the Forward Purchase Agreements is contingent upon, among other customary closing conditions, the substantially concurrent consummation of the Embark Business Combination. The purpose of the PIPE is to raise additional capital for use by the Surviving Corporation following the Closing.

 

16 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

Sponsor Support Agreement and Foundation Investor Support Agreement

 

In connection with the Merger Agreement, the Company, Embark and the Sponsor entered into the Sponsor Support Agreement pursuant to which Sponsor agreed to vote all of its shares of NGA Common Stock in favor of the approval and adoption of the Business Combination. Additionally, Sponsor agreed, among other things, not to (i) transfer any of its shares of New Class A Common Stock or warrants for certain periods of time as set forth in the Sponsor Support Agreement, subject to certain customary exceptions or (ii) enter into any voting arrangement that is inconsistent with the commitment under the Sponsor Support Agreement to vote in favor of the approval and adoption of the Business Combination. Sponsor also agreed to forfeit, immediately prior to Closing, (i) a relative percentage of up to 1,130,239 Founder Shares to the extent that the Sponsor’s institutional investors fail to hold, at the Closing, at least one-half of the shares of NGA Common Stock issued to such investors in connection with our initial public offering, and (ii) up to 627,910 Founder Shares (currently expected to be 393,025 Founder Shares) in connection with the Forward Purchase Agreements investment. The Sponsor Support Agreement will terminate upon the termination of the Merger Agreement if the Closing does not occur.

 

In addition, in connection with the Merger Agreement, the Sponsor expects certain of its institutional investors to enter into separate Support Agreements pursuant to which such investors will agree, among other things, to vote all shares of our common stock held by such investor at the time of such vote (i) in favor of the approval and adoption of the Business Combination, the Merger Agreement and each of the Transaction Proposals (as defined in the Merger Agreement), (ii) against any other business combination proposal or related proposals; and (iii) against any proposal, action or agreement that would reasonably be expected to impede, frustrate, or prevent the Merger or the satisfaction of any of the conditions thereto. Each such investor is further expected to represent and agree that such investor has not entered into, and will not enter, any agreement that would restrict, limit or interfere with the voting agreement made in the Support Agreement. The Business Combination Agreement and related agreements are further described in the Form 8-K filed by the Company on June 23, 2021.

 

NOTE 8. STOCKHOLDERS’ EQUITY

 

Preferred Stock The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.

 

Common Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share. At September 30, 2021 and December 31, 2020, there were 10,350,000 shares of common stock issued and outstanding, excluding 41,400,000 and -0- shares of common stock subject to possible redemption, respectively.

 

NOTE 9. WARRANT LIABILITY

 

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

 

The Company has agreed that as soon as practicable, but in no event later than 15 days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of common stock issuable upon exercise of the warrants and thereafter will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Company’s common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

17 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

 

Once the warrants become exercisable, the Company may redeem the Public Warrants:

 

  in whole and not in part;
     
  at a price of $0.01 per warrant;
     
  upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
     
  if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), for any 20 trading days within a 30 trading day period commencing once the warrants become exercisable and ending commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders

 

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

 

The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

 

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

 

The Private Placement Warrants and Working Capital Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants, Working Capital Warrants, and the common stock issuable upon the exercise of the Private Placement Warrants and Working Capital Warrants cannot be transferred until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Working Capital Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If any Private Placement Warrants or Working Capital Warrants are held by someone other than the initial purchasers or their permitted transferees, such Private Placement Warrants and Working Capital Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

 

18 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

   

NOTE 10. FAIR VALUE MEASUREMENTS 

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. 

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

  

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level   September 30,
2021
 
Assets:        
Marketable securities held in Trust Account   1   $414,028,694 
Liabilities:          
Warrant liability – Public Warrants   1   $14,766,000 
Warrant liability – Private Placement Warrants   3   $7,489,067 
FPA Liability   2   $713,333 

 

The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations.

 

The Private Warrants were initially valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date.

  

The following table presents the changes in the fair value of private and public warrant liabilities:

 

   Private Placement   Public   Warrant
Liabilities
 
Fair value as of September 25, 2020 (inception)  $
   $
   $
 
Initial measurement on January 15, 2021   10,297,467    20,286,000    30,583,467 
Change in valuation inputs or other assumptions   (2,808,400)   (5,520,000)   (8,328,400)
Fair value as of September 30, 2021  $7,849,067   $14,766,000   $22,255,067 

 

19 

 

 

NORTHERN GENESIS ACQUISITION CORP. II

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

  

The measurements of the FPA liability are classified as Level 2 due to the use of an observable market quote for a similar asset in an active market.

 

The following table presents a summary of the changes in the fair value of the FPA liability, a Level 2 liability, measured on a recurring basis.

 

   FPA 
   Liability 
Fair value, April 21, 2021  $966,667 
Loss on change in fair value   (253,333)
Fair value, September 30, 2021  $713,334 

 

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

 

The fair value of the Private Placement Warrants was estimated at January 15, 2021 to be $1.54 per share and at September 30, 2021 to be $1.12 per share using the modified Black-Scholes option pricing model and the following assumptions:

 

   January 15, 2021   September 30,
2021
 
Expected Volatility   25.0%   17.0%
Risk-free interest rate   0.58%   1.02%
Expected term (years)   5.00    5.00 
Fair value per share of common stock  $9.51   $9.93 

  

NOTE 11. SUBSEQUENT EVENTS 

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.

 

On September 30, 2021, the Sponsor has amended the August 12, 2021 Commitment Letter to provide $2,000,000 in working capital loans in addition to the previously provided $1,000,000. As of September 30, 2021, there was $750,000 of working capital loans outstanding.

 

On November 9, 2021, the Company issued 2,000,000 Working Capital Warrants in full payment of its obligation under the Working Capital Loans.

 

At a special meeting of stockholders on November 9, 2021 (the “Special Meeting”), the stockholders of the Company voted and approved Proposal Nos. 1 through 7, including the Embark Business Combination, each of which is further described in the Proxy Statement/Prospectus filed by the Company with the SEC on October 19, 2021.

 

20 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Northern Genesis Acquisition Corp. II. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Northern Genesis Sponsor II LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q/A including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Embark Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. 

 

Overview

 

We are a blank check company formed under the laws of the State of Delaware on September 25, 2020 for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

Recent Developments

 

Personnel Services Agreement

 

We entered to a Personnel Services Agreement, dated April 1, 2021, with Northern Genesis Sponsor II LLC (the “Sponsor”) pursuant to which, subject to maintaining funds adequate for our projected obligations, we expect to pay up to $2,000,000 in the aggregate in respect of the services of personnel affiliated with the Sponsor, including persons who may be our directors or officers, for activities on our behalf, including services related to identifying, investigating and completing an initial business combination and other operational and support services. To the extent any amounts are in respect of the services of individuals who also serve as directors or executive officers of the Company, such amounts will be reviewed and approved by its audit committee.

 

The Sponsor, our officers and directors or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 

Forward Purchase Agreements

 

On April 21, 2021, the Company entered into an Amended and Restated Forward Purchase Agreement with Northern Genesis Capital II LLC (formerly known as Northern Genesis Capital LLC) (“NGC”) (the “NGC Forward Purchase Agreement”), and certain additional Forward Purchase Agreements with additional institutional investors (collectively, with the NGC Forward Purchase Agreement, the “Forward Purchase Agreements”). The Forward Purchase Agreements collectively replace that certain Forward Purchase Agreement previously entered into by the Company and NGC in connection with the closing of the Company’s initial public offering (the “Original Agreement”).

 

21 

 

 

Pursuant to the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of its initial business combination (subject to certain limited exceptions), the members of NGC (institutional investors that also are members of the Company’s Sponsor) and the parties to the additional Forward Purchase Agreements have the first right to purchase an aggregate amount of up to 7,500,000 “forward purchase units” of the Company (under all Forward Purchase Agreements, taken together) for $10.00 per forward purchase unit, or an aggregate total of $75,000,000. Each forward purchase unit would consist of one share of the Company’s common stock and one-sixth of one warrant, with each whole warrant exercisable to purchase one share of the Company’s common stock at $11.50 per share. The common stock and warrants included in the forward purchase units would have the same terms as the Company’s publicly traded common stock and warrants but would not be freely tradable until registered. As with the Original Agreement, any commitment by any potential purchaser under any of the Forward Purchase Agreements is subject to and conditioned upon written confirmation from the prospective purchaser, following the Company’s notification to such purchaser of its intention to enter into an initial business combination agreement, which a prospective purchaser was grant or withhold in its sole discretion.

 

In addition, if a private placement of equity securities in connection with the Company’s initial business combination exceeds $75,000,000, the Company agreed under each Forward Purchase Agreement to use its commercially reasonable efforts to permit priority participation in such additional amount by the members of NGC and the parties to the additional Forward Purchase Agreements, in an aggregate additional amount up to $150,000,000, on the same terms as those offered to other prospective purchasers in connection with such additional private placement amount.

  

Each Forward Purchase Agreement that the holders of the shares of common stock and warrants included in the forward purchase units will be entitled to registration rights pursuant to the terms of any registration rights agreement applicable to any equity securities issued by way of private placement in connection with the closing of the Company’s initial business combination or, in the absence of the foregoing, pursuant to the terms of the registration rights agreement entered into by the Company, Sponsor and NGC in connection with the Company’s initial public offering (the “Registration Rights Agreement”). Pursuant to the foregoing, on April 21, 2021, the Registration Rights Agreement was amended to clarify that the shares and warrants included in up to 7,500,000 total forward purchase units remain subject to the Registration Rights Agreement, regardless of the specific Forward Purchase Agreement pursuant to which they may be issued.

 

Each Forward Purchase Agreement contains representations and warranties by each party, conditions to closing, and additional provisions that are customary for agreements of this nature. The terms of all of the Forward Purchase Agreements are substantively the same, except that the NGC Forward Purchase Agreement gives NGC board observation rights prior to the Company’s initial business combination, and gives the members of NGC a priority right to subscribe for any of the forward purchase units that any other prospective purchasers do not elect to purchase under any of the other Forward Purchase Agreements.

 

Proposed Business Combination

 

On June 22, 2021, we, Embark Trucks Inc., a Delaware Corporation (“Embark”), and NGAB Merger Sub Inc., a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), entered into an agreement and plan of merger (the “Merger Agreement”), pursuant to which, among other things, Merger Sub will be merged with and into Embark (the “Merger,” together with the other transactions related thereto, the “Embark Business Combination”), with Embark surviving the Merger as a wholly owned subsidiary of us (the “Surviving Corporation”).

 

On the date of closing of the Merger (the “Closing”) immediately prior to the effective time of the Merger (the “Effective Time”), we will amend and restate our certificate of incorporation (the “Post-Closing Charter”), pursuant to which, among other things, (i) we will have a dual class share structure with (x) shares of Class A common stock that will carry voting rights in the form of one vote per share (the “New Class A Common Stock”), and (y) shares of Class B common stock that will carry voting rights in the form of ten votes per share (the “New Class B Common Stock” and, together with the New Class A Common Stock, the “New Common Stock”) and (ii) all outstanding shares of our common stock will be reclassified into shares of New Class A Common Stock. At Closing, we will also change our name to Embark Technology, Inc.

 

Consummation of the transactions contemplated by the Merger Agreement is subject to customary conditions of the respective parties, including the approval of the Embark Business Combination by our stockholders.

 

Subscription Agreements

 

In connection with the execution of the Merger Agreement, we and Embark entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to purchase, and we agreed to sell to the PIPE Investors, an aggregate of 16,000,000 shares of New Class A Common Stock (the “PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $160 million, in the PIPE Financing.

 

In addition, in connection with the execution of the Merger Agreement, and pursuant to the Forward Purchase Agreements, certain FPA PIPE Investors agreed to purchase, and we agreed to sell to the FPA PIPE Investors, an aggregate of 4,000,000 units, consisting of one share of New Class A Common Stock and one-sixth of a warrant (the “PIPE Units”), for a purchase price of $10.00 per unit and an aggregate purchase price of $40 million, in the PIPE Financing.

 

The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements and PIPE Units pursuant to the Forward Purchase Agreements is contingent upon, among other customary closing conditions, the substantially concurrent consummation of the Embark Business Combination. The purpose of the PIPE is to raise additional capital for use by the Surviving Corporation following the Closing.

 

22 

 

 

Sponsor Support Agreement and Foundation Investor Support Agreement

 

In connection with the Merger Agreement, we, Embark and the Sponsor entered into the Sponsor Support Agreement pursuant to which Sponsor agreed to vote all of its shares of NGA Common Stock in favor of the approval and adoption of the Business Combination. Additionally, Sponsor agreed, among other things, not to (i) transfer any of its shares of New Class A Common Stock or warrants for certain periods of time as set forth in the Sponsor Support Agreement, subject to certain customary exceptions or (ii) enter into any voting arrangement that is inconsistent with the commitment under the Sponsor Support Agreement to vote in favor of the approval and adoption of the Business Combination. Sponsor also agreed to forfeit, immediately prior to Closing, (i) a relative percentage of up to 1,130,239 Founder Shares to the extent that the Sponsor’s institutional investors fail to hold, at the Closing, at least one-half of the shares of NGA Common Stock issued to such investors in connection with our initial public offering, and (ii) up to 627,910 Founder Shares (currently expected to be 393,025 Founder Shares) in connection with the Forward Purchase Agreement investment. The Sponsor Support Agreement will terminate upon the termination of the Merger Agreement if the Closing does not occur.

 

In addition, in connection with the Merger Agreement, the Sponsor expects certain of its institutional investors to enter into separate Support Agreements pursuant to which such investors will agree, among other things, to vote all shares of our common stock held by such investor at the time of such vote (i) in favor of the approval and adoption of the Business Combination, the Merger Agreement and each of the Transaction Proposals (as defined in the Merger Agreement), (ii) against any other business combination proposal or related proposals; and (iii) against any proposal, action or agreement that would reasonably be expected to impede, frustrate, or prevent the Merger or the satisfaction of any of the conditions thereto. Each such investor is further expected to represent and agree that such investor has not entered into, and will not enter, any agreement that would restrict, limit or interfere with the voting agreement made in the Support Agreement. The Business Combination Agreement and related agreements are further described in the Form 8-K filed by the Company on June 23, 2021.

 

Embark Holders Support Agreement 

 

In connection with the Merger Agreement, we, Embark and certain stockholders of Embark (the “Embark Holders”) entered into the Company Holders Support Agreement (the “Embark Holders Support Agreement”) pursuant to which the Embark Holders each agreed to (i) vote his, her or its shares of Embark common stock in favor of the approval and adoption of the Business Combination, (ii) not transfer, subject to limited exceptions, any shares of Embark common stock prior to the Closing or termination of the Merger Agreement, (iii) deliver a duly executed counterpart to the Registration Rights Agreement at Closing and (iv) be bound by certain other covenants and agreements related to the Business Combination. The Embark Holders Support Agreement will terminate upon the termination of the Merger Agreement if the Closing does not occur.

 

Registration Rights Agreement 

 

In connection with the Closing, we will enter into a Registration Rights Agreement with the Sponsor and certain former Embark Holders. The Registration Rights Agreement, subject to the terms thereof, will require the Surviving Corporation to, among other things, file a resale shelf registration statement on behalf of the Sponsor and the Embark Holders and their respective permitted transferees within thirty (30) days following the Closing. The Registration Rights Agreement will also provide for certain demand rights and piggyback registration rights in favor of each of the Sponsor and the Embark Holders and their respective permitted transferees, subject to customary underwriter cutbacks. The Surviving Corporation will agree to pay certain fees and expenses relating to registrations under the Registration Rights Agreement.

 

On July 2, 2021, we filed a registration statement on Form S-4 (File No: 333-257647) relating to the Embark Business Combination, which was subsequently amended through October 14, 2021. The SEC declared the Registration Statement effective on October 18, 2021, and we commenced mailing on or about October 20, 2021 of the definitive proxy statement/prospectus statement relating to the special meeting (the “Special Meeting”) of our stockholders in connection with the Embark Business Combination. At the Special Meeting held on November 9, 2021, our stockholders voted and approved Proposal Nos. 1 through 7, including the Embark Business Combination, each of which is further described in the definitive proxy statement/prospectus.

 

Other than as specifically discussed, this report does not assume the closing of the Embark Business Combination.

 

Working Capital Warrants

 

On November 9, 2021, we issued 2,000,000 Working Capital Warrants in full payment of its obligation under the Working Capital Loans.

 

23 

 

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from September 25, 2020 (inception) through January 15, 2021 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 

For the three months ended September 30, 2021, we had net income of $11,546,198, which consists, change in fair value of warrant liabilities of $12,701,734, change in fair value of FPA liability of $393,333, and interest earned on marketable securities held in Trust Account of $5,328, offset by formation and operating costs of $1,554,197.

 

For the nine months ended September 30, 2021, we had net income of $4,182,273 which consists of change in fair value of warrant liabilities of $8,328,400, change in fair value of FPA liability of $253,333, and interest earned on marketable securities held in Trust Account of $28,694, offset by formation and operating costs of $3,012,398, loss on initial issuance of private warrants of $267,467, and offering costs allocated to warrant liability of $1,148,289.

 

Liquidity and Capital Resources

 

On January 15, 2021, we completed the Initial Public Offering of 41,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000. Simultaneously with the closing of the Initial Public Offering, we completed the sale of 6,686,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement to Northern Genesis Sponsor II LLC, the Sponsor, generating gross proceeds of $10,030,000.

 

Following the Initial Public Offering and the full exercise of the over-allotment option, a total of $414,000,000 was placed in the Trust Account. We incurred $23,221,415 in Initial Public Offering related costs, including $8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $451,415 of other costs.

 

For the nine months ended September 30, 2021, cash used in operating activities was $2,038,897. Net income of $4,182,273 was affected by interest earned on marketable securities held in the Trust Account of $28,694, the decrease in fair value of warrant liability of $8,328,400, loss on initial issuance of private warrants of $267,467, decrease in fair value of FPA liability of $253,333 and offering cost related to warrant liabilities of $1,148,289. Changes in operating assets and liabilities provided $973,501 of cash for operating activities.  

 

As of September 30, 2021, we had marketable securities held in the Trust Account of $414,028,694 (including $28,694 of interest income) consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through September 30, 2021, we have not withdrawn any interest earned from the Trust Account.  

 

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

As of September 30, 2021, we had cash of $34,688. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

 

24 

 

 

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $3,000,000 of such loans may be convertible into warrants at a price of $1.50 per warrant, at the option of the lender. The warrants would be identical to the Private Placement Warrants.

 

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. On August 12, 2021, the Sponsor has signed a Commitment Letter to provide up to $1,000,000 in working capital loans if required.

 

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual obligations

  

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor or an affiliate of the Sponsor a monthly fee of $10,000 for office space, utilities, secretarial support and administrative services. We began incurring these fees on January 12, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.

 

The underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or $14,490,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

 

In connection with the Initial Public Offering, the Company entered into the NGC Forward Purchase Agreement with NGC, which NGC Forward Purchase Agreement was subsequently amended and restated as described under “—Recent Developments—Forward Purchase Agreements” above.

 

The forward purchase transaction is not dependent upon or affected by the percentage of stockholders electing to redeem their Public Shares and may provide the Company with an increased minimum funding level for the initial Business Combination. The forward purchase transaction is subject to conditions, including the forward purchase investor giving the Company its irrevocable written confirmation, confirming its commitment to purchase forward purchase securities and the amount thereof, no later than fifteen days after the Company notifies it of the Company’s intention to raise capital through the issuance of equity securities in connection with the closing of an initial Business Combination. The forward purchase investor may grant or withhold its consent and confirmation entirely within its sole discretion. Accordingly, if the forward purchase investor does not consent to and confirm the purchase, it will not be obligated to purchase any of the forward purchase securities. In connection with the proposed Embark Business Combination, certain FPA Investors agreed to purchase PIPE Units as described under “—Recent Developments—Proposed Business Combination” above.

 

25 

 

 

Critical Accounting Policies

 

The preparation of condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

 

Warrant Liability

 

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own common shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

 

Common Stock Subject to Possible Redemption

 

We account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of our condensed consolidated balance sheets.

 

Net Income Per Common Share

 

Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. We apply the two-class method in calculating earnings per share. Accretion associated with the redeemable shares is excluded from earnings per share as the redemption value approximates fair value. 

 

Recent Accounting Standards

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed consolidated financial statements.

 

26 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not required for smaller reporting companies.

  

Item 4. Controls and Procedures (As Revised)

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective. Our internal control over financial reporting did not result in the proper accounting classification of complex financial instruments which, due to its impact on our financial statements, we determined to be a material weakness.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2021 covered by this Quarterly Report on Form 10-Q/A that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. The Company previously identified a material weakness in internal controls related to the accounting for warrants issued in connection with our initial public offering. As a result of the restatement described in this First Amendment on Form 10-Q/A, management has identified a material weakness in internal controls related to complex financial instruments, as described above.

 

Remediation Plan

 

Management has implemented remediation steps to address the material weakness and to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

 

The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

 

27 

 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None

 

Item 1A. Risk Factors

 

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC. Except as described below, as of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report filed with the SEC.

 

Our warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results. 

 

On April 12, 2021, the SEC issued the SEC Staff Statement regarding the accounting and reporting considerations for warrants issued by SPACs. Specifically, the SEC Staff Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement governing our warrants. As a result of the SEC Staff Statement, we reevaluated the accounting treatment of our public warrants and private placement warrants, and determined to classify the warrants as derivative liabilities measured at fair value, with changes in fair value each period reported in earnings. 

 

As a result, included on our balance sheet as of September 30, 2021 contained elsewhere in this Quarterly Report are derivative liabilities related to embedded features contained within our warrants. ASC Subtopic 815, Derivatives and Hedging, provides for the remeasurement of the fair value of such derivatives at each balance sheet date, with a resulting non-cash gain or loss related to the change in the fair value being recognized in earnings in the statements of operations. As a result of the recurring fair value measurement, our financial statements and results of operations may fluctuate quarterly, based on factors which are outside of our control. Due to the recurring fair value measurement, we expect that we will recognize non-cash gains or losses on our warrants each reporting period and that the amount of such gains or losses could be material.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On January 15, 2021, we consummated the Initial Public Offering of 41,400,000 Units. The Units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $414,000,000. J.P. Morgan Securities LLC, Barclays Capital Inc. and CIBC Capital Markets acted as joint book-running managers of the Initial Public Offering. The securities in the offering were registered under the Securities Act on registration statement on Form S-1 (No. 333-251639 and 333-252056). The Securities and Exchange Commission declared the registration statements effective on January 12, 2021.

 

Simultaneous with the consummation of the Initial Public Offering, the Sponsor and Northern Genesis Sponsor II LLC consummated the private placement of an aggregate of 6,686,667 Units at a price of $1.50 per Private Placement Warrant, generating total proceeds of $10,030,000. Each Private Placement Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

The Private Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions.

 

Of the gross proceeds received from the Initial Public Offering, the exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $414,000,000 was placed in the Trust Account.

 

We paid a total of $8,280,000 in underwriting fees, $14,490,000 of deferred underwriting fees and $451,415 for other costs and expenses related to the Initial Public Offering.

 

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q/A.

 

Item 3. Defaults Upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

None

 

Item 5. Other Information

 

None

 

28 

 

 

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q/A.

 

No.   Description of Exhibit
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Filed herewith.

 

29 

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  EMBARK TECHNOLOGY, INC.
     
Date: November 23, 2021 By: /s/ Alex Rodrigues
  Name:  Alex Rodrigues
  Title: Chief Executive Officer
    (Principal Executive Officer)
     
Date: November 23, 2021 By: /s/ Richard Hawwa
  Name: Richard Hawwa
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

30

 

 

Embark Technology, Inc. Embark Technology, Inc., formerly known as Northern Genesis Acquisition Corp. II (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on this Form 10-Q/A for the three and nine month period ended September 30, 2021 (the “First Amendment”), as originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 10, 2021 (the “Original Form 10-Q”) to amend and restate the Company’s September 30, 2021 Quarterly Report on Form 10-Q, as further described below. This amended and restated report on Form 10-Q/A is presented as of the filing date of the Original Form 10-Q and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the restatement as described below. Accordingly, this Amendment No. 1 on Form 10-Q/A should be read in conjunction with our filings with the SEC subsequent to the date on which we filed the Original Form 10-Q. The Company is filing this First Amendment on Form 10-Q/A to reflect a restatement of the Company’s condensed financial statements as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021 to correct errors in the Company’s classification of public shares as permanent equity as further described below. On November 10, 2021, subsequent to the fiscal quarter ended September 30, 2021, Northern Genesis Acquisition Corp. II, our predecessor and a Delaware corporation (“NGA”), consummated the previously announced business combination pursuant to the agreement and plan of merger, dated as of June 22, 2021 (the “Merger Agreement”), by and among NGA, NGAB Merger Sub Inc., a Delaware corporation (“Merger Sub”), and Embark Trucks Inc., a Delaware corporation (“Embark Trucks”).Pursuant to the Merger Agreement, NGA acquired Embark Trucks, by way of Merger Sub merging with and into Embark Trucks, with Embark Trucks becoming a direct subsidiary of NGA as a result thereof (the “Business Combination”). On November 9, 2021, NGA held a special meeting of stockholders (the “Special Meeting”), at which the NGA stockholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Merger Agreement and (b) approving the other transactions contemplated by the Merger Agreement and related agreements described in the proxy statement/prospectus related thereto. Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, on November 10, 2021 (the “Closing Date”), the Business Combination was consummated (the “Closing”). On November 11, 2021, the business day following the Closing Date, the Company’s Class A common stock and warrants began trading on Nasdaq under the symbols “EMBK” and “EMBKW”. NGA’s public units automatically separated into their component securities upon consummation of the Business Combination and, as a result, no longer trade as a separate security and were delisted from the New York Stock Exchange. Unless stated otherwise, this report contains information about NGA before the consummation of the Business Combination. References to the “Company” in this report refer to NGA before the consummation of the Business Combination. Background of Restatement In the Company’s previously issued financial statements as of January 15, 2021 and March 31, 2021, a portion of the public shares were classified as permanent equity to maintain stockholders’ equity greater than $5,000,000 on the basis that the Company could consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001 under the Company’s charter. Thus, the Company can only complete a merger and continue to exist as a public company if there are sufficient public shares that do not redeem at the merger and so it was deemed appropriate to classify the portion of its public shares required to keep its stockholders’ equity above the $5,000,000 threshold as “shares not subject to redemption.” However, in light of recent comment letters issued by the Securities & Exchange Commission (“SEC”) to several special purpose acquisition companies, management re-evaluated the Company’s application of ASC 480-10-99 to its accounting classification of public shares. Upon re-evaluation, management determined that the public shares include certain provisions that require classification of the public shares as temporary equity regardless of the minimum net tangible asset required by the Company to complete its initial business combination. The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate all of the Company’s previously issued financial statements to report all public shares as temporary equity as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021. This First Amendment on Form 10-Q/A sets forth the Original Form 10-Q in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Form 10-Q have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-Q, and such forward-looking statements should be read in their historical context. The following items have been amended as a result of the restatement: Part I, Item 1, “Financial Statements” and Part I, Item 4, “Controls and Procedures.” In accordance with applicable SEC rules, this First Amendment on Form 10-Q/A includes an updated signature page and certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15. Refer to Note 2, Restatement of Previously Issued Financial Statements of this Form 10-Q/A for additional information and for the summary of the accounting impacts of these adjustments to the Company’s condensed financial statements as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021. The Company previously identified a material weakness in internal controls related to the accounting for warrants issued in connection with our initial public offering. As a result of the restatement described in this First Amendment on Form 10-Q/A, the Company has concluded there was a material weakness in the Company's internal control over financial reporting at the time the abovementioned financial statements were issued, and its disclosure controls and procedures were not effective at the time the abovementioned financial statements were issued. true --12-31 Q3 N/A 0001827980 0001827980 2021-01-01 2021-09-30 0001827980 2021-11-09 0001827980 2021-09-30 0001827980 2020-12-31 0001827980 2021-07-01 2021-09-30 0001827980 2020-09-25 2020-09-30 0001827980 us-gaap:CommonStockMember 2020-12-31 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001827980 us-gaap:RetainedEarningsMember 2020-12-31 0001827980 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001827980 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001827980 2021-01-01 2021-03-31 0001827980 us-gaap:CommonStockMember 2021-03-31 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001827980 us-gaap:RetainedEarningsMember 2021-03-31 0001827980 2021-03-31 0001827980 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001827980 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001827980 2021-04-01 2021-06-30 0001827980 us-gaap:CommonStockMember 2021-06-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001827980 us-gaap:RetainedEarningsMember 2021-06-30 0001827980 2021-06-30 0001827980 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001827980 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001827980 us-gaap:CommonStockMember 2021-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001827980 us-gaap:RetainedEarningsMember 2021-09-30 0001827980 us-gaap:CommonStockMember 2020-09-24 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-09-24 0001827980 us-gaap:RetainedEarningsMember 2020-09-24 0001827980 2020-09-24 0001827980 us-gaap:CommonStockMember 2020-09-25 2020-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-09-25 2020-09-30 0001827980 us-gaap:RetainedEarningsMember 2020-09-25 2020-09-30 0001827980 us-gaap:CommonStockMember 2020-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001827980 us-gaap:RetainedEarningsMember 2020-09-30 0001827980 2020-09-30 0001827980 us-gaap:IPOMember 2021-01-15 0001827980 us-gaap:OverAllotmentOptionMember 2021-01-15 0001827980 2021-01-01 2021-01-15 0001827980 embk:PrivatePlacementWarrantMember 2021-01-01 2021-09-30 0001827980 embk:BusinessCombinationMember 2021-01-01 2021-09-30 0001827980 embk:TrustAccountMember 2021-09-30 0001827980 us-gaap:IPOMember 2021-09-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-15 0001827980 srt:RestatementAdjustmentMember 2021-01-15 0001827980 embk:AsRestatedMember 2021-01-15 0001827980 srt:ScenarioPreviouslyReportedMember 2021-03-31 0001827980 srt:RestatementAdjustmentMember 2021-03-31 0001827980 embk:AsRestatedMember 2021-03-31 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-03-31 0001827980 srt:RestatementAdjustmentMember 2021-01-01 2021-03-31 0001827980 embk:AsRestatedMember 2021-01-01 2021-03-31 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-06-30 0001827980 srt:RestatementAdjustmentMember 2021-01-01 2021-06-30 0001827980 embk:AsRestatedMember 2021-01-01 2021-06-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-06-30 0001827980 embk:AsRestatedMember 2021-06-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-04-01 2021-06-30 0001827980 embk:AsRestatedMember 2021-04-01 2021-06-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-07-01 2021-09-30 0001827980 embk:AsRestatedMember 2021-07-01 2021-09-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-09-30 0001827980 embk:AsRestatedMember 2021-01-01 2021-09-30 0001827980 us-gaap:CommonClassAMember 2021-09-30 0001827980 embk:RedeemableMember 2021-07-01 2021-09-30 0001827980 embk:NonredeemableMember 2021-07-01 2021-09-30 0001827980 embk:RedeemableMember 2021-01-01 2021-09-30 0001827980 embk:NonredeemableMember 2021-01-01 2021-09-30 0001827980 embk:RedeemableMember 2020-09-25 2020-09-30 0001827980 embk:NonredeemableMember 2020-09-25 2020-09-30 0001827980 us-gaap:IPOMember 2021-01-01 2021-09-30 0001827980 us-gaap:OverAllotmentOptionMember 2021-01-01 2021-09-30 0001827980 us-gaap:PrivatePlacementMember 2021-01-01 2021-09-30 0001827980 us-gaap:PrivatePlacementMember 2021-09-30 0001827980 embk:SponsorMember us-gaap:PrivatePlacementMember 2021-01-01 2021-09-30 0001827980 embk:FounderShareMember 2020-09-25 2020-10-02 0001827980 embk:FounderShareMember 2021-01-12 0001827980 embk:FounderShareMember 2021-01-01 2021-01-12 0001827980 embk:BusinessCombinationMember embk:FounderShareMember 2021-01-01 2021-09-30 0001827980 2021-01-12 0001827980 2021-01-15 0001827980 2020-09-25 0001827980 2021-08-01 2021-08-12 0001827980 embk:SponsorMember 2021-01-01 2021-09-30 0001827980 2021-01-01 2021-01-08 0001827980 embk:PIPEInvestorsMember us-gaap:CommonClassAMember 2021-09-30 0001827980 embk:PIPEInvestorsMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001827980 embk:FPAPIPEInvestorsMember 2021-01-01 2021-09-30 0001827980 embk:FPAPIPEInvestorsMember 2021-09-30 0001827980 2020-01-01 2020-12-31 0001827980 us-gaap:WarrantMember 2021-09-30 0001827980 us-gaap:CommonStockMember 2021-09-30 0001827980 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-09-30 0001827980 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001827980 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-09-30 0001827980 embk:WarrantLiabilityPublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-01-01 2021-09-30 0001827980 embk:WarrantLiabilityPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-09-30 0001827980 embk:FPALiabilityMember us-gaap:FairValueInputsLevel2Member 2021-01-01 2021-09-30 0001827980 us-gaap:PrivatePlacementMember 2020-12-31 0001827980 embk:PublicMember 2020-12-31 0001827980 us-gaap:NoteWarrantMember 2020-12-31 0001827980 embk:PublicMember 2021-01-01 2021-09-30 0001827980 us-gaap:NoteWarrantMember 2021-01-01 2021-09-30 0001827980 embk:PublicMember 2021-09-30 0001827980 us-gaap:NoteWarrantMember 2021-09-30 0001827980 2021-04-20 0001827980 2021-04-21 2021-09-30 0001827980 us-gaap:SubsequentEventMember 2021-11-01 2021-11-09 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0921a1ex31-1_embarktech.htm CERTIFICATION

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Alex Rodrigues certify that:

 

1. I have reviewed this quarterly report on Form 10-Q/A of EMBARK TECHNOLOGY, INC.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15I and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b) (Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a);

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 23, 2021

 

  /s/ Alex Rodrigues
  Alex Rodrigues
  Chief Executive Officer
  (Principal Executive Officer)

 

EX-31.2 3 f10q0921a1ex31-2_embarktech.htm CERTIFICATION

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Hawwa, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q/A of EMBARK TECHNOLOGY, INC.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b) (Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a);

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 23, 2021

 

  /s/ Richard Hawwa
  Richard Hawwa
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

EX-32.1 4 f10q0921a1ex32-1_embarktech.htm CERTIFICATION

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of EMBARK TECHNOLOGY, INC. (the “Company”) on Form 10-Q/A for the quarterly period ended September 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Alex Rodrigues, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 23, 2021

 

  /s/ Alex Rodrigues
  Alex Rodrigues
  Chief Executive Officer
  (Principal Executive Officer)

 

EX-32.2 5 f10q0921a1ex32-2_embarktech.htm CERTIFICATION

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of EMBARK TECHNOLOGY, INC. (the “Company”) on Form 10-Q/A for the quarterly period ended September 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Richard Hawwa, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 23, 2021

 

  /s/ Richard Hawwa
  Richard Hawwa
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

EX-101.SCH 6 embk-20210930.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Restatement of Previously Issued Financial Statements link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Public Offering link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Warrant Liability link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Restatement of Previously Issued Financial Statements (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Description of Organization and Business Operations (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Restatement of Previously Issued Financial Statements (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of class A common stock reflected in the condensed consolidated balance sheets link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Public Offering (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Private Placement (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Warrant Liability (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Fair Value Measurements (Details) - Schedule of company's assets and liabilities link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of the FPA liability link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Fair Value Measurements (Details) - Schedule of black scholes option pricing model link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 embk-20210930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 embk-20210930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 embk-20210930_lab.xml XBRL LABEL FILE EX-101.PRE 10 embk-20210930_pre.xml XBRL PRESENTATION FILE XML 11 f10q0921a1_embarktech_htm.xml IDEA: XBRL DOCUMENT 0001827980 2021-01-01 2021-09-30 0001827980 2021-11-09 0001827980 2021-09-30 0001827980 2020-12-31 0001827980 2021-07-01 2021-09-30 0001827980 2020-09-25 2020-09-30 0001827980 us-gaap:CommonStockMember 2020-12-31 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001827980 us-gaap:RetainedEarningsMember 2020-12-31 0001827980 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001827980 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001827980 2021-01-01 2021-03-31 0001827980 us-gaap:CommonStockMember 2021-03-31 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001827980 us-gaap:RetainedEarningsMember 2021-03-31 0001827980 2021-03-31 0001827980 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001827980 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001827980 2021-04-01 2021-06-30 0001827980 us-gaap:CommonStockMember 2021-06-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001827980 us-gaap:RetainedEarningsMember 2021-06-30 0001827980 2021-06-30 0001827980 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001827980 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001827980 us-gaap:CommonStockMember 2021-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001827980 us-gaap:RetainedEarningsMember 2021-09-30 0001827980 us-gaap:CommonStockMember 2020-09-24 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-09-24 0001827980 us-gaap:RetainedEarningsMember 2020-09-24 0001827980 2020-09-24 0001827980 us-gaap:CommonStockMember 2020-09-25 2020-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-09-25 2020-09-30 0001827980 us-gaap:RetainedEarningsMember 2020-09-25 2020-09-30 0001827980 us-gaap:CommonStockMember 2020-09-30 0001827980 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001827980 us-gaap:RetainedEarningsMember 2020-09-30 0001827980 2020-09-30 0001827980 us-gaap:IPOMember 2021-01-15 0001827980 us-gaap:OverAllotmentOptionMember 2021-01-15 0001827980 2021-01-01 2021-01-15 0001827980 embk:PrivatePlacementWarrantMember 2021-01-01 2021-09-30 0001827980 embk:BusinessCombinationMember 2021-01-01 2021-09-30 0001827980 embk:TrustAccountMember 2021-09-30 0001827980 us-gaap:IPOMember 2021-09-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-15 0001827980 srt:RestatementAdjustmentMember 2021-01-15 0001827980 embk:AsRestatedMember 2021-01-15 0001827980 srt:ScenarioPreviouslyReportedMember 2021-03-31 0001827980 srt:RestatementAdjustmentMember 2021-03-31 0001827980 embk:AsRestatedMember 2021-03-31 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-03-31 0001827980 srt:RestatementAdjustmentMember 2021-01-01 2021-03-31 0001827980 embk:AsRestatedMember 2021-01-01 2021-03-31 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-06-30 0001827980 srt:RestatementAdjustmentMember 2021-01-01 2021-06-30 0001827980 embk:AsRestatedMember 2021-01-01 2021-06-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-06-30 0001827980 embk:AsRestatedMember 2021-06-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-04-01 2021-06-30 0001827980 embk:AsRestatedMember 2021-04-01 2021-06-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-07-01 2021-09-30 0001827980 embk:AsRestatedMember 2021-07-01 2021-09-30 0001827980 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-09-30 0001827980 embk:AsRestatedMember 2021-01-01 2021-09-30 0001827980 us-gaap:CommonClassAMember 2021-09-30 0001827980 embk:RedeemableMember 2021-07-01 2021-09-30 0001827980 embk:NonredeemableMember 2021-07-01 2021-09-30 0001827980 embk:RedeemableMember 2021-01-01 2021-09-30 0001827980 embk:NonredeemableMember 2021-01-01 2021-09-30 0001827980 embk:RedeemableMember 2020-09-25 2020-09-30 0001827980 embk:NonredeemableMember 2020-09-25 2020-09-30 0001827980 us-gaap:IPOMember 2021-01-01 2021-09-30 0001827980 us-gaap:OverAllotmentOptionMember 2021-01-01 2021-09-30 0001827980 us-gaap:PrivatePlacementMember 2021-01-01 2021-09-30 0001827980 us-gaap:PrivatePlacementMember 2021-09-30 0001827980 embk:SponsorMember us-gaap:PrivatePlacementMember 2021-01-01 2021-09-30 0001827980 embk:FounderShareMember 2020-09-25 2020-10-02 0001827980 embk:FounderShareMember 2021-01-12 0001827980 embk:FounderShareMember 2021-01-01 2021-01-12 0001827980 embk:BusinessCombinationMember embk:FounderShareMember 2021-01-01 2021-09-30 0001827980 2021-01-12 0001827980 2021-01-15 0001827980 2020-09-25 0001827980 2021-08-01 2021-08-12 0001827980 embk:SponsorMember 2021-01-01 2021-09-30 0001827980 2021-01-01 2021-01-08 0001827980 embk:PIPEInvestorsMember us-gaap:CommonClassAMember 2021-09-30 0001827980 embk:PIPEInvestorsMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001827980 embk:FPAPIPEInvestorsMember 2021-01-01 2021-09-30 0001827980 embk:FPAPIPEInvestorsMember 2021-09-30 0001827980 2020-01-01 2020-12-31 0001827980 us-gaap:WarrantMember 2021-09-30 0001827980 us-gaap:CommonStockMember 2021-09-30 0001827980 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-09-30 0001827980 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001827980 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-09-30 0001827980 embk:WarrantLiabilityPublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-01-01 2021-09-30 0001827980 embk:WarrantLiabilityPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-09-30 0001827980 embk:FPALiabilityMember us-gaap:FairValueInputsLevel2Member 2021-01-01 2021-09-30 0001827980 us-gaap:PrivatePlacementMember 2020-12-31 0001827980 embk:PublicMember 2020-12-31 0001827980 us-gaap:NoteWarrantMember 2020-12-31 0001827980 embk:PublicMember 2021-01-01 2021-09-30 0001827980 us-gaap:NoteWarrantMember 2021-01-01 2021-09-30 0001827980 embk:PublicMember 2021-09-30 0001827980 us-gaap:NoteWarrantMember 2021-09-30 0001827980 2021-04-20 0001827980 2021-04-21 2021-09-30 0001827980 us-gaap:SubsequentEventMember 2021-11-01 2021-11-09 shares iso4217:USD iso4217:USD shares pure 10-Q/A true 2021-09-30 2021 false 001-39881 DE 86-3343965 424 Townsend Street San Francisco CA (415) 671-9628 Class A common Stock, par value $0.0001 per share EMBK NASDAQ Yes Yes Non-accelerated Filer true true false true 51750000 34688 116653 151341 249917 414028694 414180035 249917 1091604 1450 107000 750000 117917 1841604 226367 713334 22255067 14490000 39300005 226367 41400000 0 414000000 0.0001 0.0001 1000000 1000000 0.0001 0.0001 100000000 100000000 10350000 10350000 10350000 10350000 1035 1035 23965 -39121005 -1450 -39119970 23550 414180035 249917 1554197 1000 3016548 -1554197 -1000 -3016548 -12701734 -8328400 -393333 -253333 267467 1148289 5328 28694 13100395 7194671 11546198 -1000 4178123 41400000 39125275 0.22 0.08 10350000 10350000 10275824 0.22 0 0.08 10350000 1035 23965 -1450 23550 -23965 -42335161 -42359126 4880183 4880183 10350000 1035 -37456428 -37455393 -966667 -966667 -12244108 -12244108 10350000 1035 -50667203 -50666168 11546198 11546198 10350000 1035 -39121005 -39119970 10350000 1035 23965 25000 -1000 -1000 10350000 1035 23965 -1000 24000 -4182273 1000 28694 -8328400 -253333 267467 1148289 116653 1090154 1000 -2038897 414000000 -414000000 405720000 10030000 750000 5000 117917 308498 5000 416073585 34688 34688 414000000 30583467 14490000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Northern Genesis Acquisition Corp. II (the “Company”) was incorporated in Delaware on September 25, 2020. The Company is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to initially concentrate on target businesses making a positive contribution to sustainability through the ownership, financing and management of societal infrastructure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has a wholly owned subsidiary NGAB Merger Sub Inc., which was incorporated in Delaware on June 21, 2021 (“Merger Sub”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement for the Company’s Initial Public Offering was declared effective on January 12, 2021. On January 15, 2021, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares, which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000, which is described in Note 3.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,686,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Company’s sponsor, Northern Genesis Sponsor II LLC (the “Sponsor”), generating gross proceeds of $10,030,000, which is described in Note 4.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transaction costs amounted to $23,221,415 consisting of $8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $451,415 of other offering costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Initial Public Offering on January 15, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company intends to only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully complete a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, if a majority of the then outstanding shares of common stock present and entitled to vote at the meeting to approve the business combination (or such greater number as may be required by applicable law or the rules of any applicable national securities exchange) are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor and the Company’s officers, directors and director nominees will agree (a) to waive redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination and certain amendments to the Amended and Restated Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provisions that specifically apply only to the period prior to the consummation of our initial business combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment (See Note 7).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will have until January 15, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holders of the Founder Shares will agree to waive liquidation rights with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to protect the amounts held in the Trust Account, the Sponsor will agree to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity and Capital Resources</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2021, the Company had $34,688 in its operating bank accounts, $414,028,694 in marketable securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem stock in connection therewith and working capital deficit of ($1,544,413), which excludes franchise taxes payable of $150,000, of which such amount will be paid from interest earned on the Trust Account and $28,694 of franchise taxes paid and not yet reimbursed from the trust.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may but are not obligated to (except as described above), loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing, the Company believes it will have sufficient cash to meet its needs through the earlier of consummation of a Business Combination or January 15, 2023, the deadline to complete a Business Combination pursuant to the Company’s Amended and Restated Certificate of Incorporation (unless otherwise amended by stockholders).</p> 41400000 5400000 10 414000000 6686667 1.5 10030000 23221415 8280000 14490000 451415 Following the closing of the Initial Public Offering on January 15, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.  0.80 0.50 10 5000001 0.15 1 100000 10 In order to protect the amounts held in the Trust Account, the Sponsor will agree to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). 34688 414028694 -1544413 150000 28694 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b style="-sec-ix-redline:true">NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline:true">In connection with the preparation of the Company’s financial statements as of September 30, 2021 in its Original Form 10-Q, the Company concluded it should restate its financial statements to classify all Public Shares in temporary equity. In accordance with ASC 480, paragraph 10-S99, redemption provisions not solely within the control of the Company require common stock subject to possible redemption to be classified outside of permanent equity. The Company previously determined the common stock subject to possible redemption to be equal to the redemption value of $10.00 per share of common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. Accordingly, effective with this filing, the Company presents all redeemable common stock as temporary equity. Additionally, the Company in its Original Form 10-Q referred to these adjustments as a ‘revision’, however, these adjustments should have been identified as a ‘restatement’ of the previously issued financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline:true"> </span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-sec-ix-redline:true">As a result, management has noted a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and common stock.</span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-sec-ix-redline:true"> </span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-sec-ix-redline:true">The impact of the restatement on the Company’s financial statements is reflected in the following table:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-sec-ix-redline:true;font-size: 5pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true">As Previously<br/> Reported</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true">Adjustment</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true">As Restated</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="-sec-ix-redline:true">Balance Sheet as of January 15, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock subject to redemption</span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true">365,248,533</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock shares</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,523</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(488</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,035</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Additional paid-in capital</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">6,415,718</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(6,415,718</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Accumulated deficit</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(1,417,236</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,335,161</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(43,752,397</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total Stockholders’ Equity (Deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">5,000,005</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(43,751,362</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Balance Sheet as of March 31, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">371,544,602</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock shares</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,460</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(425</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,035</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Additional paid-in capital</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">119,812</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(119,812</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Retained Earnings (Accumulated deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">4,878,733</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,335,161</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(37,456,428</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total Stockholders’ Equity (Deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">5,000,005</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(37,455,393</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Statement of Cash Flows for the Three Months Ended March 31, 2021 </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Initial classification of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Statement of Cash Flows for the Six Months Ended June 30, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Initial classification of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) March 31, 2021</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Sale of 41,400,000 Units, net of underwriting discounts</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">371,629,911</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(371,629,911</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Initial value of common stock subject to possible redemption at IPO date</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Accretion for common stock to redemption amount</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,359,126</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,359,126</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total stockholders’ equity (deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">5,000,005</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(37,455,393</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) June 30, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total stockholders’ equity</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(50,666,168</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(50,666,168</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline:true">In connection with the change in presentation for common stock subject to redemption, the Company also restated its income (loss) per share. The impact of this restatement on the Company’s financial statements is reflected in the following table:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline:true;font-size: 6pt; ">  </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-sec-ix-redline:true">Basic and diluted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-sec-ix-redline:true">weighted average shares outstanding, Class A common stock subject to possible redemption</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="-sec-ix-redline:true"> </span></p></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted net loss per share, Class A common stock</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted net loss per share, Class B common stock</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended, March 31, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%; text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">36,524,863</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">14,187,614</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.34</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">34,500,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.11</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,125,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.11</span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended, June 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">37,153,752</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">14,596,248</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.84</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">41,400,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.24</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,350,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.24</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the six months ended, June 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">61,945,851</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">14,393,060</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.51</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">37,969,061</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.15</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,238,122</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.15</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended, September 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">51,750,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">41,400,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,350,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the nine months ended, September 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">48,906,593</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.09</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">39,125,275</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,275,824</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> </table> 10 5000001 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true">As Previously<br/> Reported</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true">Adjustment</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true">As Restated</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="-sec-ix-redline:true">Balance Sheet as of January 15, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock subject to redemption</span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true">365,248,533</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock shares</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,523</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(488</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,035</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Additional paid-in capital</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">6,415,718</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(6,415,718</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Accumulated deficit</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(1,417,236</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,335,161</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(43,752,397</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total Stockholders’ Equity (Deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">5,000,005</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(43,751,362</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Balance Sheet as of March 31, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">371,544,602</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Common stock shares</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,460</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(425</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">1,035</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Additional paid-in capital</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">119,812</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(119,812</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Retained Earnings (Accumulated deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">4,878,733</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,335,161</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(37,456,428</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total Stockholders’ Equity (Deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">5,000,005</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(37,455,393</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Statement of Cash Flows for the Three Months Ended March 31, 2021 </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Initial classification of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true;font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Statement of Cash Flows for the Six Months Ended June 30, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Initial classification of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">414,000,000</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to possible redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(48,751,367</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) March 31, 2021</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Sale of 41,400,000 Units, net of underwriting discounts</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">371,629,911</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(371,629,911</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Initial value of common stock subject to possible redemption at IPO date</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">365,248,633</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(6,295,969</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Accretion for common stock to redemption amount</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,359,126</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,359,126</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total stockholders’ equity (deficit)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">5,000,005</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(37,455,393</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) June 30, 2021</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Change in value of common stock subject to redemption</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(42,455,398</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Total stockholders’ equity</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(50,666,168</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">—</span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true">(50,666,168</span></td><td style="text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt"> </span></p> 365248533 48751367 414000000 1523 -488 1035 6415718 -6415718 -1417236 -42335161 -43752397 5000005 -48751367 -43751362 371544602 42455398 414000000 1460 -425 1035 119812 -119812 4878733 -42335161 -37456428 5000005 -42455398 -37455393 365248633 48751367 414000000 6295969 -6295969 365248633 48751367 414000000 48751367 -48751367 41400000 41400000 41400000 371629911 -371629911 -365248633 365248633 6295969 -6295969 -42359126 -42359126 5000005 -42455398 -37455393 42455398 -42455398 -50666168 -50666168 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-sec-ix-redline:true">Basic and diluted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-sec-ix-redline:true">weighted average shares outstanding, Class A common stock subject to possible redemption</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="-sec-ix-redline:true"> </span></p></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted net loss per share, Class A common stock</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted net loss per share, Class B common stock</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended, March 31, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="text-align: center"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%; text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">36,524,863</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">14,187,614</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.34</span></td> <td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">34,500,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.11</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,125,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.11</span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended, June 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">37,153,752</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">14,596,248</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.84</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">41,400,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.24</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,350,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.24</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the six months ended, June 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">61,945,851</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">14,393,060</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.51</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">37,969,061</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.15</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,238,122</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.15</span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended, September 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">51,750,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">41,400,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,350,000</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the nine months ended, September 30, 2021</b></span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Previously Reported</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">48,906,593</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.09</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></div></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 12.6pt"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">As Restated</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">39,125,275</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">10,275,824</span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true"> </span></td> <td><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="-sec-ix-redline:true;font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</span></td> <td><span style="-sec-ix-redline:true"> </span></td></tr> </table> 36524863 14187614 0.34 34500000 0.11 10125000 0.11 37153752 14596248 -0.84 41400000 -0.24 10350000 -0.24 61945851 14393060 -0.51 37969061 -0.15 10238122 -0.15 51750000 0.22 41400000 0.22 10350000 0.22 48906593 0.09 39125275 0.08 10275824 0.08 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form10-K as filed with the SEC on April 15, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Principles of Consolidation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks and Uncertainties</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Initial Public Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Cash Equivalents</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Marketable Securities Held in Trust Account</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Warrant and FPA Liabilities</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the Warrants and forward purchase warrants (as defined in Note 7) in accordance with the guidance contained in ASC 815-40, under which the Warrants and forward purchase warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants and forward purchase warrants as liabilities at their fair value and adjust the Warrants and forward purchase warrants to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statement of operations. The fair value of the Public Warrants were initially estimated using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Warrants as of each relevant date. The Private Placement Warrants and forward purchase warrants are valued using a Modified Black Scholes Option Pricing Model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Subject to Possible Redemption</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 41,400,000 shares of common stock subject to possible redemption at September 30, 2021 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s condensed consolidated balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At September 30, 2021 and December 31, 2020, the Class A common stock reflected in the condensed consolidated balance sheets are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.45pt 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 9pt">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">414,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(20,286,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Class A common stock issuance costs</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(22,073,126</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,359,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Class A common stock subject to possible redemption</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">414,000,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.45pt 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income Taxes</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2021, due to the valuation allowance recorded on the Company’s net operating losses and permanent differences.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net income (loss) per Common Share</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline:true">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,486,667 shares in the calculation of diluted loss per share, since the average stock price of the Company’s common stock for the three and nine months ended September 30, 2021 was less than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Three Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Nine Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">For the Period from September 25, 2020 (Inception) Through<br/> September 30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-style: italic"><span style="-sec-ix-redline:true">Basic and diluted net income (loss) per common share</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Numerator:</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 40%; text-align: left"><span style="-sec-ix-redline:true">Allocation of net income (loss), as adjusted</span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">9,233,638</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">2,308,410</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">3,309,040</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">869,083</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74"><span style="-sec-ix-redline:true">—</span></div></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">(1,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Denominator:</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true">Basic and diluted weighted average shares outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">41,400,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,350,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">39,125,275</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,275,824</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75"><span style="-sec-ix-redline:true">—</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,350,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="-sec-ix-redline:true">Basic and diluted net income (loss) per common share</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.22</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.22</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.08</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.08</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76"><span style="-sec-ix-redline:true">—</span></div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">(0.00</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair Value of Financial Instruments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 10).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair Value Measurements</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.8pt; text-align: justify"> </td> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"> </td> <td style="padding-right: 0.8pt; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"> </td> <td style="padding-right: 0.8pt; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Derivative Financial Instruments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Accounting Standards</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form10-K as filed with the SEC on April 15, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Principles of Consolidation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks and Uncertainties</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Initial Public Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Cash Equivalents</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Marketable Securities Held in Trust Account</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Warrant and FPA Liabilities</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the Warrants and forward purchase warrants (as defined in Note 7) in accordance with the guidance contained in ASC 815-40, under which the Warrants and forward purchase warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants and forward purchase warrants as liabilities at their fair value and adjust the Warrants and forward purchase warrants to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statement of operations. The fair value of the Public Warrants were initially estimated using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Warrants as of each relevant date. The Private Placement Warrants and forward purchase warrants are valued using a Modified Black Scholes Option Pricing Model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Subject to Possible Redemption</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 41,400,000 shares of common stock subject to possible redemption at September 30, 2021 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s condensed consolidated balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At September 30, 2021 and December 31, 2020, the Class A common stock reflected in the condensed consolidated balance sheets are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.45pt 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 9pt">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">414,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(20,286,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Class A common stock issuance costs</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(22,073,126</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,359,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Class A common stock subject to possible redemption</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">414,000,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.45pt 0pt 0; text-align: justify"> </p> 41400000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 9pt">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">414,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(20,286,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Class A common stock issuance costs</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(22,073,126</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,359,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Class A common stock subject to possible redemption</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">414,000,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.45pt 0pt 0; text-align: justify"> </p> 414000000 20286000 -22073126 42359126 414000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income Taxes</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2021, due to the valuation allowance recorded on the Company’s net operating losses and permanent differences.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.21 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net income (loss) per Common Share</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline:true">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,486,667 shares in the calculation of diluted loss per share, since the average stock price of the Company’s common stock for the three and nine months ended September 30, 2021 was less than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Three Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Nine Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">For the Period from September 25, 2020 (Inception) Through<br/> September 30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-style: italic"><span style="-sec-ix-redline:true">Basic and diluted net income (loss) per common share</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Numerator:</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 40%; text-align: left"><span style="-sec-ix-redline:true">Allocation of net income (loss), as adjusted</span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">9,233,638</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">2,308,410</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">3,309,040</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">869,083</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74"><span style="-sec-ix-redline:true">—</span></div></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">(1,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Denominator:</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true">Basic and diluted weighted average shares outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">41,400,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,350,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">39,125,275</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,275,824</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75"><span style="-sec-ix-redline:true">—</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,350,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="-sec-ix-redline:true">Basic and diluted net income (loss) per common share</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.22</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.22</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.08</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.08</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76"><span style="-sec-ix-redline:true">—</span></div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">(0.00</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 20486667 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Three Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Nine Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">For the Period from September 25, 2020 (Inception) Through<br/> September 30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="-sec-ix-redline:true">Non-redeemable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-style: italic"><span style="-sec-ix-redline:true">Basic and diluted net income (loss) per common share</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Numerator:</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td colspan="2"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 40%; text-align: left"><span style="-sec-ix-redline:true">Allocation of net income (loss), as adjusted</span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">9,233,638</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">2,308,410</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">3,309,040</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">869,083</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74"><span style="-sec-ix-redline:true">—</span></div></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline:true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-redline:true">(1,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true">Denominator:</span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td><span style="-sec-ix-redline:true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="-sec-ix-redline:true">Basic and diluted weighted average shares outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">41,400,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,350,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">39,125,275</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,275,824</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75"><span style="-sec-ix-redline:true">—</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline:true">10,350,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt"><span style="-sec-ix-redline:true"> </span></td> <td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: right"><span style="-sec-ix-redline:true"> </span></td><td style="font-size: 1pt; text-align: left"><span style="-sec-ix-redline:true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="-sec-ix-redline:true">Basic and diluted net income (loss) per common share</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.22</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.22</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.08</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">0.08</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76"><span style="-sec-ix-redline:true">—</span></div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="-sec-ix-redline:true"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-redline:true">(0.00</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="-sec-ix-redline:true">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 9233638 2308410 3309040 869083 -1000 41400000 10350000 39125275 10275824 10350000 0.22 0.22 0.08 0.08 0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> 250000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair Value of Financial Instruments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 10).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair Value Measurements</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.8pt; text-align: justify"> </td> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"> </td> <td style="padding-right: 0.8pt; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"> </td> <td style="padding-right: 0.8pt; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt; text-align: justify"> </td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Derivative Financial Instruments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Accounting Standards</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4. PUBLIC OFFERING</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 5,400,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one-third of one redeemable warrant redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). </p> 41400000 5400000 10 Each Unit consists of one share of common stock and one-third of one redeemable warrant redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5. PRIVATE PLACEMENT</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,686,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $10,030,000, from the Company in a private placement. Each Private Placement Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the Private Placement Warrants were deposited into the Company’s operating account, $8,280,000 of which was used to pay deferred underwriting fees and $1,080,000 was due to the Sponsor for working capital and $670,000 was maintained in the operating account to be used towards working capital purposes. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.</p> 6686667 1.5 10030000 11.5 8280000 1080000 670000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6. RELATED PARTY TRANSACTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Founder Shares</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 2, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 8,625,000 shares of the Company’s common stock (the “Founder Shares”). On January 12, 2021, the Company effected a stock dividend of 0.2 shares for each founder share outstanding, resulting in 10,350,000 shares of common stock outstanding. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, a total of 1,350,000 Founder Shares are no longer subject to forfeiture.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor will agree, subject to limited exceptions, not to transfer title to any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Administrative Services Agreement</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company entered into an agreement, commencing on January 12, 2021, pursuant to which the Company will pay an affiliate of the Sponsor a total of up to $10,000 per month for office space, utilities, secretarial support and administrative services. For the three and nine months ended September 30, 2021, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 is included in accrued expenses in the accompanying balance sheet. For the period from September 25, 2020 (inception) through September 30, 2020, the Company did not incur any fees for these services.</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due from Sponsor</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 0; text-align: justify; text-indent: 11.7pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the closing of the Initial Public Offering on January 15, 2021, a portion of the proceeds from the sale of the Private Placement Warrants in the amount of $1,080,000 was due to the Company to be held outside of the Trust Account for working capital purposes. Such amount was paid by the Sponsor to the Company on January 18, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Promissory Note — Related Party</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 25, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $150,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii.) the consummation of the Initial Public Offering or (iii) the abandonment of the Initial Public Offering. As of September 30, 2021 and December 31, 2020, there was $0 and $117,917, respectively, outstanding under the Promissory Note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 12, 2021 the sponsor committed to provide up to $1,000,000 in working capital loans as needed by the Company in order to finance transaction costs in connection with a Business Combination. The loans, if issued, will be non-interest bearing, unsecured and will be repaid upon the consummation of an initial business combination. If the Company does not consummate an initial business combination, all amounts loaned to the Company will be forgiven except to the extent that we have funds available outside of the Trust Account to repay such loans. As of September 30, 2021 there was $750,000 of working capital loans outstanding. On September 30, 2021 the sponsor committed to provide up to an additional $2,000,000 in working capital loans as needed by the Company in order to finance transaction costs in connection with a Business Combination. The loans will follow the same structure as the $1,000,000 working capital loans as described above. This borrowing is in addition to the above note initiated on August 12, 2021. The total commitment provided by the Sponsor will total $3,000,000, where $750,000 of which has been borrowed as of September 30, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0; text-align: justify"><b><i>Personnel Services Agreement</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0; text-align: justify">The Company entered into a Personnel Services Agreement, dated April 1, 2021, with the Sponsor pursuant to which, subject to maintaining funds adequate for our projected obligations, the Company expects to pay up to $2,000,000 in the aggregate in respect of the services of personnel affiliated with the Sponsor, including persons who may be directors or officers of the Company, for activities on the Company’s behalf, including services related to identifying, investigating and completing an initial business combination and other operational and support services. To the extent any amounts are in respect of the services of individuals who also serve as directors or executive officers of the Company, such amounts will be reviewed and approved by its audit committee. For the nine months ended September 30, 2021, the Company incurred $680,000, inclusive of $200,000 in initial payment of the agreement and $80,000 for each month within the second and third quarter for these services, of which $80,000 is included in accounts payable in the accompanying balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0; text-align: justify">The Sponsor, the Company’s officers, and directors or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf. For the three and nine months ended September 30, 2021, there were no amounts relating to the above arrangement recorded.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Related Party Loans</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers, directors and director nominees or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of the notes may be converted into warrants at a price of $1.50 per warrant (“Working Capital Warrants”). Such Working Capital Warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. </p> 25000 8625000 0.2 10350000 1350000 The Sponsor will agree, subject to limited exceptions, not to transfer title to any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. 10000 30000 90000 10000 1080000 150000 0 117917 1000000 750000 2000000 1000000 3000000 750000 2000000 For the nine months ended September 30, 2021, the Company incurred $680,000, inclusive of $200,000 in initial payment of the agreement and $80,000 for each month within the second and third quarter for these services, of which $80,000 is included in accounts payable in the accompanying balance sheets. 3000000 1.5 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7. COMMITMENTS<i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Registration Rights</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to a registration rights agreement entered into on January 12, 2021, the holders of the Founder Shares, Private Placement Warrants and any Working Capital Warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or Working Capital Warrants) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to four demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The agreement was amended as described below under “–Forward Purchase Agreement” to add the forward purchase securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>   </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Underwriting Agreement</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or $14,490,000. The deferred fee will be payable in cash to the underwriters solely in the event that the Company completes a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Forward Purchase Agreement</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 8, 2021. the Company entered into the forward purchase agreement (the “Forward Purchase Agreement”) with Northern Genesis Capital LLC (the “forward purchase investor”), pursuant to which, if the Company determines to raise capital by issuing equity securities in connection with the closing of its initial business combination, the forward purchase investor, an entity which is affiliated with the Company’s Sponsor, agreed and has the first right to purchase, subject to certain conditions, in an aggregate maximum amount of $75,000,000 of either (i) a number of units (the “forward purchase units”), consisting of one share of Class A common stock (the “forward purchase shares”) and one-sixth of one redeemable warrant (the “forward purchase warrants”), for $10.00 per unit or (ii) a number of forward purchase shares for $9.75 per share (such forward purchase shares valued at $9.75 per share or the forward purchase units, as the case may be, the “forward purchase securities”), in a private placement that would close simultaneously with the closing of the Initial Business Combination. The forward purchase warrants would have the same terms as the Public Warrants and the forward purchase shares would be identical to the shares of common stock included in the Units sold in the Initial Public Offering, except the forward purchase shares and the forward purchase warrants would be subject to transfer restrictions and certain registration rights. The funds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination and for expenses in connection with an initial Business Combination, and any excess funds may be used for the working capital needs of the post-transaction company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The forward purchase transaction is not dependent upon or affected by the percentage of stockholders electing to redeem their Public Shares and may provide the Company with an increased minimum funding level for the initial Business Combination. The forward purchase transaction is subject to conditions, including the forward purchase investor giving the Company its irrevocable written confirmation, confirming its commitment to purchase forward purchase securities and the amount thereof, no later than fifteen days after the Company notifies it of the Company’s intention to raise capital through the issuance of equity securities in connection with the closing of an initial Business Combination. The forward purchase investor may grant or withhold its consent and confirmation entirely within its sole discretion. Accordingly, if the forward purchase investor does not consent to and confirm the purchase, it will not be obligated to purchase any of the forward purchase securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 21, 2021, the Company entered into an Amended and Restated Forward Purchase Agreement with Northern Genesis Capital II LLC (formerly known as Northern Genesis Capital LLC) (“NGC”) (the “NGC Forward Purchase Agreement”), and certain additional forward purchase agreements with additional institutional investors (collectively, with the NGC Forward Purchase Agreement, the “Forward Purchase Agreements”). The Forward Purchase Agreements collectively replace that certain Forward Purchase Agreement previously entered into by the Company and NGC in connection with the closing of the Company’s initial public offering (the “Original Agreement”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of its initial business combination (subject to certain limited exceptions), the members of NGC (institutional investors that also are members of the Company’s Sponsor,) and the parties to the additional Forward Purchase Agreements have the first right to purchase an aggregate amount of up to 7,500,000 “forward purchase units” of the Company (under all Forward Purchase Agreements, taken together) for $10.00 per forward purchase unit, or an aggregate total of $75,000,000. Each forward purchase unit would consist of one share of the Company’s common stock and one-sixth of one warrant, with each whole warrant exercisable to purchase one share of the Company’s common stock at $11.50 per share. The common stock and warrants included in the forward purchase units would have the same terms as the Company’s publicly traded common stock and warrants but would not be freely tradable until registered. As with the Original Agreement, any commitment by any potential purchaser under any of the Forward Purchase Agreements is subject to and conditioned upon written confirmation from the prospective purchaser, following the Company’s notification to such purchaser of its intention to enter into an initial business combination agreement, which a prospective purchaser was grant or withhold in its sole discretion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if a private placement of equity securities in connection with the Company’s initial business combination exceeds $75,000,000, the Company agreed under each Forward Purchase Agreement to use its commercially reasonable efforts to permit priority participation in such additional amount by the members of NGC and the parties to the additional Forward Purchase Agreements, in an aggregate additional amount up to $150,000,000, on the same terms as those offered to other prospective purchasers in connection with such additional private placement amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Forward Purchase Agreement that the holders of the shares of common stock and warrants included in the forward purchase units will be entitled to registration rights pursuant to the terms of any registration rights agreement applicable to any equity securities issued by way of private placement in connection with the closing of the Company’s initial business combination or, in the absence of the foregoing, pursuant to the terms of the registration rights agreement entered into by the Company, Sponsor and NGC in connection with the Company’s initial public offering (the “Registration Rights Agreement”). Pursuant to the foregoing, on April 21, 2021, the Registration Rights Agreement was amended to clarify that the shares and warrants included in up to 7,500,000 total forward purchase units remain subject to the Registration Rights Agreement, regardless of the specific Forward Purchase Agreement pursuant to which they may be issued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Forward Purchase Agreement contains representations and warranties by each party, conditions to closing, and additional provisions that are customary for agreements of this nature. The terms of all of the Forward Purchase Agreements are substantively the same, except that the NGC Forward Purchase Agreement gives NGC board observation rights prior to the Company’s initial business combination, and gives the members of NGC a priority right to subscribe for any of the forward purchase units that any other prospective purchasers do not elect to purchase under any of the other Forward Purchase Agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0; text-align: justify"><b><i>Proposed Business Combination</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 22, 2021, the Company, Embark Trucks Inc., a Delaware Corporation (“Embark”), and NGAB Merger Sub Inc., a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), entered into an agreement and plan of merger (the “Merger Agreement”), pursuant to which, among other things, Merger Sub will be merged with and into Embark (the “Merger,” together with the other transactions related thereto, the “Embark Business Combination”), with Embark surviving the Merger as a wholly owned subsidiary of us (the “Surviving Corporation”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the date of closing of the Merger (the “Closing”) immediately prior to the effective time of the Merger (the “Effective Time”), the Company will amend and restate our certificate of incorporation (the “Post-Closing Charter”), pursuant to which, among other things, (i) the Company will have a dual class share structure with (x) shares of Class A common stock that will carry voting rights in the form of one vote per share (the “New Class A Common Stock”), and (y) shares of Class B common stock that will carry voting rights in the form of ten votes per share (the “New Class B Common Stock” and, together with the New Class A Common Stock, the “New Common Stock”) and (ii) all outstanding shares of Company common stock will be reclassified into shares of New Class A Common Stock. At Closing, the Company will also change its name to Embark Technology, Inc.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consummation of the transactions contemplated by the Merger Agreement is subject to customary conditions of the respective parties, including the approval of the Embark Business Combination by the Company’s stockholders. (See Note 11)</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Subscription Agreements</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the execution of the Merger Agreement, the Company and Embark entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to purchase, and the Company agreed to sell to the PIPE Investors, an aggregate of 16,000,000 shares of New Class A Common Stock (the “PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $160 million, in the PIPE Financing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in connection with the execution of the Merger Agreement, and pursuant to the Forward Purchase Agreements, certain FPA PIPE Investors agreed to purchase, and the Company agreed to sell to the FPA PIPE Investors, an aggregate of 4,000,000 units, consisting of one share of New Class A Common Stock and one-sixth of a warrant (the “PIPE Units”), for a purchase price of $10.00 per unit and an aggregate purchase price of $40 million, in the PIPE Financing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements and PIPE Units pursuant to the Forward Purchase Agreements is contingent upon, among other customary closing conditions, the substantially concurrent consummation of the Embark Business Combination. The purpose of the PIPE is to raise additional capital for use by the Surviving Corporation following the Closing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Sponsor Support Agreement and Foundation Investor Support Agreement</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Merger Agreement, the Company, Embark and the Sponsor entered into the Sponsor Support Agreement pursuant to which Sponsor agreed to vote all of its shares of NGA Common Stock in favor of the approval and adoption of the Business Combination. Additionally, Sponsor agreed, among other things, not to (i) transfer any of its shares of New Class A Common Stock or warrants for certain periods of time as set forth in the Sponsor Support Agreement, subject to certain customary exceptions or (ii) enter into any voting arrangement that is inconsistent with the commitment under the Sponsor Support Agreement to vote in favor of the approval and adoption of the Business Combination. Sponsor also agreed to forfeit, immediately prior to Closing, (i) a relative percentage of up to 1,130,239 Founder Shares to the extent that the Sponsor’s institutional investors fail to hold, at the Closing, at least one-half of the shares of NGA Common Stock issued to such investors in connection with our initial public offering, and (ii) up to 627,910 Founder Shares (currently expected to be 393,025 Founder Shares) in connection with the Forward Purchase Agreements investment. The Sponsor Support Agreement will terminate upon the termination of the Merger Agreement if the Closing does not occur.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in connection with the Merger Agreement, the Sponsor expects certain of its institutional investors to enter into separate Support Agreements pursuant to which such investors will agree, among other things, to vote all shares of our common stock held by such investor at the time of such vote (i) in favor of the approval and adoption of the Business Combination, the Merger Agreement and each of the Transaction Proposals (as defined in the Merger Agreement), (ii) against any other business combination proposal or related proposals; and (iii) against any proposal, action or agreement that would reasonably be expected to impede, frustrate, or prevent the Merger or the satisfaction of any of the conditions thereto. Each such investor is further expected to represent and agree that such investor has not entered into, and will not enter, any agreement that would restrict, limit or interfere with the voting agreement made in the Support Agreement. The Business Combination Agreement and related agreements are further described in the Form 8-K filed by the Company on June 23, 2021.</p> 0.035 14490000 the Company entered into the forward purchase agreement (the “Forward Purchase Agreement”) with Northern Genesis Capital LLC (the “forward purchase investor”), pursuant to which, if the Company determines to raise capital by issuing equity securities in connection with the closing of its initial business combination, the forward purchase investor, an entity which is affiliated with the Company’s Sponsor, agreed and has the first right to purchase, subject to certain conditions, in an aggregate maximum amount of $75,000,000 of either (i) a number of units (the “forward purchase units”), consisting of one share of Class A common stock (the “forward purchase shares”) and one-sixth of one redeemable warrant (the “forward purchase warrants”), for $10.00 per unit or (ii) a number of forward purchase shares for $9.75 per share (such forward purchase shares valued at $9.75 per share or the forward purchase units, as the case may be, the “forward purchase securities”), in a private placement that would close simultaneously with the closing of the Initial Business Combination. 7500000 10 75000000 11.5 75000000 150000000 7500000 16000000 10 160000000 4000000 10 40000000 Sponsor also agreed to forfeit, immediately prior to Closing, (i) a relative percentage of up to 1,130,239 Founder Shares to the extent that the Sponsor’s institutional investors fail to hold, at the Closing, at least one-half of the shares of NGA Common Stock issued to such investors in connection with our initial public offering, and (ii) up to 627,910 Founder Shares (currently expected to be 393,025 Founder Shares) in connection with the Forward Purchase Agreements investment. <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8. STOCKHOLDERS’ EQUITY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Preferred Stock</i> —</b> The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock</i></b> — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share. At September 30, 2021 and December 31, 2020, there were 10,350,000 shares of common stock issued and outstanding, excluding 41,400,000 and -0- shares of common stock subject to possible redemption, respectively.</p> 1000000 0.0001 At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding. 100000000 0.0001 10350000 10350000 10350000 10350000 41400000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9. WARRANT LIABILITY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Warrants</i></b> — Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has agreed that as soon as practicable, but in no event later than 15 days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of common stock issuable upon exercise of the warrants and thereafter will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Company’s common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once the warrants become exercisable, the Company may redeem the Public Warrants:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $0.01 per warrant;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30 days’ prior written notice of redemption to each warrant holder; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), for any 20 trading days within a 30 trading day period commencing once the warrants become exercisable and ending commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Private Placement Warrants and Working Capital Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants, Working Capital Warrants, and the common stock issuable upon the exercise of the Private Placement Warrants and Working Capital Warrants cannot be transferred until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Working Capital Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If any Private Placement Warrants or Working Capital Warrants are held by someone other than the initial purchasers or their permitted transferees, such Private Placement Warrants and Working Capital Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p> P5Y 0.01 18 9.2 0.60 9.2 1.15 18 1.80 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10. FAIR VALUE MEASUREMENTS </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.05pt"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Assets:</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Marketable securities held in Trust Account</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 9%; text-align: center">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">414,028,694</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Liabilities:</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrant liability – Public Warrants</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,766,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Warrant liability – Private Placement Warrants</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,489,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">FPA Liability</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">713,333</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Private Warrants were initially valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the changes in the fair value of private and public warrant liabilities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair value as of September 25, 2020 (inception)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 64%">Initial measurement on January 15, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,297,467</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,286,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">30,583,467</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,808,400</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,520,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,328,400</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Fair value as of September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,849,067</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14,766,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">22,255,067</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurements of the FPA liability are classified as Level 2 due to the use of an observable market quote for a similar asset in an active market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents a summary of the changes in the fair value of the FPA liability, a Level 2 liability, measured on a recurring basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">FPA</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Fair value, April 21, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">966,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Loss on change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(253,333</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Fair value, September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">713,334</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no transfers in or out of Level 3 from other levels in the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Private Placement Warrants was estimated at January 15, 2021 to be $1.54 per share and at September 30, 2021 to be $1.12 per share using the modified Black-Scholes option pricing model and the following assumptions:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 15, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Expected Volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">25.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">17.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.58</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.02</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Fair value per share of common stock</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.93</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Assets:</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Marketable securities held in Trust Account</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 9%; text-align: center">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">414,028,694</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Liabilities:</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrant liability – Public Warrants</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,766,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Warrant liability – Private Placement Warrants</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,489,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">FPA Liability</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">713,333</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 414028694 14766000 7489067 713333 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair value as of September 25, 2020 (inception)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 64%">Initial measurement on January 15, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,297,467</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,286,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">30,583,467</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,808,400</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,520,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,328,400</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Fair value as of September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,849,067</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14,766,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">22,255,067</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt"> </p> 10297467 20286000 30583467 -2808400 -5520000 -8328400 7849067 14766000 22255067 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">FPA</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Fair value, April 21, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">966,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Loss on change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(253,333</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Fair value, September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">713,334</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 966667 -253333 713334 1.54 1.12 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 15, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Expected Volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">25.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">17.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.58</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.02</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Fair value per share of common stock</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.93</td><td style="text-align: left"> </td></tr> </table> 0.25 0.17 0.0058 0.0102 P5Y P5Y 9.51 9.93 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11. SUBSEQUENT EVENTS</b> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 30, 2021, the Sponsor has amended the August 12, 2021 Commitment Letter to provide $2,000,000 in working capital loans in addition to the previously provided $1,000,000. As of September 30, 2021, there was $750,000 of working capital loans outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 9, 2021, the Company issued 2,000,000 Working Capital Warrants in full payment of its obligation under the Working Capital Loans.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At a special meeting of stockholders on November 9, 2021 (the “Special Meeting”), the stockholders of the Company voted and approved Proposal Nos. 1 through 7, including the Embark Business Combination, each of which is further described in the Proxy Statement/Prospectus filed by the Company with the SEC on October 19, 2021.</p> the Sponsor has amended the August 12, 2021 Commitment Letter to provide $2,000,000 in working capital loans in addition to the previously provided $1,000,000. As of September 30, 2021, there was $750,000 of working capital loans outstanding. 2000000 Embark Technology, Inc. Embark Technology, Inc., formerly known as Northern Genesis Acquisition Corp. II (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on this Form 10-Q/A for the three and nine month period ended September 30, 2021 (the “First Amendment”), as originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 10, 2021 (the “Original Form 10-Q”) to amend and restate the Company’s September 30, 2021 Quarterly Report on Form 10-Q, as further described below. This amended and restated report on Form 10-Q/A is presented as of the filing date of the Original Form 10-Q and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the restatement as described below. Accordingly, this Amendment No. 1 on Form 10-Q/A should be read in conjunction with our filings with the SEC subsequent to the date on which we filed the Original Form 10-Q. The Company is filing this First Amendment on Form 10-Q/A to reflect a restatement of the Company’s condensed financial statements as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021 to correct errors in the Company’s classification of public shares as permanent equity as further described below. On November 10, 2021, subsequent to the fiscal quarter ended September 30, 2021, Northern Genesis Acquisition Corp. II, our predecessor and a Delaware corporation (“NGA”), consummated the previously announced business combination pursuant to the agreement and plan of merger, dated as of June 22, 2021 (the “Merger Agreement”), by and among NGA, NGAB Merger Sub Inc., a Delaware corporation (“Merger Sub”), and Embark Trucks Inc., a Delaware corporation (“Embark Trucks”).Pursuant to the Merger Agreement, NGA acquired Embark Trucks, by way of Merger Sub merging with and into Embark Trucks, with Embark Trucks becoming a direct subsidiary of NGA as a result thereof (the “Business Combination”). On November 9, 2021, NGA held a special meeting of stockholders (the “Special Meeting”), at which the NGA stockholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Merger Agreement and (b) approving the other transactions contemplated by the Merger Agreement and related agreements described in the proxy statement/prospectus related thereto. Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, on November 10, 2021 (the “Closing Date”), the Business Combination was consummated (the “Closing”). On November 11, 2021, the business day following the Closing Date, the Company’s Class A common stock and warrants began trading on Nasdaq under the symbols “EMBK” and “EMBKW”. NGA’s public units automatically separated into their component securities upon consummation of the Business Combination and, as a result, no longer trade as a separate security and were delisted from the New York Stock Exchange. Unless stated otherwise, this report contains information about NGA before the consummation of the Business Combination. References to the “Company” in this report refer to NGA before the consummation of the Business Combination. Background of Restatement In the Company’s previously issued financial statements as of January 15, 2021 and March 31, 2021, a portion of the public shares were classified as permanent equity to maintain stockholders’ equity greater than $5,000,000 on the basis that the Company could consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001 under the Company’s charter. Thus, the Company can only complete a merger and continue to exist as a public company if there are sufficient public shares that do not redeem at the merger and so it was deemed appropriate to classify the portion of its public shares required to keep its stockholders’ equity above the $5,000,000 threshold as “shares not subject to redemption.” However, in light of recent comment letters issued by the Securities & Exchange Commission (“SEC”) to several special purpose acquisition companies, management re-evaluated the Company’s application of ASC 480-10-99 to its accounting classification of public shares. Upon re-evaluation, management determined that the public shares include certain provisions that require classification of the public shares as temporary equity regardless of the minimum net tangible asset required by the Company to complete its initial business combination. The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate all of the Company’s previously issued financial statements to report all public shares as temporary equity as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021. This First Amendment on Form 10-Q/A sets forth the Original Form 10-Q in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Form 10-Q have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-Q, and such forward-looking statements should be read in their historical context. The following items have been amended as a result of the restatement: Part I, Item 1, “Financial Statements” and Part I, Item 4, “Controls and Procedures.” In accordance with applicable SEC rules, this First Amendment on Form 10-Q/A includes an updated signature page and certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15. Refer to Note 2, Restatement of Previously Issued Financial Statements of this Form 10-Q/A for additional information and for the summary of the accounting impacts of these adjustments to the Company’s condensed financial statements as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021. The Company previously identified a material weakness in internal controls related to the accounting for warrants issued in connection with our initial public offering. As a result of the restatement described in this First Amendment on Form 10-Q/A, the Company has concluded there was a material weakness in the Company&apos;s internal control over financial reporting at the time the abovementioned financial statements were issued, and its disclosure controls and procedures were not effective at the time the abovementioned financial statements were issued. true --12-31 Q3 N/A 0001827980 XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2021
Nov. 09, 2021
Document Information Line Items    
Entity Registrant Name Embark Technology, Inc.  
Trading Symbol EMBK  
Document Type 10-Q/A  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   51,750,000
Amendment Flag true  
Amendment Description Embark Technology, Inc., formerly known as Northern Genesis Acquisition Corp. II (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on this Form 10-Q/A for the three and nine month period ended September 30, 2021 (the “First Amendment”), as originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 10, 2021 (the “Original Form 10-Q”) to amend and restate the Company’s September 30, 2021 Quarterly Report on Form 10-Q, as further described below. This amended and restated report on Form 10-Q/A is presented as of the filing date of the Original Form 10-Q and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the restatement as described below. Accordingly, this Amendment No. 1 on Form 10-Q/A should be read in conjunction with our filings with the SEC subsequent to the date on which we filed the Original Form 10-Q. The Company is filing this First Amendment on Form 10-Q/A to reflect a restatement of the Company’s condensed financial statements as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021 to correct errors in the Company’s classification of public shares as permanent equity as further described below. On November 10, 2021, subsequent to the fiscal quarter ended September 30, 2021, Northern Genesis Acquisition Corp. II, our predecessor and a Delaware corporation (“NGA”), consummated the previously announced business combination pursuant to the agreement and plan of merger, dated as of June 22, 2021 (the “Merger Agreement”), by and among NGA, NGAB Merger Sub Inc., a Delaware corporation (“Merger Sub”), and Embark Trucks Inc., a Delaware corporation (“Embark Trucks”).Pursuant to the Merger Agreement, NGA acquired Embark Trucks, by way of Merger Sub merging with and into Embark Trucks, with Embark Trucks becoming a direct subsidiary of NGA as a result thereof (the “Business Combination”). On November 9, 2021, NGA held a special meeting of stockholders (the “Special Meeting”), at which the NGA stockholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Merger Agreement and (b) approving the other transactions contemplated by the Merger Agreement and related agreements described in the proxy statement/prospectus related thereto. Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, on November 10, 2021 (the “Closing Date”), the Business Combination was consummated (the “Closing”). On November 11, 2021, the business day following the Closing Date, the Company’s Class A common stock and warrants began trading on Nasdaq under the symbols “EMBK” and “EMBKW”. NGA’s public units automatically separated into their component securities upon consummation of the Business Combination and, as a result, no longer trade as a separate security and were delisted from the New York Stock Exchange. Unless stated otherwise, this report contains information about NGA before the consummation of the Business Combination. References to the “Company” in this report refer to NGA before the consummation of the Business Combination. Background of Restatement In the Company’s previously issued financial statements as of January 15, 2021 and March 31, 2021, a portion of the public shares were classified as permanent equity to maintain stockholders’ equity greater than $5,000,000 on the basis that the Company could consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001 under the Company’s charter. Thus, the Company can only complete a merger and continue to exist as a public company if there are sufficient public shares that do not redeem at the merger and so it was deemed appropriate to classify the portion of its public shares required to keep its stockholders’ equity above the $5,000,000 threshold as “shares not subject to redemption.” However, in light of recent comment letters issued by the Securities & Exchange Commission (“SEC”) to several special purpose acquisition companies, management re-evaluated the Company’s application of ASC 480-10-99 to its accounting classification of public shares. Upon re-evaluation, management determined that the public shares include certain provisions that require classification of the public shares as temporary equity regardless of the minimum net tangible asset required by the Company to complete its initial business combination. The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate all of the Company’s previously issued financial statements to report all public shares as temporary equity as of January 15, 2021, as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021. This First Amendment on Form 10-Q/A sets forth the Original Form 10-Q in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Form 10-Q have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-Q, and such forward-looking statements should be read in their historical context. The following items have been amended as a result of the restatement: Part I, Item 1, “Financial Statements” and Part I, Item 4, “Controls and Procedures.” In accordance with applicable SEC rules, this First Amendment on Form 10-Q/A includes an updated signature page and certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15. Refer to Note 2, Restatement of Previously Issued Financial Statements of this Form 10-Q/A for additional information and for the summary of the accounting impacts of these adjustments to the Company’s condensed financial statements as of and for the three months ended March 31, 2021, as of and for the three and six months ended June 30, 2021 and for the three and nine months ended September 30, 2021. The Company previously identified a material weakness in internal controls related to the accounting for warrants issued in connection with our initial public offering. As a result of the restatement described in this First Amendment on Form 10-Q/A, the Company has concluded there was a material weakness in the Company's internal control over financial reporting at the time the abovementioned financial statements were issued, and its disclosure controls and procedures were not effective at the time the abovementioned financial statements were issued.  
Entity Central Index Key 0001827980  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-39881  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 86-3343965  
Entity Address, Address Line One 424 Townsend Street  
Entity Address, City or Town San Francisco  
Entity Address, Country CA  
City Area Code (415)  
Local Phone Number 671-9628  
Title of 12(b) Security Class A common Stock, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Entity Address, Postal Zip Code N/A  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 34,688
Prepaid expenses and other current assets 116,653
Total Current Assets 151,341
Deferred offering costs 249,917
Marketable securities held in Trust Account 414,028,694
TOTAL ASSETS 414,180,035 249,917
Current liabilities    
Accrued expenses 1,091,604 1,450
Accrued offering costs 107,000
Promissory note – related party 750,000 117,917
Total Current Liabilities 1,841,604 226,367
FPA liability 713,334
Warrant liability 22,255,067
Deferred underwriting fee payable 14,490,000
Total Liabilities 39,300,005 226,367
Commitments
Common stock subject to possible redemption 41,400,000 and 0 shares at redemption value at September 30, 2021 and December 31, 2020, respectively 414,000,000  
Stockholders’ Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 10,350,000 at September 30, 2021 and December 31, 2020 1,035 1,035
Additional paid-in capital 23,965
Accumulated deficit (39,121,005) (1,450)
Total Stockholders’ Equity (Deficit) (39,119,970) 23,550
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 414,180,035 $ 249,917
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Shares subject to possible redemption 41,400,000 0
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 10,350,000 10,350,000
Common stock, shares outstanding 10,350,000 10,350,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2021
Income Statement [Abstract]      
Operating and formation costs $ 1,000 $ 1,554,197 $ 3,016,548
Loss from operations (1,000) (1,554,197) (3,016,548)
Other income (loss):      
Change in fair value of warrant liability 12,701,734 8,328,400
Change in fair value of FPA liability 393,333 253,333
Loss on initial issuance of private warrants (267,467)
Offering costs allocated to warrant and FPA liabilities (1,148,289)
Interest earned on marketable securities held in Trust Account 5,328 28,694
Total other income, net 13,100,395 7,194,671
Net income $ (1,000) $ 11,546,198 $ 4,178,123
Basic and diluted weighted average shares outstanding, Common Stock (in Shares)   41,400,000 39,125,275
Basic and diluted net income (loss) per share, redeemable common stock (in Dollars per share)   $ 0.22 $ 0.08
Basic and diluted weighted average shares outstanding, non-redeemable common stock subject to possible redemption (in Shares) 10,350,000 10,350,000 10,275,824
Basic and diluted net income per share, Common Stock (in Dollars per share) $ 0 $ 0.22 $ 0.08
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Retained Earnings / (Accumulated Deficit)
Total
Balance at Sep. 24, 2020
Balance (in Shares) at Sep. 24, 2020      
Issuance of common stock to Sponsor $ 1,035 23,965 25,000
Issuance of common stock to Sponsor (in Shares) 10,350,000      
Net Income (Loss) (1,000) (1,000)
Balance at Sep. 30, 2020 $ 1,035 23,965 (1,000) 24,000
Balance (in Shares) at Sep. 30, 2020 10,350,000      
Balance at Dec. 31, 2020 $ 1,035 23,965 (1,450) 23,550
Balance (in Shares) at Dec. 31, 2020 10,350,000      
Accretion for common stock subject to redemption amount (23,965) (42,335,161) (42,359,126)
Net Income (Loss) 4,880,183 4,880,183
Balance at Mar. 31, 2021 $ 1,035 (37,456,428) (37,455,393)
Balance (in Shares) at Mar. 31, 2021 10,350,000      
Balance at Dec. 31, 2020 $ 1,035 23,965 (1,450) 23,550
Balance (in Shares) at Dec. 31, 2020 10,350,000      
Balance at Sep. 30, 2021 $ 1,035 (39,121,005) (39,119,970)
Balance (in Shares) at Sep. 30, 2021 10,350,000      
Balance at Mar. 31, 2021 $ 1,035 (37,456,428) (37,455,393)
Balance (in Shares) at Mar. 31, 2021 10,350,000      
Initial classification of FPA liability (966,667) (966,667)
Net Income (Loss) (12,244,108) (12,244,108)
Balance at Jun. 30, 2021 $ 1,035 (50,667,203) (50,666,168)
Balance (in Shares) at Jun. 30, 2021 10,350,000      
Net Income (Loss) 11,546,198 11,546,198
Balance at Sep. 30, 2021 $ 1,035 $ (39,121,005) $ (39,119,970)
Balance (in Shares) at Sep. 30, 2021 10,350,000      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (1,000) $ 4,182,273
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (28,694)
Changes in fair value of warrant liability (8,328,400)
Change in fair value of FPA liability (253,333)
Loss on initial issuance of private warrants 267,467
Offering costs allocable to warrant liabilities 1,148,289
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (116,653)
Accrued expenses 1,000 1,090,154
Net cash used in operating activities (2,038,897)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (414,000,000)
Net cash used in investing activities (414,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 405,720,000
Proceeds from sale of Private Placement Warrants 10,030,000
Proceeds from promissory note - related party 5,000 750,000
Repayment of promissory note – related party (117,917)
Payment of offering costs (5,000) (308,498)
Net cash provided by financing activities 416,073,585
Net Change in Cash 34,688
Cash – Beginning of period
Cash – End of period 34,688
Non-Cash investing and financing activities:    
Initial classification of common stock subject to possible redemption 414,000,000
Initial Classification of Warrant Liabilities 30,583,467
Deferred underwriting fee payable $ 14,490,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Organization and Business Operations
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Northern Genesis Acquisition Corp. II (the “Company”) was incorporated in Delaware on September 25, 2020. The Company is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to initially concentrate on target businesses making a positive contribution to sustainability through the ownership, financing and management of societal infrastructure.

 

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

The Company has a wholly owned subsidiary NGAB Merger Sub Inc., which was incorporated in Delaware on June 21, 2021 (“Merger Sub”).

 

As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

 

The registration statement for the Company’s Initial Public Offering was declared effective on January 12, 2021. On January 15, 2021, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares, which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000, which is described in Note 3.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,686,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Company’s sponsor, Northern Genesis Sponsor II LLC (the “Sponsor”), generating gross proceeds of $10,030,000, which is described in Note 4.

 

Transaction costs amounted to $23,221,415 consisting of $8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $451,415 of other offering costs.

 

Following the closing of the Initial Public Offering on January 15, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company intends to only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully complete a Business Combination.

 

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

 

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, if a majority of the then outstanding shares of common stock present and entitled to vote at the meeting to approve the business combination (or such greater number as may be required by applicable law or the rules of any applicable national securities exchange) are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

 

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

 

The Sponsor and the Company’s officers, directors and director nominees will agree (a) to waive redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination and certain amendments to the Amended and Restated Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provisions that specifically apply only to the period prior to the consummation of our initial business combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment (See Note 7).

 

The Company will have until January 15, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

 

The holders of the Founder Shares will agree to waive liquidation rights with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

 

In order to protect the amounts held in the Trust Account, the Sponsor will agree to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Capital Resources

 

As of September 30, 2021, the Company had $34,688 in its operating bank accounts, $414,028,694 in marketable securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem stock in connection therewith and working capital deficit of ($1,544,413), which excludes franchise taxes payable of $150,000, of which such amount will be paid from interest earned on the Trust Account and $28,694 of franchise taxes paid and not yet reimbursed from the trust.

 

The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may but are not obligated to (except as described above), loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing, the Company believes it will have sufficient cash to meet its needs through the earlier of consummation of a Business Combination or January 15, 2023, the deadline to complete a Business Combination pursuant to the Company’s Amended and Restated Certificate of Incorporation (unless otherwise amended by stockholders).

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements
9 Months Ended
Sep. 30, 2021
Restatement of Previously Issued Financial Statement [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

In connection with the preparation of the Company’s financial statements as of September 30, 2021 in its Original Form 10-Q, the Company concluded it should restate its financial statements to classify all Public Shares in temporary equity. In accordance with ASC 480, paragraph 10-S99, redemption provisions not solely within the control of the Company require common stock subject to possible redemption to be classified outside of permanent equity. The Company previously determined the common stock subject to possible redemption to be equal to the redemption value of $10.00 per share of common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. Accordingly, effective with this filing, the Company presents all redeemable common stock as temporary equity. Additionally, the Company in its Original Form 10-Q referred to these adjustments as a ‘revision’, however, these adjustments should have been identified as a ‘restatement’ of the previously issued financial statements.

 

As a result, management has noted a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and common stock.

 

The impact of the restatement on the Company’s financial statements is reflected in the following table:

 

   As Previously
Reported
   Adjustment   As Restated 
Balance Sheet as of January 15, 2021            
Common stock subject to redemption  $365,248,533   $48,751,367   $414,000,000 
Common stock shares  $1,523   $(488)  $1,035 
Additional paid-in capital  $6,415,718   $(6,415,718)  $ 
Accumulated deficit  $(1,417,236)  $(42,335,161)  $(43,752,397)
Total Stockholders’ Equity (Deficit)  $5,000,005   $(48,751,367)  $(43,751,362)
                
Balance Sheet as of March 31, 2021               
Common stock subject to possible redemption  $371,544,602   $42,455,398   $414,000,000 
Common stock shares  $1,460   $(425)  $1,035 
Additional paid-in capital  $119,812   $(119,812)  $ 
Retained Earnings (Accumulated deficit)  $4,878,733   $(42,335,161)  $(37,456,428)
Total Stockholders’ Equity (Deficit)  $5,000,005   $(42,455,398)  $(37,455,393)
                
Statement of Cash Flows for the Three Months Ended March 31, 2021    As Previously Reported    Adjustment    As Restated 
Initial classification of common stock subject to possible redemption  $365,248,633   $48,751,367   $414,000,000 
Change in value of common stock subject to possible redemption  $6,295,969   $(6,295,969)  $ 
                
Statement of Cash Flows for the Six Months Ended June 30, 2021               
Initial classification of common stock subject to possible redemption  $365,248,633   $48,751,367   $414,000,000 
Change in value of common stock subject to possible redemption  $48,751,367   $(48,751,367)  $ 
                
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) March 31, 2021   As Previously Reported    Adjustment    As Restated 
Sale of 41,400,000 Units, net of underwriting discounts  $371,629,911   $(371,629,911)  $ 
Initial value of common stock subject to possible redemption at IPO date   (365,248,633)   365,248,633     
Change in value of common stock subject to redemption   6,295,969    (6,295,969)    
Accretion for common stock to redemption amount       (42,359,126)   (42,359,126)
Total stockholders’ equity (deficit)   5,000,005    (42,455,398)   (37,455,393)
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) June 30, 2021               
Change in value of common stock subject to redemption  $42,455,398   $(42,455,398)  $ 
Total stockholders’ equity   (50,666,168)       (50,666,168)

 

In connection with the change in presentation for common stock subject to redemption, the Company also restated its income (loss) per share. The impact of this restatement on the Company’s financial statements is reflected in the following table:

  

   

Basic and diluted

weighted average shares outstanding, Class A common stock subject to possible redemption

 

    Basic and diluted net loss per share, Class A common stock     Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption     Basic and diluted net loss per share, Class B common stock  
For the three months ended, March 31, 2021                        
As Previously Reported     36,524,863     $
      14,187,614     $ 0.34  
As Restated     34,500,000     $ 0.11       10,125,000     $ 0.11  
For the three months ended, June 30, 2021                                
As Previously Reported     37,153,752     $
      14,596,248     $ (0.84 )
As Restated     41,400,000     $ (0.24 )     10,350,000     $ (0.24 )
For the six months ended, June 30, 2021                                
As Previously Reported     61,945,851     $
      14,393,060     $ (0.51 )
As Restated     37,969,061     $ (0.15 )     10,238,122     $ (0.15 )
For the three months ended, September 30, 2021                                
As Previously Reported     51,750,000     $ 0.22      
    $
 
As Restated     41,400,000     $ 0.22       10,350,000     $ 0.22  
For the nine months ended, September 30, 2021                                
As Previously Reported     48,906,593     $ 0.09      
    $
 
As Restated     39,125,275     $ 0.08       10,275,824     $ 0.08  
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form10-K as filed with the SEC on April 15, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods.

 

Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Risks and Uncertainties

 

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Initial Public Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.

  

Marketable Securities Held in Trust Account

 

At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

 

Warrant and FPA Liabilities

 

The Company accounts for the Warrants and forward purchase warrants (as defined in Note 7) in accordance with the guidance contained in ASC 815-40, under which the Warrants and forward purchase warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants and forward purchase warrants as liabilities at their fair value and adjust the Warrants and forward purchase warrants to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statement of operations. The fair value of the Public Warrants were initially estimated using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Warrants as of each relevant date. The Private Placement Warrants and forward purchase warrants are valued using a Modified Black Scholes Option Pricing Model.

 

Common Stock Subject to Possible Redemption

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 41,400,000 shares of common stock subject to possible redemption at September 30, 2021 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s condensed consolidated balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

 

At September 30, 2021 and December 31, 2020, the Class A common stock reflected in the condensed consolidated balance sheets are reconciled in the following table:

 

Gross proceeds  $414,000,000 
Less:     
Proceeds allocated to Public Warrants  $(20,286,000)
Class A common stock issuance costs  $(22,073,126)
Plus:     
Accretion of carrying value to redemption value  $42,359,126 
Class A common stock subject to possible redemption  $414,000,000 

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2021, due to the valuation allowance recorded on the Company’s net operating losses and permanent differences.

 

Net income (loss) per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value.

 

The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,486,667 shares in the calculation of diluted loss per share, since the average stock price of the Company’s common stock for the three and nine months ended September 30, 2021 was less than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive.

 

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

 

   Three Months Ended
September 30, 2021
   Nine Months Ended
September 30, 2021
   For the Period from September 25, 2020 (Inception) Through
September 30, 2020
 
   Redeemable   Non-redeemable   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
Basic and diluted net income (loss) per common share                        
Numerator:                        
Allocation of net income (loss), as adjusted  $9,233,638   $2,308,410   $3,309,040   $869,083   $
   $(1,000)
Denominator:                              
Basic and diluted weighted average shares outstanding   41,400,000    10,350,000    39,125,275    10,275,824    
    10,350,000 
                               
Basic and diluted net income (loss) per common share  $0.22   $0.22   $0.08   $0.08   $
   $(0.00)

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 10).

  

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
     
  Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
     
  Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Recent Accounting Standards

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Public Offering
9 Months Ended
Sep. 30, 2021
Public Offering Disclosure [Abstract]  
PUBLIC OFFERING

NOTE 4. PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 5,400,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one-third of one redeemable warrant redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Private Placement
9 Months Ended
Sep. 30, 2021
Private Placement Disclosure [Abstract]  
PRIVATE PLACEMENT

NOTE 5. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,686,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $10,030,000, from the Company in a private placement. Each Private Placement Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the Private Placement Warrants were deposited into the Company’s operating account, $8,280,000 of which was used to pay deferred underwriting fees and $1,080,000 was due to the Sponsor for working capital and $670,000 was maintained in the operating account to be used towards working capital purposes. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
9 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On October 2, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 8,625,000 shares of the Company’s common stock (the “Founder Shares”). On January 12, 2021, the Company effected a stock dividend of 0.2 shares for each founder share outstanding, resulting in 10,350,000 shares of common stock outstanding. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, a total of 1,350,000 Founder Shares are no longer subject to forfeiture.

 

The Sponsor will agree, subject to limited exceptions, not to transfer title to any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. 

 

Administrative Services Agreement

 

The Company entered into an agreement, commencing on January 12, 2021, pursuant to which the Company will pay an affiliate of the Sponsor a total of up to $10,000 per month for office space, utilities, secretarial support and administrative services. For the three and nine months ended September 30, 2021, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 is included in accrued expenses in the accompanying balance sheet. For the period from September 25, 2020 (inception) through September 30, 2020, the Company did not incur any fees for these services. 

 

Due from Sponsor

 

At the closing of the Initial Public Offering on January 15, 2021, a portion of the proceeds from the sale of the Private Placement Warrants in the amount of $1,080,000 was due to the Company to be held outside of the Trust Account for working capital purposes. Such amount was paid by the Sponsor to the Company on January 18, 2021.

 

Promissory Note — Related Party

 

On September 25, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $150,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii.) the consummation of the Initial Public Offering or (iii) the abandonment of the Initial Public Offering. As of September 30, 2021 and December 31, 2020, there was $0 and $117,917, respectively, outstanding under the Promissory Note.

 

On August 12, 2021 the sponsor committed to provide up to $1,000,000 in working capital loans as needed by the Company in order to finance transaction costs in connection with a Business Combination. The loans, if issued, will be non-interest bearing, unsecured and will be repaid upon the consummation of an initial business combination. If the Company does not consummate an initial business combination, all amounts loaned to the Company will be forgiven except to the extent that we have funds available outside of the Trust Account to repay such loans. As of September 30, 2021 there was $750,000 of working capital loans outstanding. On September 30, 2021 the sponsor committed to provide up to an additional $2,000,000 in working capital loans as needed by the Company in order to finance transaction costs in connection with a Business Combination. The loans will follow the same structure as the $1,000,000 working capital loans as described above. This borrowing is in addition to the above note initiated on August 12, 2021. The total commitment provided by the Sponsor will total $3,000,000, where $750,000 of which has been borrowed as of September 30, 2021.

 

Personnel Services Agreement

 

The Company entered into a Personnel Services Agreement, dated April 1, 2021, with the Sponsor pursuant to which, subject to maintaining funds adequate for our projected obligations, the Company expects to pay up to $2,000,000 in the aggregate in respect of the services of personnel affiliated with the Sponsor, including persons who may be directors or officers of the Company, for activities on the Company’s behalf, including services related to identifying, investigating and completing an initial business combination and other operational and support services. To the extent any amounts are in respect of the services of individuals who also serve as directors or executive officers of the Company, such amounts will be reviewed and approved by its audit committee. For the nine months ended September 30, 2021, the Company incurred $680,000, inclusive of $200,000 in initial payment of the agreement and $80,000 for each month within the second and third quarter for these services, of which $80,000 is included in accounts payable in the accompanying balance sheets.

 

The Sponsor, the Company’s officers, and directors or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf. For the three and nine months ended September 30, 2021, there were no amounts relating to the above arrangement recorded.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers, directors and director nominees or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of the notes may be converted into warrants at a price of $1.50 per warrant (“Working Capital Warrants”). Such Working Capital Warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments
9 Months Ended
Sep. 30, 2021
Commitments [Abstract]  
COMMITMENTS

NOTE 7. COMMITMENTS 

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on January 12, 2021, the holders of the Founder Shares, Private Placement Warrants and any Working Capital Warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or Working Capital Warrants) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to four demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The agreement was amended as described below under “–Forward Purchase Agreement” to add the forward purchase securities.

   

Underwriting Agreement

 

The underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or $14,490,000. The deferred fee will be payable in cash to the underwriters solely in the event that the Company completes a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

 

Forward Purchase Agreement

 

On January 8, 2021. the Company entered into the forward purchase agreement (the “Forward Purchase Agreement”) with Northern Genesis Capital LLC (the “forward purchase investor”), pursuant to which, if the Company determines to raise capital by issuing equity securities in connection with the closing of its initial business combination, the forward purchase investor, an entity which is affiliated with the Company’s Sponsor, agreed and has the first right to purchase, subject to certain conditions, in an aggregate maximum amount of $75,000,000 of either (i) a number of units (the “forward purchase units”), consisting of one share of Class A common stock (the “forward purchase shares”) and one-sixth of one redeemable warrant (the “forward purchase warrants”), for $10.00 per unit or (ii) a number of forward purchase shares for $9.75 per share (such forward purchase shares valued at $9.75 per share or the forward purchase units, as the case may be, the “forward purchase securities”), in a private placement that would close simultaneously with the closing of the Initial Business Combination. The forward purchase warrants would have the same terms as the Public Warrants and the forward purchase shares would be identical to the shares of common stock included in the Units sold in the Initial Public Offering, except the forward purchase shares and the forward purchase warrants would be subject to transfer restrictions and certain registration rights. The funds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination and for expenses in connection with an initial Business Combination, and any excess funds may be used for the working capital needs of the post-transaction company.

 

The forward purchase transaction is not dependent upon or affected by the percentage of stockholders electing to redeem their Public Shares and may provide the Company with an increased minimum funding level for the initial Business Combination. The forward purchase transaction is subject to conditions, including the forward purchase investor giving the Company its irrevocable written confirmation, confirming its commitment to purchase forward purchase securities and the amount thereof, no later than fifteen days after the Company notifies it of the Company’s intention to raise capital through the issuance of equity securities in connection with the closing of an initial Business Combination. The forward purchase investor may grant or withhold its consent and confirmation entirely within its sole discretion. Accordingly, if the forward purchase investor does not consent to and confirm the purchase, it will not be obligated to purchase any of the forward purchase securities.

 

On April 21, 2021, the Company entered into an Amended and Restated Forward Purchase Agreement with Northern Genesis Capital II LLC (formerly known as Northern Genesis Capital LLC) (“NGC”) (the “NGC Forward Purchase Agreement”), and certain additional forward purchase agreements with additional institutional investors (collectively, with the NGC Forward Purchase Agreement, the “Forward Purchase Agreements”). The Forward Purchase Agreements collectively replace that certain Forward Purchase Agreement previously entered into by the Company and NGC in connection with the closing of the Company’s initial public offering (the “Original Agreement”).

 

Pursuant to the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of its initial business combination (subject to certain limited exceptions), the members of NGC (institutional investors that also are members of the Company’s Sponsor,) and the parties to the additional Forward Purchase Agreements have the first right to purchase an aggregate amount of up to 7,500,000 “forward purchase units” of the Company (under all Forward Purchase Agreements, taken together) for $10.00 per forward purchase unit, or an aggregate total of $75,000,000. Each forward purchase unit would consist of one share of the Company’s common stock and one-sixth of one warrant, with each whole warrant exercisable to purchase one share of the Company’s common stock at $11.50 per share. The common stock and warrants included in the forward purchase units would have the same terms as the Company’s publicly traded common stock and warrants but would not be freely tradable until registered. As with the Original Agreement, any commitment by any potential purchaser under any of the Forward Purchase Agreements is subject to and conditioned upon written confirmation from the prospective purchaser, following the Company’s notification to such purchaser of its intention to enter into an initial business combination agreement, which a prospective purchaser was grant or withhold in its sole discretion.

 

In addition, if a private placement of equity securities in connection with the Company’s initial business combination exceeds $75,000,000, the Company agreed under each Forward Purchase Agreement to use its commercially reasonable efforts to permit priority participation in such additional amount by the members of NGC and the parties to the additional Forward Purchase Agreements, in an aggregate additional amount up to $150,000,000, on the same terms as those offered to other prospective purchasers in connection with such additional private placement amount.

 

Each Forward Purchase Agreement that the holders of the shares of common stock and warrants included in the forward purchase units will be entitled to registration rights pursuant to the terms of any registration rights agreement applicable to any equity securities issued by way of private placement in connection with the closing of the Company’s initial business combination or, in the absence of the foregoing, pursuant to the terms of the registration rights agreement entered into by the Company, Sponsor and NGC in connection with the Company’s initial public offering (the “Registration Rights Agreement”). Pursuant to the foregoing, on April 21, 2021, the Registration Rights Agreement was amended to clarify that the shares and warrants included in up to 7,500,000 total forward purchase units remain subject to the Registration Rights Agreement, regardless of the specific Forward Purchase Agreement pursuant to which they may be issued.

 

Each Forward Purchase Agreement contains representations and warranties by each party, conditions to closing, and additional provisions that are customary for agreements of this nature. The terms of all of the Forward Purchase Agreements are substantively the same, except that the NGC Forward Purchase Agreement gives NGC board observation rights prior to the Company’s initial business combination, and gives the members of NGC a priority right to subscribe for any of the forward purchase units that any other prospective purchasers do not elect to purchase under any of the other Forward Purchase Agreements.

 

Proposed Business Combination

 

On June 22, 2021, the Company, Embark Trucks Inc., a Delaware Corporation (“Embark”), and NGAB Merger Sub Inc., a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), entered into an agreement and plan of merger (the “Merger Agreement”), pursuant to which, among other things, Merger Sub will be merged with and into Embark (the “Merger,” together with the other transactions related thereto, the “Embark Business Combination”), with Embark surviving the Merger as a wholly owned subsidiary of us (the “Surviving Corporation”).

 

On the date of closing of the Merger (the “Closing”) immediately prior to the effective time of the Merger (the “Effective Time”), the Company will amend and restate our certificate of incorporation (the “Post-Closing Charter”), pursuant to which, among other things, (i) the Company will have a dual class share structure with (x) shares of Class A common stock that will carry voting rights in the form of one vote per share (the “New Class A Common Stock”), and (y) shares of Class B common stock that will carry voting rights in the form of ten votes per share (the “New Class B Common Stock” and, together with the New Class A Common Stock, the “New Common Stock”) and (ii) all outstanding shares of Company common stock will be reclassified into shares of New Class A Common Stock. At Closing, the Company will also change its name to Embark Technology, Inc.

 

Consummation of the transactions contemplated by the Merger Agreement is subject to customary conditions of the respective parties, including the approval of the Embark Business Combination by the Company’s stockholders. (See Note 11)

 

Subscription Agreements

 

In connection with the execution of the Merger Agreement, the Company and Embark entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to purchase, and the Company agreed to sell to the PIPE Investors, an aggregate of 16,000,000 shares of New Class A Common Stock (the “PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $160 million, in the PIPE Financing.

 

In addition, in connection with the execution of the Merger Agreement, and pursuant to the Forward Purchase Agreements, certain FPA PIPE Investors agreed to purchase, and the Company agreed to sell to the FPA PIPE Investors, an aggregate of 4,000,000 units, consisting of one share of New Class A Common Stock and one-sixth of a warrant (the “PIPE Units”), for a purchase price of $10.00 per unit and an aggregate purchase price of $40 million, in the PIPE Financing.

 

The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements and PIPE Units pursuant to the Forward Purchase Agreements is contingent upon, among other customary closing conditions, the substantially concurrent consummation of the Embark Business Combination. The purpose of the PIPE is to raise additional capital for use by the Surviving Corporation following the Closing.

 

Sponsor Support Agreement and Foundation Investor Support Agreement

 

In connection with the Merger Agreement, the Company, Embark and the Sponsor entered into the Sponsor Support Agreement pursuant to which Sponsor agreed to vote all of its shares of NGA Common Stock in favor of the approval and adoption of the Business Combination. Additionally, Sponsor agreed, among other things, not to (i) transfer any of its shares of New Class A Common Stock or warrants for certain periods of time as set forth in the Sponsor Support Agreement, subject to certain customary exceptions or (ii) enter into any voting arrangement that is inconsistent with the commitment under the Sponsor Support Agreement to vote in favor of the approval and adoption of the Business Combination. Sponsor also agreed to forfeit, immediately prior to Closing, (i) a relative percentage of up to 1,130,239 Founder Shares to the extent that the Sponsor’s institutional investors fail to hold, at the Closing, at least one-half of the shares of NGA Common Stock issued to such investors in connection with our initial public offering, and (ii) up to 627,910 Founder Shares (currently expected to be 393,025 Founder Shares) in connection with the Forward Purchase Agreements investment. The Sponsor Support Agreement will terminate upon the termination of the Merger Agreement if the Closing does not occur.

 

In addition, in connection with the Merger Agreement, the Sponsor expects certain of its institutional investors to enter into separate Support Agreements pursuant to which such investors will agree, among other things, to vote all shares of our common stock held by such investor at the time of such vote (i) in favor of the approval and adoption of the Business Combination, the Merger Agreement and each of the Transaction Proposals (as defined in the Merger Agreement), (ii) against any other business combination proposal or related proposals; and (iii) against any proposal, action or agreement that would reasonably be expected to impede, frustrate, or prevent the Merger or the satisfaction of any of the conditions thereto. Each such investor is further expected to represent and agree that such investor has not entered into, and will not enter, any agreement that would restrict, limit or interfere with the voting agreement made in the Support Agreement. The Business Combination Agreement and related agreements are further described in the Form 8-K filed by the Company on June 23, 2021.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 8. STOCKHOLDERS’ EQUITY

 

Preferred Stock The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.

 

Common Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share. At September 30, 2021 and December 31, 2020, there were 10,350,000 shares of common stock issued and outstanding, excluding 41,400,000 and -0- shares of common stock subject to possible redemption, respectively.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Warrant Liability
9 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
WARRANT LIABILITY

NOTE 9. WARRANT LIABILITY

 

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

 

The Company has agreed that as soon as practicable, but in no event later than 15 days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of common stock issuable upon exercise of the warrants and thereafter will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Company’s common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

Once the warrants become exercisable, the Company may redeem the Public Warrants:

 

  in whole and not in part;
     
  at a price of $0.01 per warrant;
     
  upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
     
  if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), for any 20 trading days within a 30 trading day period commencing once the warrants become exercisable and ending commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders

 

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

 

The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

 

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

 

The Private Placement Warrants and Working Capital Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants, Working Capital Warrants, and the common stock issuable upon the exercise of the Private Placement Warrants and Working Capital Warrants cannot be transferred until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Working Capital Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If any Private Placement Warrants or Working Capital Warrants are held by someone other than the initial purchasers or their permitted transferees, such Private Placement Warrants and Working Capital Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 10. FAIR VALUE MEASUREMENTS 

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. 

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

  

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level   September 30,
2021
 
Assets:        
Marketable securities held in Trust Account   1   $414,028,694 
Liabilities:          
Warrant liability – Public Warrants   1   $14,766,000 
Warrant liability – Private Placement Warrants   3   $7,489,067 
FPA Liability   2   $713,333 

 

The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations.

 

The Private Warrants were initially valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date.

  

The following table presents the changes in the fair value of private and public warrant liabilities:

 

   Private Placement   Public   Warrant
Liabilities
 
Fair value as of September 25, 2020 (inception)  $
   $
   $
 
Initial measurement on January 15, 2021   10,297,467    20,286,000    30,583,467 
Change in valuation inputs or other assumptions   (2,808,400)   (5,520,000)   (8,328,400)
Fair value as of September 30, 2021  $7,849,067   $14,766,000   $22,255,067 

 

The measurements of the FPA liability are classified as Level 2 due to the use of an observable market quote for a similar asset in an active market.

 

The following table presents a summary of the changes in the fair value of the FPA liability, a Level 2 liability, measured on a recurring basis.

 

   FPA 
   Liability 
Fair value, April 21, 2021  $966,667 
Loss on change in fair value   (253,333)
Fair value, September 30, 2021  $713,334 

 

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

 

The fair value of the Private Placement Warrants was estimated at January 15, 2021 to be $1.54 per share and at September 30, 2021 to be $1.12 per share using the modified Black-Scholes option pricing model and the following assumptions:

 

   January 15, 2021   September 30,
2021
 
Expected Volatility   25.0%   17.0%
Risk-free interest rate   0.58%   1.02%
Expected term (years)   5.00    5.00 
Fair value per share of common stock  $9.51   $9.93 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 11. SUBSEQUENT EVENTS 

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.

 

On September 30, 2021, the Sponsor has amended the August 12, 2021 Commitment Letter to provide $2,000,000 in working capital loans in addition to the previously provided $1,000,000. As of September 30, 2021, there was $750,000 of working capital loans outstanding.

 

On November 9, 2021, the Company issued 2,000,000 Working Capital Warrants in full payment of its obligation under the Working Capital Loans.

 

At a special meeting of stockholders on November 9, 2021 (the “Special Meeting”), the stockholders of the Company voted and approved Proposal Nos. 1 through 7, including the Embark Business Combination, each of which is further described in the Proxy Statement/Prospectus filed by the Company with the SEC on October 19, 2021.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form10-K as filed with the SEC on April 15, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods.

 

Principles of Consolidation

Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Risks and Uncertainties

Risks and Uncertainties

 

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Initial Public Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Emerging Growth Company

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.

  

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

 

At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

 

Warrant and FPA Liabilities

Warrant and FPA Liabilities

 

The Company accounts for the Warrants and forward purchase warrants (as defined in Note 7) in accordance with the guidance contained in ASC 815-40, under which the Warrants and forward purchase warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants and forward purchase warrants as liabilities at their fair value and adjust the Warrants and forward purchase warrants to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statement of operations. The fair value of the Public Warrants were initially estimated using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Warrants as of each relevant date. The Private Placement Warrants and forward purchase warrants are valued using a Modified Black Scholes Option Pricing Model.

 

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, the 41,400,000 shares of common stock subject to possible redemption at September 30, 2021 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s condensed consolidated balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

 

At September 30, 2021 and December 31, 2020, the Class A common stock reflected in the condensed consolidated balance sheets are reconciled in the following table:

 

Gross proceeds  $414,000,000 
Less:     
Proceeds allocated to Public Warrants  $(20,286,000)
Class A common stock issuance costs  $(22,073,126)
Plus:     
Accretion of carrying value to redemption value  $42,359,126 
Class A common stock subject to possible redemption  $414,000,000 

 

Income Taxes

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2021, due to the valuation allowance recorded on the Company’s net operating losses and permanent differences.

 

Net income (loss) per Common Share

Net income (loss) per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value.

 

The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,486,667 shares in the calculation of diluted loss per share, since the average stock price of the Company’s common stock for the three and nine months ended September 30, 2021 was less than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive.

 

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

 

   Three Months Ended
September 30, 2021
   Nine Months Ended
September 30, 2021
   For the Period from September 25, 2020 (Inception) Through
September 30, 2020
 
   Redeemable   Non-redeemable   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
Basic and diluted net income (loss) per common share                        
Numerator:                        
Allocation of net income (loss), as adjusted  $9,233,638   $2,308,410   $3,309,040   $869,083   $
   $(1,000)
Denominator:                              
Basic and diluted weighted average shares outstanding   41,400,000    10,350,000    39,125,275    10,275,824    
    10,350,000 
                               
Basic and diluted net income (loss) per common share  $0.22   $0.22   $0.08   $0.08   $
   $(0.00)

 

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 10).

  

Fair Value Measurements

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
     
  Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
     
  Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Derivative Financial Instruments

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Recent Accounting Standards

Recent Accounting Standards

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Tables)
9 Months Ended
Sep. 30, 2021
Revision Of Previously Issued Financial Statements [Abstract]  
Schedule of financial statements
   As Previously
Reported
   Adjustment   As Restated 
Balance Sheet as of January 15, 2021            
Common stock subject to redemption  $365,248,533   $48,751,367   $414,000,000 
Common stock shares  $1,523   $(488)  $1,035 
Additional paid-in capital  $6,415,718   $(6,415,718)  $ 
Accumulated deficit  $(1,417,236)  $(42,335,161)  $(43,752,397)
Total Stockholders’ Equity (Deficit)  $5,000,005   $(48,751,367)  $(43,751,362)
                
Balance Sheet as of March 31, 2021               
Common stock subject to possible redemption  $371,544,602   $42,455,398   $414,000,000 
Common stock shares  $1,460   $(425)  $1,035 
Additional paid-in capital  $119,812   $(119,812)  $ 
Retained Earnings (Accumulated deficit)  $4,878,733   $(42,335,161)  $(37,456,428)
Total Stockholders’ Equity (Deficit)  $5,000,005   $(42,455,398)  $(37,455,393)
                
Statement of Cash Flows for the Three Months Ended March 31, 2021    As Previously Reported    Adjustment    As Restated 
Initial classification of common stock subject to possible redemption  $365,248,633   $48,751,367   $414,000,000 
Change in value of common stock subject to possible redemption  $6,295,969   $(6,295,969)  $ 
                
Statement of Cash Flows for the Six Months Ended June 30, 2021               
Initial classification of common stock subject to possible redemption  $365,248,633   $48,751,367   $414,000,000 
Change in value of common stock subject to possible redemption  $48,751,367   $(48,751,367)  $ 
                
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) March 31, 2021   As Previously Reported    Adjustment    As Restated 
Sale of 41,400,000 Units, net of underwriting discounts  $371,629,911   $(371,629,911)  $ 
Initial value of common stock subject to possible redemption at IPO date   (365,248,633)   365,248,633     
Change in value of common stock subject to redemption   6,295,969    (6,295,969)    
Accretion for common stock to redemption amount       (42,359,126)   (42,359,126)
Total stockholders’ equity (deficit)   5,000,005    (42,455,398)   (37,455,393)
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) June 30, 2021               
Change in value of common stock subject to redemption  $42,455,398   $(42,455,398)  $ 
Total stockholders’ equity   (50,666,168)       (50,666,168)

 

Schedule of common stock subject to redemption
   

Basic and diluted

weighted average shares outstanding, Class A common stock subject to possible redemption

 

    Basic and diluted net loss per share, Class A common stock     Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption     Basic and diluted net loss per share, Class B common stock  
For the three months ended, March 31, 2021                        
As Previously Reported     36,524,863     $
      14,187,614     $ 0.34  
As Restated     34,500,000     $ 0.11       10,125,000     $ 0.11  
For the three months ended, June 30, 2021                                
As Previously Reported     37,153,752     $
      14,596,248     $ (0.84 )
As Restated     41,400,000     $ (0.24 )     10,350,000     $ (0.24 )
For the six months ended, June 30, 2021                                
As Previously Reported     61,945,851     $
      14,393,060     $ (0.51 )
As Restated     37,969,061     $ (0.15 )     10,238,122     $ (0.15 )
For the three months ended, September 30, 2021                                
As Previously Reported     51,750,000     $ 0.22      
    $
 
As Restated     41,400,000     $ 0.22       10,350,000     $ 0.22  
For the nine months ended, September 30, 2021                                
As Previously Reported     48,906,593     $ 0.09      
    $
 
As Restated     39,125,275     $ 0.08       10,275,824     $ 0.08  
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of class A common stock reflected in the condensed consolidated balance sheets
Gross proceeds  $414,000,000 
Less:     
Proceeds allocated to Public Warrants  $(20,286,000)
Class A common stock issuance costs  $(22,073,126)
Plus:     
Accretion of carrying value to redemption value  $42,359,126 
Class A common stock subject to possible redemption  $414,000,000 

 

Schedule of calculation of basic and diluted net income (loss) per common share
   Three Months Ended
September 30, 2021
   Nine Months Ended
September 30, 2021
   For the Period from September 25, 2020 (Inception) Through
September 30, 2020
 
   Redeemable   Non-redeemable   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
Basic and diluted net income (loss) per common share                        
Numerator:                        
Allocation of net income (loss), as adjusted  $9,233,638   $2,308,410   $3,309,040   $869,083   $
   $(1,000)
Denominator:                              
Basic and diluted weighted average shares outstanding   41,400,000    10,350,000    39,125,275    10,275,824    
    10,350,000 
                               
Basic and diluted net income (loss) per common share  $0.22   $0.22   $0.08   $0.08   $
   $(0.00)

 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of company's assets and liabilities
Description  Level   September 30,
2021
 
Assets:        
Marketable securities held in Trust Account   1   $414,028,694 
Liabilities:          
Warrant liability – Public Warrants   1   $14,766,000 
Warrant liability – Private Placement Warrants   3   $7,489,067 
FPA Liability   2   $713,333 

 

Schedule of changes in fair value of private and public warrant liabilities
   Private Placement   Public   Warrant
Liabilities
 
Fair value as of September 25, 2020 (inception)  $
   $
   $
 
Initial measurement on January 15, 2021   10,297,467    20,286,000    30,583,467 
Change in valuation inputs or other assumptions   (2,808,400)   (5,520,000)   (8,328,400)
Fair value as of September 30, 2021  $7,849,067   $14,766,000   $22,255,067 

 

Schedule of changes in the fair value of the FPA liability
   FPA 
   Liability 
Fair value, April 21, 2021  $966,667 
Loss on change in fair value   (253,333)
Fair value, September 30, 2021  $713,334 

 

Schedule of black scholes option pricing model
   January 15, 2021   September 30,
2021
 
Expected Volatility   25.0%   17.0%
Risk-free interest rate   0.58%   1.02%
Expected term (years)   5.00    5.00 
Fair value per share of common stock  $9.51   $9.93 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Organization and Business Operations (Details) - USD ($)
9 Months Ended
Jan. 15, 2021
Sep. 30, 2021
Description of Organization and Business Operations (Details) [Line Items]    
Gross proceeds from Initial public offering $ 414,000,000  
Sale of warrants (in Shares)   6,686,667
Gross proceeds   $ 10,030,000
Transaction cost   23,221,415
Underwriting fees   8,280,000
Deferred underwriting fees   14,490,000
Other offering cost   $ 451,415
Percentage of assets held in the trust account   80.00%
Percentage of outstanding voting   50.00%
Share price (in Dollars per share)   $ 11.5
Net tangible assets   $ 5,000,001
Aggregate public shares, percentage   15.00%
Percentage of redemption of public shares   100.00%
Net interest to dissolution expenses   $ 100,000
Trust account, description   In order to protect the amounts held in the Trust Account, the Sponsor will agree to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Operating bank accounts   $ 34,688
Marketable securities   414,028,694
Working capital deficit   (1,544,413)
Franchise taxes payable   150,000
Franchise taxes paid   $ 28,694
Trust Account [Member]    
Description of Organization and Business Operations (Details) [Line Items]    
Share price (in Dollars per share)   $ 10
Business Combination [Member]    
Description of Organization and Business Operations (Details) [Line Items]    
Business Combination, description   Following the closing of the Initial Public Offering on January 15, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below. 
Initial Public Offering [Member]    
Description of Organization and Business Operations (Details) [Line Items]    
Number of units issued (in Shares) 41,400,000  
Shares issued price per share (in Dollars per share) $ 10  
Share price (in Dollars per share)   $ 10
Over-Allotment Option [Member]    
Description of Organization and Business Operations (Details) [Line Items]    
Number of units issued (in Shares) 5,400,000  
Private Placement Warrant [Member]    
Description of Organization and Business Operations (Details) [Line Items]    
Price per warrant (in Dollars per share)   $ 1.5
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details)
Sep. 30, 2021
USD ($)
$ / shares
Revision Of Previously Issued Financial Statements [Abstract]  
Common stock subject to possible redemption | $ / shares $ 10
Net tangible assets | $ $ 5,000,001
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Jan. 15, 2021
As Previously Reported [Member]      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Common stock subject to possible redemption $ 371,544,602   $ 365,248,533
Common stock shares 1,460   1,523
Additional paid-in capital 119,812   6,415,718
Retained Earnings (Accumulated deficit) 4,878,733   (1,417,236)
Total Stockholders’ Equity (Deficit) 5,000,005 $ (50,666,168) 5,000,005
Initial classification of common stock subject to possible redemption 365,248,633 365,248,633  
Change in value of common stock subject to possible redemption 6,295,969 48,751,367  
Sale of 41,400,000 Units, net of underwriting discounts 371,629,911    
Initial value of common stock subject to possible redemption at IPO date (365,248,633)    
Change in value of common stock subject to redemption 6,295,969 42,455,398  
Adjustment [Member]      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Common stock subject to possible redemption 42,455,398   48,751,367
Common stock shares (425)   (488)
Additional paid-in capital (119,812)   (6,415,718)
Retained Earnings (Accumulated deficit) (42,335,161)   (42,335,161)
Total Stockholders’ Equity (Deficit) (42,455,398)   (48,751,367)
Initial classification of common stock subject to possible redemption 48,751,367 48,751,367  
Change in value of common stock subject to possible redemption (6,295,969) (48,751,367)  
Sale of 41,400,000 Units, net of underwriting discounts (371,629,911)    
Initial value of common stock subject to possible redemption at IPO date 365,248,633    
Change in value of common stock subject to redemption (6,295,969) (42,455,398)  
Accretion for common stock to redemption amount (42,359,126)    
As Restated [Member]      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Common stock subject to possible redemption 414,000,000   414,000,000
Common stock shares 1,035   1,035
Retained Earnings (Accumulated deficit) (37,456,428)   (43,752,397)
Total Stockholders’ Equity (Deficit) (37,455,393) (50,666,168) $ (43,751,362)
Initial classification of common stock subject to possible redemption 414,000,000 $ 414,000,000  
Accretion for common stock to redemption amount $ (42,359,126)    
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements (Parentheticals)
3 Months Ended
Mar. 31, 2021
shares
As Previously Reported [Member]  
Error Corrections and Prior Period Adjustments Restatement [Line Items]  
Sale underwriting discounts 41,400,000
Adjustment [Member]  
Error Corrections and Prior Period Adjustments Restatement [Line Items]  
Sale underwriting discounts 41,400,000
As Restated [Member]  
Error Corrections and Prior Period Adjustments Restatement [Line Items]  
Sale underwriting discounts 41,400,000
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption - $ / shares
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Sep. 30, 2021
As Previously Reported [Member]          
Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption [Line Items]          
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 51,750,000 37,153,752 36,524,863 61,945,851 48,906,593
Basic and diluted net loss per share, Class A common stock $ 0.22 $ 0.09
Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption 14,596,248 14,187,614 14,393,060
Basic and diluted net loss per share, Class B common stock $ (0.84) $ 0.34 $ (0.51)
As Restated [Member]          
Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption [Line Items]          
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 41,400,000 41,400,000 34,500,000 37,969,061 39,125,275
Basic and diluted net loss per share, Class A common stock $ 0.22 $ (0.24) $ 0.11 $ (0.15) $ 0.08
Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption 10,350,000 10,350,000 10,125,000 10,238,122 10,275,824
Basic and diluted net loss per share, Class B common stock $ 0.22 $ (0.24) $ 0.11 $ (0.15) $ 0.08
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details)
9 Months Ended
Sep. 30, 2021
USD ($)
shares
Summary of Significant Accounting Policies (Details) [Line Items]  
Statutory tax rate 21.00%
Purchase of aggregate shares 20,486,667
Federal depository insurance coverage (in Dollars) | $ $ 250,000
Class A Common Stock [Member]  
Summary of Significant Accounting Policies (Details) [Line Items]  
Stock subject to possible redemption 41,400,000
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - Schedule of class A common stock reflected in the condensed consolidated balance sheets
9 Months Ended
Sep. 30, 2021
USD ($)
Schedule of class A common stock reflected in the condensed consolidated balance sheets [Abstract]  
Gross proceeds $ 414,000,000
Less:  
Proceeds allocated to Public Warrants (20,286,000)
Class A common stock issuance costs (22,073,126)
Plus:  
Accretion of carrying value to redemption value 42,359,126
Class A common stock subject to possible redemption $ 414,000,000
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2021
Redeemable [Member]      
Numerator:      
Allocation of net income (loss), as adjusted $ 9,233,638 $ 3,309,040
Denominator:      
Basic and diluted weighted average shares outstanding 41,400,000 39,125,275
Basic and diluted net income (loss) per common share $ 0.22 $ 0.08
Non-redeemable [Member]      
Numerator:      
Allocation of net income (loss), as adjusted $ (1,000) $ 2,308,410 $ 869,083
Denominator:      
Basic and diluted weighted average shares outstanding 10,350,000 10,350,000 10,275,824
Basic and diluted net income (loss) per common share $ 0 $ 0.22 $ 0.08
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Public Offering (Details)
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Initial Public Offering [Member]  
Public Offering (Details) [Line Items]  
Sale of units 41,400,000
Purchase price per unit (in Dollars per share) | $ / shares $ 10
Public offering, description Each Unit consists of one share of common stock and one-third of one redeemable warrant redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 9).
Over-Allotment Option [Member]  
Public Offering (Details) [Line Items]  
Sale of units 5,400,000
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Private Placement (Details) - Private Placement [Member]
9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Private Placement (Details) [Line Items]  
Aggregate of purchase shares (in Shares) | shares 6,686,667
Warrant price per share (in Dollars per share) | $ / shares $ 1.5
Aggregate purchase price $ 10,030,000
Common stock price per share (in Dollars per share) | $ / shares $ 11.5
Deferred underwriting fees $ 8,280,000
working capital 1,080,000
Sponsor [Member]  
Private Placement (Details) [Line Items]  
working capital $ 670,000
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
Aug. 12, 2021
Jan. 12, 2021
Oct. 02, 2020
Sep. 30, 2021
Sep. 30, 2021
Jan. 15, 2021
Dec. 31, 2020
Sep. 25, 2020
Related Party Transactions (Details) [Line Items]                
Price per share (in Dollars per share)       $ 11.5 $ 11.5      
Office rent per month   $ 10,000            
Payments to services       $ 30,000 $ 90,000      
Accrued expenses       10,000 10,000      
Amount held outside trust account           $ 1,080,000    
Aggregate principal amount               $ 150,000
Borrowings outstanding       0 0   $ 117,917  
Working capital loans $ 1,000,000       1,000,000      
Working capital loans outstanding         750,000      
Sponsor total amount         3,000,000      
Borrowed amount       750,000 750,000      
Projected obligations, expects to pay       $ 2,000,000 $ 2,000,000      
Personnel services agreement, description         For the nine months ended September 30, 2021, the Company incurred $680,000, inclusive of $200,000 in initial payment of the agreement and $80,000 for each month within the second and third quarter for these services, of which $80,000 is included in accounts payable in the accompanying balance sheets.      
Warrants price (in Dollars per share)         $ 1.5      
Business Combination [Member]                
Related Party Transactions (Details) [Line Items]                
Business combination, description         Following the closing of the Initial Public Offering on January 15, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.       
Working capital loans         $ 3,000,000      
Sponsor [Member]                
Related Party Transactions (Details) [Line Items]                
Working capital loans         $ 2,000,000      
Founder Share [Member]                
Related Party Transactions (Details) [Line Items]                
Amount of sponsor paid     $ 25,000          
Shares consideration (in Shares)     8,625,000          
Price per share (in Dollars per share)   $ 0.2            
Common stock, shares outstanding (in Shares)   10,350,000            
Shares subject to forfeiture (in Shares)   1,350,000            
Founder Share [Member] | Business Combination [Member]                
Related Party Transactions (Details) [Line Items]                
Business combination, description         The Sponsor will agree, subject to limited exceptions, not to transfer title to any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.      
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments (Details) - USD ($)
9 Months Ended
Jan. 08, 2021
Sep. 30, 2021
Commitments (Details) [Line Items]    
Deferred fee percentage   3.50%
Gross proceeds from proposed public offering   $ 14,490,000
Forward purchase agreement, description the Company entered into the forward purchase agreement (the “Forward Purchase Agreement”) with Northern Genesis Capital LLC (the “forward purchase investor”), pursuant to which, if the Company determines to raise capital by issuing equity securities in connection with the closing of its initial business combination, the forward purchase investor, an entity which is affiliated with the Company’s Sponsor, agreed and has the first right to purchase, subject to certain conditions, in an aggregate maximum amount of $75,000,000 of either (i) a number of units (the “forward purchase units”), consisting of one share of Class A common stock (the “forward purchase shares”) and one-sixth of one redeemable warrant (the “forward purchase warrants”), for $10.00 per unit or (ii) a number of forward purchase shares for $9.75 per share (such forward purchase shares valued at $9.75 per share or the forward purchase units, as the case may be, the “forward purchase securities”), in a private placement that would close simultaneously with the closing of the Initial Business Combination.  
Forward purchase units (in Shares)   7,500,000
Forward purchase price per share (in Dollars per share)   $ 10
Aggregate maximum amount   $ 75,000,000
Common stock price per share (in Dollars per share)   $ 11.5
Total forward purchase units (in Shares)   7,500,000
Sponsor support agreement and foundation investor support agreement, description   Sponsor also agreed to forfeit, immediately prior to Closing, (i) a relative percentage of up to 1,130,239 Founder Shares to the extent that the Sponsor’s institutional investors fail to hold, at the Closing, at least one-half of the shares of NGA Common Stock issued to such investors in connection with our initial public offering, and (ii) up to 627,910 Founder Shares (currently expected to be 393,025 Founder Shares) in connection with the Forward Purchase Agreements investment.
FPA PIPE Investors [Member]    
Commitments (Details) [Line Items]    
Purchase price per share (in Dollars per share)   $ 10
Aggregate purchase price   $ 40,000,000
Aggregate shares (in Shares)   4,000,000
Private Placement [Member]    
Commitments (Details) [Line Items]    
Common stock price per share (in Dollars per share)   $ 11.5
Initial business combination exceeds   $ 75,000,000
Aggregate additional amount   $ 150,000,000
Class A Common Stock [Member] | PIPE Investors [Member]    
Commitments (Details) [Line Items]    
Purchase price per share (in Dollars per share)   $ 16,000,000
Purchase price per share (in Dollars per share)   $ 10
Aggregate purchase price   $ 160,000,000
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Details) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Stockholder's Equity (Details) [Line Items]    
Preferred stock, shares authorized 1,000,000 1,000,000
Prefered stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued 10,350,000 10,350,000
Common stock, shares outstanding 10,350,000 10,350,000
Shares subject to possible redemption 41,400,000 0
Preferred stock,issued and outstanding,description At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Warrant Liability (Details)
9 Months Ended
Sep. 30, 2021
$ / shares
Warrant Liability (Details) [Line Items]  
Warrant expire term 5 years
Total equity proceeds, percentage 60.00%
Business combination market value per share $ 9.2
Market value, percentage 180.00%
Redemption trigger price per share $ 18
Business Combination [Member]  
Warrant Liability (Details) [Line Items]  
Business combination issue price or effective issue price per share 9.2
Warrant [Member]  
Warrant Liability (Details) [Line Items]  
Warrant price per share $ 0.01
Market value, percentage 115.00%
Common Stock [Member]  
Warrant Liability (Details) [Line Items]  
Common stock equals or exceeds per share $ 18
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - USD ($)
Sep. 30, 2021
Jan. 15, 2021
Fair Value Measurements (Details) [line items]    
Fair value of private placement warrants $ 1.12 $ 1.54
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - Schedule of company's assets and liabilities
9 Months Ended
Sep. 30, 2021
USD ($)
Level 1 [Member] | Marketable securities held in Trust Account [Member]  
Assets:  
Total assets $ 414,028,694
Level 1 [Member] | Warrant liability - Public Warrants [Member]  
Liabilities:  
Total liabilities 14,766,000
Level 3 [Member] | Warrant liability - Private Placement Warrants [Member]  
Liabilities:  
Total liabilities 7,489,067
Level 2 [Member] | FPA Liability [Member]  
Liabilities:  
Total liabilities $ 713,333
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities
9 Months Ended
Sep. 30, 2021
USD ($)
Private Placement [Member]  
Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities [Line Items]  
Fair value at beginning
Initial measurement on January 15, 2021 10,297,467
Change in valuation inputs or other assumptions (2,808,400)
Fair value at ending 7,849,067
Public [Member]  
Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities [Line Items]  
Fair value at beginning
Initial measurement on January 15, 2021 20,286,000
Change in valuation inputs or other assumptions (5,520,000)
Fair value at ending 14,766,000
Warrant Liabilities [Member]  
Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities [Line Items]  
Fair value at beginning
Initial measurement on January 15, 2021 30,583,467
Change in valuation inputs or other assumptions (8,328,400)
Fair value at ending $ 22,255,067
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - Schedule of changes in the fair value of the FPA liability
5 Months Ended
Sep. 30, 2021
USD ($)
Schedule of changes in the fair value of the FPA liability [Abstract]  
Fair value, April 21, 2021 $ 966,667
Loss on change in fair value (253,333)
Fair value, June 30, 2021 $ 713,334
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - Schedule of black scholes option pricing model - $ / shares
9 Months Ended
Jan. 15, 2021
Sep. 30, 2021
Schedule of black scholes option pricing model [Abstract]    
Expected Volatility 25.00% 17.00%
Risk-free interest rate 0.58% 1.02%
Expected term (years) 5 years 5 years
Fair value per share of common stock (in Dollars per share) $ 9.51 $ 9.93
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events (Details) - USD ($)
9 Months Ended
Nov. 09, 2021
Sep. 30, 2021
Subsequent Events (Details) [Line Items]    
Subsequent event, description   the Sponsor has amended the August 12, 2021 Commitment Letter to provide $2,000,000 in working capital loans in addition to the previously provided $1,000,000. As of September 30, 2021, there was $750,000 of working capital loans outstanding.
Subsequent Event [Member]    
Subsequent Events (Details) [Line Items]    
Working capital warrants $ 2,000,000  
EXCEL 53 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 54 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 55 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 114 308 1 false 33 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Sheet http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) Sheet http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow Condensed Consolidated Statement of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Description of Organization and Business Operations Sheet http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperations Description of Organization and Business Operations Notes 7 false false R8.htm 007 - Disclosure - Restatement of Previously Issued Financial Statements Sheet http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatements Restatement of Previously Issued Financial Statements Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Public Offering Sheet http://www.northerngenesisacquisitioncorp.com/role/PublicOffering Public Offering Notes 10 false false R11.htm 010 - Disclosure - Private Placement Sheet http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacement Private Placement Notes 11 false false R12.htm 011 - Disclosure - Related Party Transactions Sheet http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 012 - Disclosure - Commitments Sheet http://www.northerngenesisacquisitioncorp.com/role/Commitments Commitments Notes 13 false false R14.htm 013 - Disclosure - Stockholders' Equity Sheet http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 014 - Disclosure - Warrant Liability Sheet http://www.northerngenesisacquisitioncorp.com/role/WarrantLiability Warrant Liability Notes 15 false false R16.htm 015 - Disclosure - Fair Value Measurements Sheet http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 016 - Disclosure - Subsequent Events Sheet http://www.northerngenesisacquisitioncorp.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 017 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Restatement of Previously Issued Financial Statements (Tables) Sheet http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables Restatement of Previously Issued Financial Statements (Tables) Tables http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatements 19 false false R20.htm 019 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPolicies 20 false false R21.htm 020 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurements 21 false false R22.htm 021 - Disclosure - Description of Organization and Business Operations (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails Description of Organization and Business Operations (Details) Details http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperations 22 false false R23.htm 022 - Disclosure - Restatement of Previously Issued Financial Statements (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails Restatement of Previously Issued Financial Statements (Details) Details http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables 23 false false R24.htm 023 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements Details http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables 24 false false R25.htm 024 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements (Parentheticals) Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements (Parentheticals) Details http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables 25 false false R26.htm 025 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption Details http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables 26 false false R27.htm 026 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables 27 false false R28.htm 027 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of class A common stock reflected in the condensed consolidated balance sheets Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable Summary of Significant Accounting Policies (Details) - Schedule of class A common stock reflected in the condensed consolidated balance sheets Details http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables 28 false false R29.htm 028 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share Details http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables 29 false false R30.htm 029 - Disclosure - Public Offering (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails Public Offering (Details) Details http://www.northerngenesisacquisitioncorp.com/role/PublicOffering 30 false false R31.htm 030 - Disclosure - Private Placement (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails Private Placement (Details) Details http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacement 31 false false R32.htm 031 - Disclosure - Related Party Transactions (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactions 32 false false R33.htm 032 - Disclosure - Commitments (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails Commitments (Details) Details http://www.northerngenesisacquisitioncorp.com/role/Commitments 33 false false R34.htm 033 - Disclosure - Stockholders' Equity (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquity 34 false false R35.htm 034 - Disclosure - Warrant Liability (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails Warrant Liability (Details) Details http://www.northerngenesisacquisitioncorp.com/role/WarrantLiability 35 false false R36.htm 035 - Disclosure - Fair Value Measurements (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables 36 false false R37.htm 036 - Disclosure - Fair Value Measurements (Details) - Schedule of company's assets and liabilities Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable Fair Value Measurements (Details) - Schedule of company's assets and liabilities Details http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables 37 false false R38.htm 037 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities Details http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables 38 false false R39.htm 038 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of the FPA liability Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinthefairvalueoftheFPAliabilityTable Fair Value Measurements (Details) - Schedule of changes in the fair value of the FPA liability Details http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables 39 false false R40.htm 039 - Disclosure - Fair Value Measurements (Details) - Schedule of black scholes option pricing model Sheet http://www.northerngenesisacquisitioncorp.com/role/ScheduleofblackscholesoptionpricingmodelTable Fair Value Measurements (Details) - Schedule of black scholes option pricing model Details http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables 40 false false R41.htm 040 - Disclosure - Subsequent Events (Details) Sheet http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.northerngenesisacquisitioncorp.com/role/SubsequentEvents 41 false false All Reports Book All Reports f10q0921a1_embarktech.htm embk-20210930.xsd embk-20210930_cal.xml embk-20210930_def.xml embk-20210930_lab.xml embk-20210930_pre.xml f10q0921a1ex31-1_embarktech.htm f10q0921a1ex31-2_embarktech.htm f10q0921a1ex32-1_embarktech.htm f10q0921a1ex32-2_embarktech.htm http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 59 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0921a1_embarktech.htm": { "axisCustom": 0, "axisStandard": 10, "contextCount": 114, "dts": { "calculationLink": { "local": [ "embk-20210930_cal.xml" ] }, "definitionLink": { "local": [ "embk-20210930_def.xml" ] }, "inline": { "local": [ "f10q0921a1_embarktech.htm" ] }, "labelLink": { "local": [ "embk-20210930_lab.xml" ] }, "presentationLink": { "local": [ "embk-20210930_pre.xml" ] }, "schema": { "local": [ "embk-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 373, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 56, "http://www.northerngenesisacquisitioncorp.com/20210930": 23, "http://xbrl.sec.gov/dei/2021": 7, "total": 86 }, "keyCustom": 80, "keyStandard": 228, "memberCustom": 14, "memberStandard": 17, "nsprefix": "embk", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:TradingSymbol", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:TradingSymbol", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:PublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Public Offering", "role": "http://www.northerngenesisacquisitioncorp.com/role/PublicOffering", "shortName": "Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:PublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:PrivatePlacementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Private Placement", "role": "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:PrivatePlacementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Related Party Transactions", "role": "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Commitments", "role": "http://www.northerngenesisacquisitioncorp.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Stockholders' Equity", "role": "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Warrant Liability", "role": "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiability", "shortName": "Warrant Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Fair Value Measurements", "role": "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Subsequent Events", "role": "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)", "role": "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables", "shortName": "Restatement of Previously Issued Financial Statements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c44", "decimals": "0", "first": true, "lang": null, "name": "embk:GrossProceedsFromInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Description of Organization and Business Operations (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "shortName": "Description of Organization and Business Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c44", "decimals": "0", "first": true, "lang": null, "name": "embk:GrossProceedsFromInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityRedemptionPricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Restatement of Previously Issued Financial Statements (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails", "shortName": "Restatement of Previously Issued Financial Statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityRedemptionPricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c52", "decimals": "0", "first": true, "lang": null, "name": "embk:CommonStockSubjectToPossibleRedemption", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "shortName": "Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c52", "decimals": "0", "first": true, "lang": null, "name": "embk:CommonStockSubjectToPossibleRedemption", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c55", "decimals": "INF", "first": true, "lang": null, "name": "embk:SaleUnderwritingDiscounts", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements (Parentheticals)", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals", "shortName": "Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statements (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c55", "decimals": "INF", "first": true, "lang": null, "name": "embk:SaleUnderwritingDiscounts", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c65", "decimals": "INF", "first": true, "lang": null, "name": "embk:BasicAndDilutedWeightedAverageSharesOutstandingClassACommonStockSubjectToPossibl", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable", "shortName": "Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c65", "decimals": "INF", "first": true, "lang": null, "name": "embk:BasicAndDilutedWeightedAverageSharesOutstandingClassACommonStockSubjectToPossibl", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "embk:GrossProceeds", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of class A common stock reflected in the condensed consolidated balance sheets", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of class A common stock reflected in the condensed consolidated balance sheets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "embk:GrossProceeds", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c70", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c70", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "embk:OrdinarySharesSubjectToPossibleRedemption", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "embk:OrdinarySharesSubjectToPossibleRedemption", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c76", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Public Offering (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails", "shortName": "Public Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c76", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c78", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Private Placement (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails", "shortName": "Private Placement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c78", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Related Party Transactions (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c85", "decimals": "0", "lang": null, "name": "embk:OfficeRentPerMonth", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": "3", "first": true, "lang": null, "name": "embk:DeferredFeePercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Commitments (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "shortName": "Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": "3", "first": true, "lang": null, "name": "embk:DeferredFeePercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Stockholders' Equity (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:ExcessStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:WarrantExpireTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Warrant Liability (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails", "shortName": "Warrant Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:WarrantExpireTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "embk:FairValueOfPrivatePlacementWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "embk:FairValueOfPrivatePlacementWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c100", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Fair Value Measurements (Details) - Schedule of company's assets and liabilities", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable", "shortName": "Fair Value Measurements (Details) - Schedule of company's assets and liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c100", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c78", "decimals": "0", "first": true, "lang": null, "name": "embk:InitialMeasurement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable", "shortName": "Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c78", "decimals": "0", "first": true, "lang": null, "name": "embk:InitialMeasurement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "embk:ScheduleOfChangesInTheFairValueOfTheFPALiability", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c111", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherAssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of the FPA liability", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinthefairvalueoftheFPAliabilityTable", "shortName": "Fair Value Measurements (Details) - Schedule of changes in the fair value of the FPA liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "embk:ScheduleOfChangesInTheFairValueOfTheFPALiability", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c111", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherAssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c44", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Fair Value Measurements (Details) - Schedule of black scholes option pricing model", "role": "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofblackscholesoptionpricingmodelTable", "shortName": "Fair Value Measurements (Details) - Schedule of black scholes option pricing model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c44", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Subsequent Events (Details)", "role": "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c35", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "role": "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c35", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited)", "role": "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statement of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Description of Organization and Business Operations", "role": "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperations", "shortName": "Description of Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:RevisionOfPreviouslyIssuedFinancialStatements", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Restatement of Previously Issued Financial Statements", "role": "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatements", "shortName": "Restatement of Previously Issued Financial Statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "embk:RevisionOfPreviouslyIssuedFinancialStatements", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921a1_embarktech.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 33, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "embk_AccretionForCommonStockSubjectToRedemptionAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of accretion for common stock subject to redemption amount.", "label": "AccretionForCommonStockSubjectToRedemptionAmount", "terseLabel": "Accretion for common stock subject to redemption amount", "verboseLabel": "Accretion for common stock to redemption amount" } } }, "localname": "AccretionForCommonStockSubjectToRedemptionAmount", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "embk_AccruedOfferingCosts": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "AccruedOfferingCosts.", "label": "AccruedOfferingCosts", "terseLabel": "Accrued offering costs" } } }, "localname": "AccruedOfferingCosts", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "embk_AdditionalPaidinCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "AdditionalPaidinCapital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidinCapital", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_AggregateAdditionalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate additional amount.", "label": "AggregateAdditionalAmount", "terseLabel": "Aggregate additional amount" } } }, "localname": "AggregateAdditionalAmount", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "embk_AggregateMaximumAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate maximum amount.", "label": "AggregateMaximumAmount", "terseLabel": "Aggregate maximum amount" } } }, "localname": "AggregateMaximumAmount", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "embk_AggregatePublicSharesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate public shares, percentage.", "label": "AggregatePublicSharesPercentage", "terseLabel": "Aggregate public shares, percentage" } } }, "localname": "AggregatePublicSharesPercentage", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "embk_AmountHeldOutsideTrustAccount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount held outside trust account.", "label": "AmountHeldOutsideTrustAccount", "terseLabel": "Amount held outside trust account" } } }, "localname": "AmountHeldOutsideTrustAccount", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_AsRestatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AsRestatedMember", "terseLabel": "As Restated [Member]" } } }, "localname": "AsRestatedMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "domainItemType" }, "embk_AssetsAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AssetsAbstract0", "terseLabel": "Assets:" } } }, "localname": "AssetsAbstract0", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "embk_BasicAndDilutedNetIncomePerShareCommonStockinDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BasicAndDilutedNetIncomePerShareCommonStockinDollarsPerShare", "terseLabel": "Basic and diluted net income per share, Common Stock (in Dollars per share)" } } }, "localname": "BasicAndDilutedNetIncomePerShareCommonStockinDollarsPerShare", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "embk_BasicAndDilutedNetLossPerShareClassACommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted net loss per share, Class A common stock.", "label": "BasicAndDilutedNetLossPerShareClassACommonStock", "terseLabel": "Basic and diluted net loss per share, Class A common stock" } } }, "localname": "BasicAndDilutedNetLossPerShareClassACommonStock", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "perShareItemType" }, "embk_BasicAndDilutedNetLossPerShareClassBCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted net loss per share, Class B common stock.", "label": "BasicAndDilutedNetLossPerShareClassBCommonStock", "terseLabel": "Basic and diluted net loss per share, Class B common stock" } } }, "localname": "BasicAndDilutedNetLossPerShareClassBCommonStock", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "perShareItemType" }, "embk_BasicAndDilutedWeightedAverageSharesOutstandingClassACommonStockSubjectToPossibl": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption.", "label": "BasicAndDilutedWeightedAverageSharesOutstandingClassACommonStockSubjectToPossibl", "terseLabel": "Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption" } } }, "localname": "BasicAndDilutedWeightedAverageSharesOutstandingClassACommonStockSubjectToPossibl", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "sharesItemType" }, "embk_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStockSubjectToPossibl": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption.", "label": "BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStockSubjectToPossibl", "terseLabel": "Basic and diluted weighted average shares outstanding, Class B common stock subject to possible redemption" } } }, "localname": "BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStockSubjectToPossibl", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "sharesItemType" }, "embk_BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStockSubject": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStockSubject", "terseLabel": "Basic and diluted weighted average shares outstanding, non-redeemable common stock subject to possible redemption (in Shares)" } } }, "localname": "BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStockSubject", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "embk_BasicAndDilutedWeightedAverageStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted weighted average stock outstanding.", "label": "BasicAndDilutedWeightedAverageStockOutstanding", "terseLabel": "Basic and diluted weighted average shares outstanding" } } }, "localname": "BasicAndDilutedWeightedAverageStockOutstanding", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "sharesItemType" }, "embk_BorrowingsOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings outstanding.", "label": "BorrowingsOutstanding", "terseLabel": "Borrowings outstanding" } } }, "localname": "BorrowingsOutstanding", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_BusinessCombinationMarketValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination market value per share.", "label": "BusinessCombinationMarketValuePerShare", "terseLabel": "Business combination market value per share" } } }, "localname": "BusinessCombinationMarketValuePerShare", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "embk_BusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BusinessCombinationMember", "terseLabel": "Business Combination [Member]" } } }, "localname": "BusinessCombinationMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "embk_ChangeInFairValueOfFPALiability": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of FPA liability.", "label": "ChangeInFairValueOfFPALiability", "negatedLabel": "Change in fair value of FPA liability", "terseLabel": "Change in fair value of FPA liability" } } }, "localname": "ChangeInFairValueOfFPALiability", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow", "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "embk_ChangeInValueOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "terseLabel": "Initial classification of common stock subject to possible redemption", "verboseLabel": "Change in value of common stock subject to possible redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_ChangeInValueOfCommonStockSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInValueOfCommonStockSubjectToRedemption", "terseLabel": "Change in value of common stock subject to redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToRedemption", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_ClassACommonStockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Class A common stock issuance costs.", "label": "ClassACommonStockIssuanceCosts", "terseLabel": "Class A common stock issuance costs" } } }, "localname": "ClassACommonStockIssuanceCosts", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "monetaryItemType" }, "embk_ClassOfWarrantOrRightExercisePriceOfWarrantOrRights1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "ClassOfWarrantOrRightExercisePriceOfWarrantOrRights1", "terseLabel": "Warrants price (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantOrRights1", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "embk_CommitmentsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments (Details) [Line Items]" } } }, "localname": "CommitmentsDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "stringItemType" }, "embk_CommitmentsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments (Details) [Table]" } } }, "localname": "CommitmentsDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "stringItemType" }, "embk_CommonStockShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "CommonStockShares", "terseLabel": "Common stock shares" } } }, "localname": "CommonStockShares", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_CommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "CommonStockSubjectToPossibleRedemption", "terseLabel": "Common stock subject to possible redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemption", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_CommonStocksSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares outstanding.", "label": "CommonStocksSharesOutstanding", "terseLabel": "Common stock, shares outstanding (in Shares)" } } }, "localname": "CommonStocksSharesOutstanding", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "embk_DeferredFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred fee percentage.", "label": "DeferredFeePercentage", "terseLabel": "Deferred fee percentage" } } }, "localname": "DeferredFeePercentage", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "percentItemType" }, "embk_DeferredUnderwritingFeePayable": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "DeferredUnderwritingFeePayable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeePayable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "embk_DeferredUnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "deferred underwriting fees.", "label": "DeferredUnderwritingFees", "terseLabel": "Deferred underwriting fees" } } }, "localname": "DeferredUnderwritingFees", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "monetaryItemType" }, "embk_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DenominatorAbstract", "terseLabel": "Denominator:" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "embk_DescriptionofOrganizationandBusinessOperationsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization and Business Operations (Details) [Line Items]" } } }, "localname": "DescriptionofOrganizationandBusinessOperationsDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "embk_DescriptionofOrganizationandBusinessOperationsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization and Business Operations (Details) [Table]" } } }, "localname": "DescriptionofOrganizationandBusinessOperationsDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "embk_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EmergingGrowthCompanyPolicyTextBlock", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "embk_FPALiability": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "FPALiability", "terseLabel": "FPA liability" } } }, "localname": "FPALiability", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "embk_FPALiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FPALiabilityMember", "terseLabel": "FPA Liability [Member]" } } }, "localname": "FPALiabilityMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "embk_FPAPIPEInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FPAPIPEInvestorsMember", "terseLabel": "FPA PIPE Investors [Member]" } } }, "localname": "FPAPIPEInvestorsMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "domainItemType" }, "embk_FairValueMeasurementsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [line items]" } } }, "localname": "FairValueMeasurementsDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "embk_FairValueMeasurementsDetailsScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities [Line Items]" } } }, "localname": "FairValueMeasurementsDetailsScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "stringItemType" }, "embk_FairValueMeasurementsDetailsScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of changes in fair value of private and public warrant liabilities [Table]" } } }, "localname": "FairValueMeasurementsDetailsScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "stringItemType" }, "embk_FairValueMeasurementsDetailsScheduleofcompanysassetsandliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of company's assets and liabilities [Line Items]" } } }, "localname": "FairValueMeasurementsDetailsScheduleofcompanysassetsandliabilitiesLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "embk_FairValueMeasurementsDetailsScheduleofcompanysassetsandliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of company's assets and liabilities [Table]" } } }, "localname": "FairValueMeasurementsDetailsScheduleofcompanysassetsandliabilitiesTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "embk_FairValueMeasurementsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Table]" } } }, "localname": "FairValueMeasurementsDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "embk_FairValueOfPrivatePlacementWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of private placement warrants.", "label": "FairValueOfPrivatePlacementWarrants", "terseLabel": "Fair value of private placement warrants" } } }, "localname": "FairValueOfPrivatePlacementWarrants", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "embk_FairValuePerShareOfCommonStockinDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value per share of common stock.", "label": "FairValuePerShareOfCommonStockinDollarsPerShare", "terseLabel": "Fair value per share of common stock (in Dollars per share)" } } }, "localname": "FairValuePerShareOfCommonStockinDollarsPerShare", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "perShareItemType" }, "embk_ForTheNineMonthsEndedSeptember302021Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ForTheNineMonthsEndedSeptember302021Abstract", "terseLabel": "For the nine months ended, September 30, 2021" } } }, "localname": "ForTheNineMonthsEndedSeptember302021Abstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "stringItemType" }, "embk_ForTheSixMonthsEndedJune302021Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ForTheSixMonthsEndedJune302021Abstract", "terseLabel": "For the six months ended, June 30, 2021" } } }, "localname": "ForTheSixMonthsEndedJune302021Abstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "stringItemType" }, "embk_ForTheThreeMonthsEndedJune302021Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ForTheThreeMonthsEndedJune302021Abstract", "terseLabel": "For the three months ended, June 30, 2021" } } }, "localname": "ForTheThreeMonthsEndedJune302021Abstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "stringItemType" }, "embk_ForTheThreeMonthsEndedSeptember302021Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ForTheThreeMonthsEndedSeptember302021Abstract", "terseLabel": "For the three months ended, September 30, 2021" } } }, "localname": "ForTheThreeMonthsEndedSeptember302021Abstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "stringItemType" }, "embk_ForwardPurchaseAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ForwardPurchaseAgreementDescription", "terseLabel": "Forward purchase agreement, description" } } }, "localname": "ForwardPurchaseAgreementDescription", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "stringItemType" }, "embk_ForwardPurchasePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward purchase price per share.", "label": "ForwardPurchasePricePerShare", "terseLabel": "Forward purchase price per share (in Dollars per share)" } } }, "localname": "ForwardPurchasePricePerShare", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "perShareItemType" }, "embk_ForwardPurchaseUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward purchase units.", "label": "ForwardPurchaseUnits", "terseLabel": "Forward purchase units (in Shares)" } } }, "localname": "ForwardPurchaseUnits", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "sharesItemType" }, "embk_FounderShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FounderShareMember", "terseLabel": "Founder Share [Member]" } } }, "localname": "FounderShareMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "embk_GrossProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds.", "label": "GrossProceeds", "terseLabel": "Gross proceeds" } } }, "localname": "GrossProceeds", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "monetaryItemType" }, "embk_GrossProceedsFromInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds from Initial public offering.", "label": "GrossProceedsFromInitialPublicOffering", "terseLabel": "Gross proceeds from Initial public offering" } } }, "localname": "GrossProceedsFromInitialPublicOffering", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "embk_HeldInTheTrustAccountDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Held in the Trust Account, description.", "label": "HeldInTheTrustAccountDescription", "terseLabel": "Trust account, description" } } }, "localname": "HeldInTheTrustAccountDescription", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "embk_InitialClassificationOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "InitialClassificationOfCommonStockSubjectToPossibleRedemption", "terseLabel": "Initial classification of common stock subject to possible redemption" } } }, "localname": "InitialClassificationOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_InitialClassificationOfFPALiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial classification of FPA liability.", "label": "InitialClassificationOfFPALiability", "terseLabel": "Initial classification of FPA liability" } } }, "localname": "InitialClassificationOfFPALiability", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "embk_InitialClassificationOfWarrantLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "InitialClassificationOfWarrantLiabilities", "terseLabel": "Initial Classification of Warrant Liabilities" } } }, "localname": "InitialClassificationOfWarrantLiabilities", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "embk_InitialMeasurement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "InitialMeasurement", "terseLabel": "Initial measurement on January 15, 2021" } } }, "localname": "InitialMeasurement", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "embk_InitialValueOfCommonStockSubjectToPossibleRedemptionAtIPODate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "InitialValueOfCommonStockSubjectToPossibleRedemptionAtIPODate", "terseLabel": "Initial value of common stock subject to possible redemption at IPO date" } } }, "localname": "InitialValueOfCommonStockSubjectToPossibleRedemptionAtIPODate", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_LessAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LessAbstract", "terseLabel": "Less:" } } }, "localname": "LessAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "stringItemType" }, "embk_LossOnInitialIssuanceOfPrivateWarrants": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on initial issuance of private warrants.", "label": "LossOnInitialIssuanceOfPrivateWarrants", "negatedLabel": "Loss on initial issuance of private warrants" } } }, "localname": "LossOnInitialIssuanceOfPrivateWarrants", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "embk_MarketValuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market value, percentage.", "label": "MarketValuePercentage", "terseLabel": "Market value, percentage" } } }, "localname": "MarketValuePercentage", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "embk_NetInterestToDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of net interest to dissolution expenses.", "label": "NetInterestToDissolutionExpenses", "terseLabel": "Net interest to dissolution expenses" } } }, "localname": "NetInterestToDissolutionExpenses", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "embk_NetTangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net tangible assets.", "label": "NetTangibleAssets", "terseLabel": "Net tangible assets" } } }, "localname": "NetTangibleAssets", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "embk_NonredeemableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NonredeemableMember", "terseLabel": "Non-redeemable [Member]" } } }, "localname": "NonredeemableMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "domainItemType" }, "embk_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NumeratorAbstract", "terseLabel": "Numerator:" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "embk_OfferingCostsAllocableToWarrantLiabilities": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "OfferingCostsAllocableToWarrantLiabilities", "terseLabel": "Offering costs allocable to warrant liabilities" } } }, "localname": "OfferingCostsAllocableToWarrantLiabilities", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "embk_OfferingCostsAllocatedToWarrantAndFPAliabilities": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs allocated to warrant and FPA liabilities.", "label": "OfferingCostsAllocatedToWarrantAndFPAliabilities", "negatedLabel": "Offering costs allocated to warrant and FPA liabilities" } } }, "localname": "OfferingCostsAllocatedToWarrantAndFPAliabilities", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "embk_OfficeRentPerMonth": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Office rent per month.", "label": "OfficeRentPerMonth", "terseLabel": "Office rent per month" } } }, "localname": "OfficeRentPerMonth", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_OrdinarySharesSubjectToPossibleRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OrdinarySharesSubjectToPossibleRedemption", "terseLabel": "Shares subject to possible redemption" } } }, "localname": "OrdinarySharesSubjectToPossibleRedemption", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "embk_OtherIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OtherIncomeLossAbstract", "terseLabel": "Other income (loss):" } } }, "localname": "OtherIncomeLossAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "embk_PIPEInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PIPEInvestorsMember", "terseLabel": "PIPE Investors [Member]" } } }, "localname": "PIPEInvestorsMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "domainItemType" }, "embk_PaymentToServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payment to services", "label": "PaymentToServices", "terseLabel": "Payments to services" } } }, "localname": "PaymentToServices", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_PercentageOfAssetsHeldInTheTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of assets held in the trust account.", "label": "PercentageOfAssetsHeldInTheTrustAccount", "terseLabel": "Percentage of assets held in the trust account" } } }, "localname": "PercentageOfAssetsHeldInTheTrustAccount", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "embk_PercentageOfOutstandingVoting": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding voting rights.", "label": "PercentageOfOutstandingVoting", "terseLabel": "Percentage of outstanding voting" } } }, "localname": "PercentageOfOutstandingVoting", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "embk_PersonnelServicesAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personnel Services Agreement, Description", "label": "PersonnelServicesAgreementDescription", "terseLabel": "Personnel services agreement, description" } } }, "localname": "PersonnelServicesAgreementDescription", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "embk_PlusAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PlusAbstract", "terseLabel": "Plus:" } } }, "localname": "PlusAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "stringItemType" }, "embk_PreferredStockissuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock,issued and outstanding.", "label": "PreferredStockissuedAndOutstanding", "terseLabel": "Preferred stock,issued and outstanding,description" } } }, "localname": "PreferredStockissuedAndOutstanding", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "embk_PricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per warrant.", "label": "PricePerWarrant", "terseLabel": "Price per warrant (in Dollars per share)" } } }, "localname": "PricePerWarrant", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "perShareItemType" }, "embk_PrivatePlacementDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement (Details) [Line Items]" } } }, "localname": "PrivatePlacementDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "embk_PrivatePlacementDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement (Details) [Table]" } } }, "localname": "PrivatePlacementDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "embk_PrivatePlacementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Disclosure [Abstract]" } } }, "localname": "PrivatePlacementDisclosureAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_PrivatePlacementDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PrivatePlacementDisclosureTextBlock", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementDisclosureTextBlock", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "embk_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PrivatePlacementWarrantMember", "terseLabel": "Private Placement Warrant [Member]" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "embk_ProceedsFromIssuanceBusinessCombination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "ProceedsFromIssuanceBusinessCombination", "terseLabel": "Initial business combination exceeds" } } }, "localname": "ProceedsFromIssuanceBusinessCombination", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "embk_ProjectedObligationsExpectsToPay": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Projected obligations, expects to pay.", "label": "ProjectedObligationsExpectsToPay", "terseLabel": "Projected obligations, expects to pay" } } }, "localname": "ProjectedObligationsExpectsToPay", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_PublicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PublicMember", "terseLabel": "Public [Member]" } } }, "localname": "PublicMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "domainItemType" }, "embk_PublicOfferingDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public offering description.", "label": "PublicOfferingDescription", "terseLabel": "Public offering, description" } } }, "localname": "PublicOfferingDescription", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails" ], "xbrltype": "stringItemType" }, "embk_PublicOfferingDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Offering (Details) [Line Items]" } } }, "localname": "PublicOfferingDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails" ], "xbrltype": "stringItemType" }, "embk_PublicOfferingDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Offering (Details) [Table]" } } }, "localname": "PublicOfferingDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails" ], "xbrltype": "stringItemType" }, "embk_PublicOfferingDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Offering Disclosure [Abstract]" } } }, "localname": "PublicOfferingDisclosureAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_PublicOfferingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Offering Text Block.", "label": "PublicOfferingDisclosureTextBlock", "terseLabel": "PUBLIC OFFERING" } } }, "localname": "PublicOfferingDisclosureTextBlock", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PublicOffering" ], "xbrltype": "textBlockItemType" }, "embk_PurchaseOfAggregateShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase of aggregate shares.", "label": "PurchaseOfAggregateShares", "terseLabel": "Purchase of aggregate shares" } } }, "localname": "PurchaseOfAggregateShares", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "embk_PurchasePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price per share.", "label": "PurchasePricePerShare", "terseLabel": "Purchase price per share (in Dollars per share)" } } }, "localname": "PurchasePricePerShare", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "perShareItemType" }, "embk_RedeemableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RedeemableMember", "terseLabel": "Redeemable [Member]" } } }, "localname": "RedeemableMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "domainItemType" }, "embk_RedemptionTriggerPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption trigger price per share.", "label": "RedemptionTriggerPricePerShare", "terseLabel": "Redemption trigger price per share" } } }, "localname": "RedemptionTriggerPricePerShare", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "embk_RelatedPartyTransactionsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Line Items]" } } }, "localname": "RelatedPartyTransactionsDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "embk_RelatedPartyTransactionsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "embk_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofcommonstocksubjecttoredemptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption [Line Items]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofcommonstocksubjecttoredemptionLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "stringItemType" }, "embk_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofcommonstocksubjecttoredemptionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of common stock subject to redemption [Table]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofcommonstocksubjecttoredemptionTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable" ], "xbrltype": "stringItemType" }, "embk_RestatementofPreviouslyIssuedFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statement [Abstract]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatements" ], "xbrltype": "stringItemType" }, "embk_RestatementofPreviouslyIssuedFinancialStatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements [Table]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatements" ], "xbrltype": "stringItemType" }, "embk_RevisionOfPreviouslyIssuedFinancialStatements": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RevisionOfPreviouslyIssuedFinancialStatements", "terseLabel": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" } } }, "localname": "RevisionOfPreviouslyIssuedFinancialStatements", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "embk_RevisionOfPreviouslyIssuedFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revision Of Previously Issued Financial Statements [Abstract]" } } }, "localname": "RevisionOfPreviouslyIssuedFinancialStatementsAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_RisksAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RisksAndUncertaintiesPolicyTextBlock", "terseLabel": "Risks and Uncertainties" } } }, "localname": "RisksAndUncertaintiesPolicyTextBlock", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "embk_SaleOf4UnitsNetOfUnderwritingDiscounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "SaleOf4UnitsNetOfUnderwritingDiscounts", "terseLabel": "Sale of 41,400,000 Units, net of underwriting discounts" } } }, "localname": "SaleOf4UnitsNetOfUnderwritingDiscounts", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "embk_SaleOfStockNumberOfShareIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "SaleOfStockNumberOfShareIssuedInTransaction", "terseLabel": "Shares consideration (in Shares)" } } }, "localname": "SaleOfStockNumberOfShareIssuedInTransaction", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "embk_SaleOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of warrants.", "label": "SaleOfWarrants", "terseLabel": "Sale of warrants (in Shares)" } } }, "localname": "SaleOfWarrants", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "sharesItemType" }, "embk_SaleUnderwritingDiscounts": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SaleUnderwritingDiscounts", "terseLabel": "Sale underwriting discounts" } } }, "localname": "SaleUnderwritingDiscounts", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "sharesItemType" }, "embk_ScheduleOfBlackScholesOptionPricingModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of black scholes option pricing model [Abstract]" } } }, "localname": "ScheduleOfBlackScholesOptionPricingModelAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of calculation of basic and diluted net income (loss) per common share [Abstract]" } } }, "localname": "ScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfChangesInFairValueOfPrivateAndPublicWarrantLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in fair value of private and public warrant liabilities [Abstract]" } } }, "localname": "ScheduleOfChangesInFairValueOfPrivateAndPublicWarrantLiabilitiesAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfChangesInTheFairValueOfTheFPALiability": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the fair value of the FPA liability.", "label": "ScheduleOfChangesInTheFairValueOfTheFPALiability", "terseLabel": "Schedule of changes in the fair value of the FPA liability" } } }, "localname": "ScheduleOfChangesInTheFairValueOfTheFPALiability", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "embk_ScheduleOfChangesInTheFairValueOfTheFpaLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in the fair value of the FPA liability [Abstract]" } } }, "localname": "ScheduleOfChangesInTheFairValueOfTheFpaLiabilityAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfClassACommonStockReflectedInTheCondensedConsolidatedBalanceSheetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of class A common stock reflected in the condensed consolidated balance sheets [Abstract]" } } }, "localname": "ScheduleOfClassACommonStockReflectedInTheCondensedConsolidatedBalanceSheetsAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfCommonStockSubjectToRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of common stock subject to redemption [Abstract]" } } }, "localname": "ScheduleOfCommonStockSubjectToRedemptionAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfCompanysAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of company's assets and liabilities [Abstract]" } } }, "localname": "ScheduleOfCompanysAssetsAndLiabilitiesAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_ScheduleOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of financial statements [Abstract]" } } }, "localname": "ScheduleOfFinancialStatementsAbstract", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "xbrltype": "stringItemType" }, "embk_SharesSubjectToPossibleRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares subject to possible redemption.", "label": "SharesSubjectToPossibleRedemption", "terseLabel": "Shares subject to possible redemption" } } }, "localname": "SharesSubjectToPossibleRedemption", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "embk_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SponsorMember", "terseLabel": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "embk_SponsorSupportAgreementAndFoundationInvestorSupportAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor support agreement and foundation investor support agreement.", "label": "SponsorSupportAgreementAndFoundationInvestorSupportAgreement", "terseLabel": "Sponsor support agreement and foundation investor support agreement, description" } } }, "localname": "SponsorSupportAgreementAndFoundationInvestorSupportAgreement", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "stringItemType" }, "embk_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholder's Equity (Details) [Line Items]" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "embk_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "embk_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "embk_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "embk_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "embk_SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshareLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "embk_SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per common share [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "embk_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "embk_TotalEquityProceedsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total equity proceeds, percentage.", "label": "TotalEquityProceedsPercentage", "terseLabel": "Total equity proceeds, percentage" } } }, "localname": "TotalEquityProceedsPercentage", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "embk_TransactionCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction cost.", "label": "TransactionCost", "terseLabel": "Transaction cost" } } }, "localname": "TransactionCost", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "embk_TrustAccountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TrustAccountMember", "terseLabel": "Trust Account [Member]" } } }, "localname": "TrustAccountMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "embk_WarrantExpireTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expire term.", "label": "WarrantExpireTerm", "terseLabel": "Warrant expire term" } } }, "localname": "WarrantExpireTerm", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "embk_WarrantLiabilityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability (Details) [Line Items]" } } }, "localname": "WarrantLiabilityDetailsLineItems", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "embk_WarrantLiabilityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability (Details) [Table]" } } }, "localname": "WarrantLiabilityDetailsTable", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "embk_WarrantLiabilityPrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantLiabilityPrivatePlacementWarrantsMember", "terseLabel": "Warrant liability - Private Placement Warrants [Member]" } } }, "localname": "WarrantLiabilityPrivatePlacementWarrantsMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "embk_WarrantLiabilityPublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantLiabilityPublicWarrantsMember", "terseLabel": "Warrant liability - Public Warrants [Member]" } } }, "localname": "WarrantLiabilityPublicWarrantsMember", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "embk_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Working capital.", "label": "WorkingCapital", "terseLabel": "Working capital deficit", "verboseLabel": "working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "monetaryItemType" }, "embk_WorkingCapitalLoans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "WorkingCapitalLoans", "terseLabel": "Working capital loans" } } }, "localname": "WorkingCapitalLoans", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_WorkingCapitalLoansOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of working capital loans outstanding.", "label": "WorkingCapitalLoansOutstanding", "terseLabel": "Working capital loans outstanding" } } }, "localname": "WorkingCapitalLoansOutstanding", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "embk_WorkingCapitalWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of working capital warrants.", "label": "WorkingCapitalWarrants", "terseLabel": "Working capital warrants" } } }, "localname": "WorkingCapitalWarrants", "nsuri": "http://www.northerngenesisacquisitioncorp.com/20210930", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r70", "r71", "r72", "r73", "r74", "r75", "r76", "r78", "r80", "r81", "r83", "r84", "r99", "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Adjustment [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r70", "r71", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r80", "r81", "r82", "r83", "r84", "r85", "r99", "r124", "r125", "r187", "r197", "r222", "r223", "r224", "r225", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "stringItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r1", "r70", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r80", "r81", "r83", "r84", "r99", "r124", "r125", "r187", "r197", "r222", "r223", "r224", "r225", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Previously Reported [Member]", "terseLabel": "As Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcommonstocksubjecttoredemptionTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet [Table Text Block]", "terseLabel": "Schedule of class A common stock reflected in the condensed consolidated balance sheets" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r187", "r256" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r70", "r71", "r72", "r184", "r185", "r186", "r223" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r65", "r113", "r115", "r119", "r122", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r205", "r210", "r234", "r254", "r256", "r277", "r290" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r29", "r65", "r122", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r205", "r210", "r234", "r254", "r256" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "periodEndLabel": "Fair value at ending", "periodStartLabel": "Fair value at beginning" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r178", "r179" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r178", "r179", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Business combination issue price or effective issue price per share" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationReasonForBusinessCombination": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "This element represents a description of the primary reason for the business combination which may consist of general categories such as top-line growth, synergistic benefits, market share, and diversification and the more detailed factors that might apply.", "label": "Business Combination, Reason for Business Combination", "terseLabel": "Business Combination, description", "verboseLabel": "Business combination, description" } } }, "localname": "BusinessCombinationReasonForBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r20", "r256", "r306", "r307" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Operating bank accounts" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r20", "r55" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash \u2013 End of period", "periodStartLabel": "Cash \u2013 Beginning of period", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet", "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r8", "r56" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r49", "r235" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-Cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r63", "r65", "r88", "r89", "r90", "r93", "r95", "r101", "r102", "r103", "r122", "r131", "r135", "r136", "r137", "r140", "r141", "r150", "r151", "r153", "r157", "r234", "r313" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails", "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Total forward purchase units (in Shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r130", "r280", "r294" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsDisclosureTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.", "label": "Commitments Disclosure [Text Block]", "terseLabel": "COMMITMENTS" } } }, "localname": "CommitmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r70", "r71", "r223" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding", "terseLabel": "Stock subject to possible redemption" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r163" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r256" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 100,000,000 shares authorized; 10,350,000 at September 30, 2021 and December 31, 2020" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r106", "r288" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r62", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r142", "r144", "r145", "r243", "r244", "r245" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Percentage of redemption of public shares" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r28", "r126" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred Offering Costs", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r221", "r226" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "WARRANT LIABILITY" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r31", "r32", "r33", "r233" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Warrant liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r68", "r216", "r217", "r218", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Warrant and FPA Liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesReportingOfDerivativeActivity": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.", "label": "Derivatives, Reporting of Derivative Activity [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesReportingOfDerivativeActivity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net income (loss) per share, redeemable common stock (in Dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r96", "r98" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net income (loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r66", "r191", "r198" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r37", "r38", "r39", "r70", "r71", "r72", "r74", "r81", "r84", "r100", "r123", "r163", "r165", "r184", "r185", "r186", "r196", "r197", "r223", "r236", "r237", "r238", "r239", "r240", "r241", "r296", "r297", "r298", "r318" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_ExcessStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders.", "label": "Excess Stock, Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "ExcessStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ExcessStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of excess stock held by shareholders.", "label": "Excess Stock, Shares Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "ExcessStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense related to distribution, servicing and underwriting fees.", "label": "Expense Related to Distribution or Servicing and Underwriting Fees", "terseLabel": "Underwriting fees" } } }, "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r53", "r146" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Changes in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow", "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r227", "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of company's assets and liabilities" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r143", "r144", "r145", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r228", "r260", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r143", "r169", "r170", "r175", "r177", "r228", "r260" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r143", "r144", "r145", "r169", "r170", "r175", "r177", "r228", "r261" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r143", "r144", "r145", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r228", "r262" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)", "terseLabel": "Change in valuation inputs or other assumptions", "verboseLabel": "Loss on change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinthefairvalueoftheFPAliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalDepositInsuranceCorporationPremiumExpense": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.", "label": "Federal Deposit Insurance Corporation Premium Expense", "terseLabel": "Federal depository insurance coverage (in Dollars)" } } }, "localname": "FederalDepositInsuranceCorporationPremiumExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.", "label": "Income (Loss) from Continuing Operations, Per Basic and Diluted Share", "terseLabel": "Basic and diluted net income (loss) per common share" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r36", "r189", "r190", "r192", "r193", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r50", "r57" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Franchise taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r52" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r52" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r127", "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Net tangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeSecuritiesOtherUSGovernment": { "auth_ref": [ "r284" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest income on securities issued by US government agencies not including US Treasury Securities.", "label": "Interest Income, Securities, Other US Government", "terseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InterestIncomeSecuritiesOtherUSGovernment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r42", "r112" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Total assets" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r65", "r116", "r122", "r131", "r132", "r133", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r206", "r210", "r211", "r234", "r254", "r255" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r65", "r122", "r234", "r256", "r279", "r293" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r25", "r65", "r122", "r131", "r132", "r133", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r206", "r210", "r211", "r234", "r254", "r255", "r256" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.", "label": "Liabilities, Fair Value Adjustment", "terseLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesNoncurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as noncurrent.", "label": "Marketable Securities, Noncurrent", "terseLabel": "Marketable securities held in Trust Account" } } }, "localname": "MarketableSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Marketable securities held in Trust Account [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcompanysassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r49" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r49" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r51", "r54" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r34", "r35", "r39", "r40", "r54", "r65", "r73", "r75", "r76", "r78", "r79", "r83", "r84", "r91", "r113", "r114", "r117", "r118", "r120", "r122", "r131", "r132", "r133", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r225", "r234", "r282", "r295" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Income (Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r75", "r76", "r78", "r79", "r86", "r87", "r92", "r95", "r113", "r114", "r117", "r118", "r120" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1": { "auth_ref": [ "r58", "r59", "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Payables Assumed", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "NoncashOrPartNoncashAcquisitionPayablesAssumed1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestExpenseOfferingCost": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.", "label": "Noninterest Expense Offering Cost", "terseLabel": "Other offering cost" } } }, "localname": "NoninterestExpenseOfferingCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoteWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue.", "label": "Note Warrant [Member]", "terseLabel": "Warrant Liabilities [Member]" } } }, "localname": "NoteWarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r22", "r67", "r250" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Promissory note \u2013 related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "terseLabel": "Operating and formation costs" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r113", "r114", "r117", "r118", "r120" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r3", "r215" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of other assets.", "label": "Other Assets, Fair Value Disclosure", "periodEndLabel": "Fair value, June 30, 2021", "periodStartLabel": "Fair value, April 21, 2021" } } }, "localname": "OtherAssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinthefairvalueoftheFPAliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "totalLabel": "Total other income, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering": { "auth_ref": [ "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "The number of units sold in a public offering of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners.", "label": "Partners' Capital Account, Units, Sold in Public Offering", "terseLabel": "Sale of units" } } }, "localname": "PartnersCapitalAccountUnitsSoldInPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r47" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToInvestInDecommissioningFund": { "auth_ref": [ "r43" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the purchase of investments that will be held in a decommissioning trust fund.", "label": "Payments to Acquire Investments to be Held in Decommissioning Trust Fund", "negatedLabel": "Investment of cash in Trust Account" } } }, "localname": "PaymentsToInvestInDecommissioningFund", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11", "r150" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)", "verboseLabel": "Prefered stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r11", "r150" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11", "r256" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r18", "r19" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Gross proceeds from proposed public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r44" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from sale of Units, net of underwriting discounts paid" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r44" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from sale of Private Placement Warrants", "verboseLabel": "Aggregate purchase price" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "negatedLabel": "Proceeds allocated to Public Warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r45" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from promissory note - related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r34", "r35", "r39", "r48", "r65", "r73", "r83", "r84", "r113", "r114", "r117", "r118", "r120", "r122", "r131", "r132", "r133", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r204", "r208", "r209", "r213", "r214", "r225", "r234", "r285" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r176", "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r176", "r248", "r249", "r251" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r176", "r248", "r251", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r246", "r247", "r249", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r46" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of promissory note \u2013 related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r165", "r187", "r256", "r292", "r300", "r305" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAppropriated": { "auth_ref": [ "r30", "r64", "r148", "r149", "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies.", "label": "Retained Earnings, Appropriated", "terseLabel": "Retained Earnings (Accumulated deficit)" } } }, "localname": "RetainedEarningsAppropriated", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r70", "r71", "r72", "r74", "r81", "r84", "r123", "r184", "r185", "r186", "r196", "r197", "r223", "r296", "r298" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings / (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Amount of sponsor paid" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Aggregate of purchase shares (in Shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "netLabel": "Price per share (in Dollars per share)", "terseLabel": "Share price (in Dollars per share)", "verboseLabel": "Common stock price per share (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.", "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]", "terseLabel": "Schedule of changes in fair value of private and public warrant liabilities" } } }, "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of calculation of basic and diluted net income (loss) per common share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "auth_ref": [ "r75", "r76", "r77", "r80", "r81", "r83", "r84", "r99" ], "lang": { "en-us": { "role": { "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "auth_ref": [ "r82", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.", "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Schedule of financial statements" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of black scholes option pricing model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).", "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "terseLabel": "Schedule of common stock subject to redemption" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuritiesBorrowed": { "auth_ref": [ "r31", "r32", "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after the effects of master netting arrangements, of securities borrowed from entities in exchange for collateral. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Securities Borrowed", "terseLabel": "Borrowed amount" } } }, "localname": "SecuritiesBorrowed", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Business Combination [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r52" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Loss on initial issuance of private warrants" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "netLabel": "Common stock equals or exceeds per share", "terseLabel": "Purchase price per unit (in Dollars per share)", "verboseLabel": "Purchase price per share (in Dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r181", "r188" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Number of units issued (in Shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued price per share (in Dollars per share)", "verboseLabel": "Warrant price per share (in Dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.", "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]", "terseLabel": "Common Stock Subject to Possible Redemption" } } }, "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r61", "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SponsorFees": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.", "label": "Sponsor Fees", "terseLabel": "Sponsor total amount" } } }, "localname": "SponsorFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r10", "r11", "r12", "r63", "r65", "r88", "r89", "r90", "r93", "r95", "r101", "r102", "r103", "r122", "r131", "r135", "r136", "r137", "r140", "r141", "r150", "r151", "r153", "r157", "r163", "r234", "r313" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails", "http://www.northerngenesisacquisitioncorp.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r27", "r37", "r38", "r39", "r70", "r71", "r72", "r74", "r81", "r84", "r100", "r123", "r163", "r165", "r184", "r185", "r186", "r196", "r197", "r223", "r236", "r237", "r238", "r239", "r240", "r241", "r296", "r297", "r298", "r318" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3", "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r70", "r71", "r72", "r100", "r264" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r163", "r165" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock to Sponsor (in Shares)", "verboseLabel": "Aggregate shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r11", "r12", "r163", "r165" ], "lang": { "en-us": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "terseLabel": "Shares subject to forfeiture (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r163", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock to Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r15", "r16", "r65", "r121", "r122", "r234", "r256" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet", "http://www.northerngenesisacquisitioncorp.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r38", "r65", "r70", "r71", "r72", "r74", "r81", "r122", "r123", "r165", "r184", "r185", "r186", "r196", "r197", "r202", "r203", "r212", "r223", "r234", "r236", "r237", "r241", "r297", "r298", "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Total Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleoffinancialstatementsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r64", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r165", "r167" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event, Description", "terseLabel": "Subsequent event, description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r242", "r258" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r242", "r258" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r242", "r258" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r257", "r259" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails", "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://www.northerngenesisacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.northerngenesisacquisitioncorp.com/role/PublicOfferingDetails", "http://www.northerngenesisacquisitioncorp.com/role/RelatedPartyTransactionsDetails", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofchangesinfairvalueofprivateandpublicwarrantliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r58", "r59", "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Supplemental Deferred Purchase Price", "terseLabel": "Aggregate purchase price" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/CommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "auth_ref": [ "r9", "r278", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.", "label": "Taxes Payable", "terseLabel": "Franchise taxes payable" } } }, "localname": "TaxesPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Accretion of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r131", "r135", "r136", "r137", "r140", "r141" ], "calculation": { "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Common stock subject to possible redemption 41,400,000 and 0 shares at redemption value at September 30, 2021 and December 31, 2020, respectively", "verboseLabel": "Class A common stock subject to possible redemption" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedBalanceSheet", "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofclassAcommonstockreflectedinthecondensedconsolidatedbalancesheetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Allocation of net income (loss), as adjusted" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ScheduleofcalculationofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r7", "r147" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Common stock subject to possible redemption" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r104", "r105", "r107", "r108", "r109", "r110", "r111" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Basic and diluted weighted average shares outstanding, Common Stock (in Shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.northerngenesisacquisitioncorp.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r129": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21332-112643" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21346-112643" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r259": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(23)(a)(4)(i))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(30)(a)(3)(ii))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r308": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r309": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r310": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r311": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r312": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r313": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r314": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r315": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "i", "Publisher": "SEC", "Section": "3", "Subsection": "10" }, "r316": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" } }, "version": "2.1" } ZIP 60 0001213900-21-061727-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-061727-xbrl.zip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�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end

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